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Summary 
Wastewater treatment plants throughout Europe are retrofitted for a sufficient 
removal of micropollutants. Most target compounds are eliminated efficiently at 
reasonable costs by oxidation. Sorption processes, on the other hand, are favored as 
no transformation products are formed. For oxidation, ozone is preferred presently. 
Its action is divided in two main reaction pathways: Via ozone and via 
hydroxyl radicals formed by ozone-matrix reactions. Oxidation efficiency strongly 
depends on reaction rate constants. Sorption processes are usually characterized, 
including sorption strength, by determination of isotherms. Also, for description of 
filtration processes isotherm data are necessary.  
So far, gadolinium chelates, used as contrast agents in magnetic resonance imaging, 
have not been investigated in both advanced wastewater treatment processes. The 
stable chelates are excreted without metabolization. Conventional wastewater 
treatment does not remove them substantially. They remain intact and no free Gd(III) 
is released. This may be changed due to oxidative treatment which potentially 
destroys the chelates, and Gd(III) ions which are toxic, contrary to the chelated form, 
may be liberated. 
Monitoring campaigns in wastewater and drinking water have been performed to 
demonstrate the relevance of gadolinium in such treatment steps. In a European 
monitoring campaign an average concentration of 118 ng L-1 gadolinium has been 
determined for 75 wastewater treatment plants effluents, corresponding to a 
non-geogenic gadolinium concentration of 116 ng L-1. In drinking water in the Ruhr 
area, a densely populated region in Germany, gadolinium and the anomaly were 
measurable by a factor of five lower than the average in the investigated wastewater 
samples. The determined concentrations in drinking water are lower than acute toxic 
effect concentration. The speciation of gadolinium in the investigated samples is 
unknown, as only total element concentration has been determined, however, it is 
strongly assumed that the anthropogenic gadolinium fraction is present as chelate.  
Adsorption characteristics were evaluated by bottle point isotherm experiments on 
different activated carbon types and activated polymer based sorbents. The 
Freundlich coefficients vary between 0.013 and 2.83 (µmol kg-1)(L µmol-1)1/n for 
Gd-BT-DO3A, on Chemviron RD 90® and on the best synthetic adsorbent, 
II 
 
respectively. Lab scale experiments with small adsorber columns in a drinking water 
matrix gave insight in the behavior during fixed-bed adsorption processes. The 
breakthrough was described successfully by the Linear Driving Force model. 
Modeling has shown that a description of experimental results is only possible by 
including dissolved organic carbon isotherm results from drinking water in the model, 
to describe an additional competitive adsorption effect within the fixed-bed adsorber, 
different from direct competition. First investigations in a wastewater treatment plant 
proved a poor adsorption of gadolinium similar to iodinated X-ray contrast media 
such as iopamidole. Therefore, gadolinium will hardly be removed from wastewater 
by implementation of a further adsorptive treatment step. However, gadolinium may 
be utilized as indicator substance for breakthrough. 
Rate constants of the chelates with ozone and hydroxyl radicals have been 
determined under pseudo-first-order conditions. Rate constants for the ozone 
reaction were determined to be < 50 M-1 s-1 for all tested chelates. Hence, the 
chelates may be considered ozone refractory. For determination of hydroxyl radical 
rate constants different methods were applied. Radicals were generated either by 
pulse radiolysis, in this case rate constant were determined directly and by 
competition with thiocyanate, or by the peroxone process, where only competition 
kinetics were applied (para-chlorobenzoic acid and tert-butanol as competitors). From 
pulse radiolysis determinations (rate constants > 109 M-1 s-1) it is concluded that a 
reaction in wastewater via hydroxyl radicals is possible. No toxic transformation 
products were detected in the applied cytotoxicity, genotoxicity and estrogenity tests. 
Concerning the speciation of gadolinium after oxidation, it is suggested that 
gadolinium ions form new chelates with ligands formed during oxidation. These new 
chelates may be less stable than the original chelates which benefits transmetalation. 
This process is also of interest for other chelates present in a water matrix.  
In this study it could be demonstrated, that gadolinium is not removed efficiently by 
the investigated treatment steps. Research on effects of oxidative treatment on 
metal-organic species is recommended, especially in cases, where the metal ion is 
toxic. 
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Kurzfassung 
Zurzeit werden in ganz Europa Kläranlagen mit zusätzlichen Aufbereitungsstufen 
ausgerüstet, um Spurenstoffe besser zu entfernen. Die meisten Spurenstoffe werden 
durch Oxidation kostengünstig entfernt. Sorptionsprozesse werden hingegen 
bevorzugt, da keine Transformationsprodukte entstehen. Der Reaktionsweg des für 
die Oxidation präferierten Ozons wird in Pfade über Ozon und über Hydroylradikale, 
die durch Ozon-Matrix Reaktionen entstehen, geteilt. Die Oxidationseffizienz hängt 
stark von den Reaktionsgeschwindigkeiten der Stoffe ab. Sorptionsprozesse werden 
üblicherweise durch Sorptionsisothermen beschrieben, einschließlich der 
Sorptionsstärke. Zur Beschreibung von Filtrationsprozessen sind ebenfalls 
Isothermendaten notwendig. 
Bisher wurde das Verhalten von Gadolinium Chelaten, die als Kontrastmittel in der 
Magnetresonanztomographie verwendet werden, nicht in den genannten 
Aufbereitungsstufen untersucht. Die stabilen Chelate werden unmetabolisiert 
ausgeschieden und nur unzureichend in konventionellen Kläranlagen entfernt. Sie 
bleiben intakt und Gd(III) wird nicht freigesetzt. Dies könnte durch oxidative 
Verfahren geändert werden, da diese potentiell in der Lage sind Chelate zu zerstören 
und Gd(III), das im Gegensatz zu der Chelatform toxisch ist, freizusetzen. 
Untersuchungen in Trink- und Abwasser wurden durchgeführt, um die Relevanz von 
Gadolinium in den Aufbereitungsstufen zu zeigen. In einer europaweiten Studie 
wurde in 75 Kläranlagen eine durchschnittliche Konzentration von 118 ng L-1 
Gadolinium ermittelt, was einer nicht-geogenen Konzentration von 116 ng L-1 
entspricht. Im Trinkwasser aus dem Ruhrgebiet wurde eine fünfmal geringere 
Gadolinium Konzentration und Anomalie ermittelt als in den untersuchten 
Abwasserproben. Die im Trinkwasser bestimmten Konzentrationen sind geringer als 
akute Toxizitätskonzentrationen. Die Speziation des Gadoliniums in den 
untersuchten Proben wurde nicht bestimmt, jedoch wird angenommen, dass die 
anthropogene Gadoliniumfraktion als Chelat vorliegt.  
Adsorptionseigenschaften wurden für unterschiedliche Aktivkohletypen und aktivierte 
Polymer-basierte Sorbentien ermittelt. Der Freundlich Koeffizient ist für Gd-BT-DO3A 
zwischen 0.013 und 2.83 (µmol kg-1)(L µmol-1)1/n bezogen auf Chemviron RD 90® und 
das am stärksten aktivierte synthetische Adsorbent. Laborversuche mit 
Kleinfiltersäulen, die mit Trinkwasser betrieben wurden, geben Einblick in das 
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Adsorptionsverhalten während der Festbett-Filtration. Das Durchbruchverhalten 
wurde anhand des Linear Driving Force Modells beschrieben. Um die 
experimentellen Daten zu beschreiben, wurden Isothermen des gelösten 
organischen Kohlenstoffs in das Modell integriert. Dadurch wurde ein Filtrations-
Kompetitionseffekt nachgewiesen, der sich von dem direkten Kompetitionseffekt 
unterscheidet. Erste Untersuchungen in einer Kläranlage verifizierten die schlechte 
Adsorbierbarkeit des Gadoliniums, die ähnlich der des Röntgen-Kontrastmittels 
Iopamidol ist. Daher wird Gadolinium aus Abwasser durch Adsorptionsstufen kaum 
entfernt werden. Jedoch kann Gadolinium als Indikatorsubstanz für die Ermittlung 
von Filterdurchbrüchen verwendet werden. 
Die Geschwindigkeitskonstanten der Reaktion der Chelate mit Ozon und 
Hydroxylradikalen wurden unter Bedingungen pseudo-erster Ordnung bestimmt. Die 
Konstante für die Reaktion mit Ozon ist für alle Chelate < 50 M-1 s-1. Daher können 
die Chelate als Ozon-refraktär bezeichnet werden. Zur Bestimmung von 
Geschwindigkeitskonstanten mit Hydroxylradikalen wurden verschiedene Methoden 
angewandt. Wurden die Radikale durch Pulsradiolyse erzeugt, erfolgte die 
Bestimmung der Geschwindigkeitskonstanten entweder direkt oder anhand einer 
Kompetition mit Thiocyanat. Bei einer Generierung der Radikale durch den Peroxon-
Prozess, erfolgte die Bestimmung nur durch Kompetitionskinetiken (mit 
para-Chlorbenzoesäure und tert-Butanol). Die Ergebnisse der Pulsradiolyse 
Bestimmungen (Geschwindigkeitskonstanten > 109 M-1 s-1) zeigen, dass eine 
Reaktion mit Hydroxylradikalen im Abwasser möglich ist. Die Reaktionsprodukte der 
Oxidationen zeigten keinen Effekt in den angewandten Zell- und Gentoxizitätstests, 
sowie dem Östrogenitätstest. Hinsichtlich der Speziation des Gadoliniums wird 
angenommen, dass neue Chelate gebildet werden, die jedoch weniger stabil sein 
können, was eine Transmetallierung begünstigt. Dies ist auch für andere Chelate in 
der Wasseraufbereitung von Interesse. 
In dieser Studie konnte erstmalig gezeigt werden, dass Gadolinium kaum durch die 
untersuchten Aufbereitungsstufen entfernt wird. Der Effekt der oxidativen 
Aufbereitung auf metall-organische Spezies, bedarf jedoch weiterer Untersuchung, 
insbesondere in Fällen in denen das freie Metallion als toxisch gilt. 
 
 
Table of Content 
Summary .................................................................................................................... I 
Kurzfassung ............................................................................................................. III 
1 General Introduction ......................................................................................... 1 
1.1 Preface ............................................................................................................ 1 
1.2 Gadolinium in medical diagnostics ................................................................... 3 
1.2.1 Gadolinium chelates in magnetic resonance imaging ............................... 3 
1.2.2 Magnetic resonance imaging and contrast enhancement ......................... 5 
1.3 Characteristics of Gadolinium-Diagnostics ...................................................... 7 
1.4 Water treatment processes ............................................................................ 12 
1.4.1 Overview on water treatment processes ................................................. 12 
1.4.2 Ozonation of water .................................................................................. 15 
1.4.3 Adsorption processes in water treatment ................................................ 22 
1.5 Scope ............................................................................................................. 24 
1.6 Supplement .................................................................................................... 26 
1.7 References .................................................................................................... 27 
2 Important aspects in the determination of gadolinium in aquatic samples 35 
2.1 Introduction .................................................................................................... 35 
2.2 Methods ......................................................................................................... 39 
2.2.1 Chemicals and Materials ........................................................................ 39 
2.2.2 ICP-MS ................................................................................................... 40 
2.2.3 Spectral data ........................................................................................... 41 
2.2.4 Interactions with glass ............................................................................ 41 
2.2.5 HILIC-ICP-MS ......................................................................................... 42 
2.2.6 Sample preconcentration ........................................................................ 43 
2.3 Results and discussion .................................................................................. 46 
2.3.1 Spectral data ........................................................................................... 46 
2.3.2 Interactions with glass ............................................................................ 46 
2.3.3 Determination of complexes with HILIC-ICP-MS .................................... 48 
2.3.4 Sample preconcentration ........................................................................ 52 
2.4 Conclusions ................................................................................................... 55 
2.5 Supplement .................................................................................................... 57 
2.6 Literature ........................................................................................................ 58 
3 Occurrence of gadolinium in the water cycle ............................................... 63 
3.1 Introduction .................................................................................................... 63 
3.2 Experimental .................................................................................................. 69 
3.2.1 Sampling ................................................................................................. 69 
3.2.2 Instrumentation ....................................................................................... 70 
3.2.3 Calculation of the anomaly...................................................................... 70 
3.3 Results ........................................................................................................... 72 
3.4 Conclusion ..................................................................................................... 82 
 
 
 
 
3.5 Supplement .................................................................................................... 84 
3.5.1 Detailed results of the pan-European study ............................................ 84 
3.5.2 Detailed results of the gadolinium anomaly in the Ruhr area .................. 88 
3.6 References .................................................................................................... 89 
4 Adsorption of gadolinium-based diagnostics in water treatment ............... 95 
4.1 Introduction .................................................................................................... 95 
4.2 Experimental .................................................................................................. 98 
4.2.1 Chemicals and Materials ........................................................................ 98 
4.2.2 Adsorption experiments .......................................................................... 99 
4.2.3 Measurements ...................................................................................... 102 
4.2.4 Modeling of fixed-bed filters .................................................................. 102 
4.3 Results and discussion ................................................................................ 104 
4.4 Conclusion ................................................................................................... 111 
4.5 Supplement .................................................................................................. 112 
4.5.1 Description of the wastewater treatment plant ...................................... 112 
4.5.2 Modeling input parameters ................................................................... 113 
4.5.3 Use of the gadolinium anomaly in filter experiments in a wastewater 
treatment plant ................................................................................................ 114 
4.6 References .................................................................................................. 117 
5 Reaction of Gadolinium Chelates with Ozone and Hydroxyl Radicals ..... 121 
5.1 Introduction .................................................................................................. 121 
5.2 Experimental ................................................................................................ 123 
5.2.1 Reagents .............................................................................................. 123 
5.2.2 Rate constants ...................................................................................... 124 
5.2.3 Toxicity tests ......................................................................................... 127 
5.3 Results and discussion: ............................................................................... 129 
5.4 Conclusion ................................................................................................... 140 
5.5 Supplement .................................................................................................. 141 
5.5.1 Details for determination of rate constants ........................................... 141 
5.5.2 Estrogenity tests ................................................................................... 146 
5.6 Literature ...................................................................................................... 148 
6 Concluding Remarks and Future Perspectives .......................................... 153 
6.1 References .................................................................................................. 157 
7 Appendix ........................................................................................................ 159 
7.1 Abbreviations ............................................................................................... 159 
7.2 List of publications ....................................................................................... 165 
7.3 Curriculum Vitae .......................................................................................... 167 
7.4 Erklärung ..................................................................................................... 169 
7.5 Acknowledgment.......................................................................................... 171 
 
1 
 
1 General Introduction 
1.1 Preface 
Gadolinium is a rare earth element (REE) which is widely used in applications such 
as radar technologies, compact discs, microwaves and many more. However, since 
the 1980`s there is another very important application of gadolinium. It is used as 
contrast agent in medical diagnostics because of its paramagnetic properties. The 
application of gadolinium diagnostics has been very successful. Only considering the 
time between 1998 and 2008 its applications worldwide increased almost tenfold 
(1998: 20 million applications worldwide [1]); 2008: 150-180 million applications 
worldwide [2]).  
There are no numbers available on the production volume for gadolinium. However, 
estimations of Angerer et al. [3] point out an annual production volume of 4500 t 
gadolinium in the year 2006. Based on the assumption that 1.2 g Gd are used for 
each application in diagnostics [4], this specific consumption amounts to ca. 5% 
(180-220 t Gd / y-1) of the total gadolinium produced. Yet, one has to consider that 
the gadolinium diagnostics are excreted mainly unmetabolized from the body [5] and 
reach the sewage system. In conventional wastewater treatment plants (WWTPs) 
gadolinium diagnostics are not effectively removed [4, 6] and enter the environment 
and potentially drinking water. In 1999, 1,100 kg Gd were emitted to the environment 
in Germany [7], which is ca. 5% of the total amount of gadolinium used for 
diagnostics worldwide. By extrapolation of all these numbers (7.5 fold increase 
in 10 y in applications related to 1998 (→ 225 million applications y-1 worldwide in 
2013), 4.6% of all applications in Germany, use of 1.2 g Gd per application) in 
Germany in 2013, ca. 12 t Gd / y-1 are used for this purpose and consequently 
released via the sewage system to the environment. An Impact on the aquatic 
environment from other gadolinium applications is rather unlikely. Other applications 
of gadolinium (see above) usually incorporate gadolinium into a material, which is not 
disposed via the sewage system. Only illegal dumps and a subsequent leaching may 
contribute to a further anthropogenic impact on the aquatic environment.  
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The gadolinium diagnostics are not toxic. However, water treatment processes might 
change the speciation of gadolinium and a toxicological relevant species can 
potentially be formed. Its increasing use in diagnostics and the potential of species 
transformation aroused concern on its prevalence in the water cycle. This study gives 
insight in the behavior of gadolinium diagnostics in advanced water treatment 
technologies. 
For a comprehensive overview of the motivation of this work, background information 
on water treatment and gadolinium chelates will be given in the following introductive 
chapters. First the function of gadolinium diagnostics will be explained, to understand 
their necessity in medical diagnostics (cf. chapter 1.2). Furthermore, chemical and 
physical properties as well as basic toxicological data of the diagnostics will be 
presented (cf. chapter 1.3). These data are necessary to predict and understand 
environmental behavior and consequently environmental effects. Subsequently, 
details on water treatment will be presented (cf. chapter 1.4). The overall scope of 
this study is to give information on the behavior of gadolinium diagnostics during 
advanced water treatment processes, in detail oxidation and adsorption. For the 
evaluation of oxidation reactions in water treatment it is necessary to have knowledge 
on the kinetics of such reactions. In chapter 1.4.2, an explanation of the kinetic 
concept which is used in this study is given. For characterization of sorption 
processes isotherms are used. Different isotherms are used to describe sorption 
processes. A short introduction on sorption isotherms and their relevance for 
evaluation in water treatment is presented in chapter 1.4.3.  
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1.2 Gadolinium in medical diagnostics 
1.2.1 Gadolinium chelates in magnetic resonance imaging 
Gadolinium chelates are applied in medical diagnostics for contrast enhancement in 
magnetic resonance imaging (MRI). However, contrast enhancing elements, such as 
gadolinium, are toxic in concentrations needed for clinical imaging [8]. The general 
mechanism of metal toxicity is coordination of the metal to donating groups in 
bio-macromolecules, e.g. proteins, and subsequently a modified molecular 
structure [8]. By such a coordination, membrane function or enzyme activity can be 
disturbed [8]. In case of Gd(III), voltage-gated calcium channels are blocked in the 
range of a few ng kg-1 to a few µg kg-1, as Gd(III) has a similar ion radius as 
Ca(II) (107.8 pm and 114 pm, respectively) [1]. Hence, physiological processes, 
dependent on Ca(II) fluxes, are inhibited, e.g. contraction of smooth, skeletal and 
cardiac muscle, transmission of nervous influx or blood coagulation [1].  
Due to these effects gadolinium is applied in a chelated form. Magnevist® (Gd-DTPA) 
was first introduced to the market, followed by other linear chelates (Gd-DTPA-BMA 
and Gd-BOPTA) and later by the macrocyclic chelates Gd-BT-DO3A and 
Gd-DOTA [5]. Up to date, in Germany nine chemically different gadolinium 
diagnostics are licensed (cf. Figure 1.1). 
By complexation of Gd(III) its toxicity is reduced remarkably. The lethal dosage for 
50% of a population (LD50), in this case for rats, is increasing from 0.1 mmol kg
-1 (for 
GdCl3) to 14 mmol kg
-1, when gadolinium is complexed with DTPA-BMA [8]. Factors 
influencing the toxicity of the element species are among others solubility, selectivity 
and osmolality. Data on these parameters are given for all gadolinium chelates in the 
following chapter (cf.chapter 1.3).  
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Figure 1.1: Gadolinium diagnostics licensed in Germany; below each molecule the molecular weight 
is given; first row: macrocyclic extracellular fluid agents (ionic and non-ionic); second row: linear 
extracellular fluid agents (ionic and non-ionic); third row: organ specific contrast agents (Gd-BOPTA 
and Gd-EOP-DTPA) and albumin-binding blood pool agent (Gd-MS-325); first row ligands are DOTA 
or DOTA-like; second and third row ligands are DTPA or DTPA-like 
Complexation as precautionary measure seems to be insufficient in certain cases. 
In 1996 the disease nephrogenic systemic fibrosis (NSF) was reported for the first 
time and soon afterwards linked to the application of gadolinium based contrast 
agents [9, 10]. Up to date, there are more than 190 biopsy-proven cases published in 
peer-reviewed journals [9]. All NSF patients suffered, prior to application of the 
diagnostics, from severe or even end-stage renal failure [10]. Most of these cases are 
linked to Gd-DTPA-BMA (82%) [9, 11]. Symptoms, which may vary in severity, are a 
formation of excess skin tissue (skin fibrosis) and fibrosing of other organs [12-14]. 
The mechanism responsible for NSF is assumed to be triggered by transmetalation 
of the gadolinium chelates, resulting in a release of free Gd(III) and consequently 
interactions of Gd(III) with biomolecules [9, 11, 15].  
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1.2.2 Magnetic resonance imaging and contrast enhancement 
MRI is widely used for imaging anatomical structures. Three-dimensional (3D) 
images of living organisms can be obtained by this method without using ionizing 
radiation, as in X-ray methods (e.g. computer tomography (CT), computed axial 
tomography (CAT), or positron emission tomography (PET). The obtained images are 
used for the identification of malfunctional tissue. 
MRI has to be understood, to understand the way the diagnostics work. It is generally 
speaking the medical application of nuclear magnetic resonance (NMR), which is 
used in analytical chemistry most commonly for the determination of molecular 
structures. NMR (including MRI) is based on the spin of atoms. The magnetic field of 
the nuclei is dependent on direction and speed of the rotation. The spin of the nuclei 
can be determined by measuring the magnetic moment of the nuclei, yielding a 
discrete value. The Pauli-Principle states that spins are usually present as couples 
with opposite direction. Atoms with an odd number of protons have an overall spin 
which is not equal to zero. These are of special interest for NMR spectroscopy. For 
MRI, especially hydrogen atoms are relevant, as their magnetic moment is rather 
high and they are the most frequent atoms in living organisms [16]. 
The average magnetic moment of the protons is aligned to magnetic field direction by 
application of an external magnetic field. An additional radio frequency yields a 
varying electromagnetic field. The resulting resonance frequency energy can be 
absorbed and changes the proton spin in the magnetic field. Without this 
electromagnetic field, the spins return to the thermodynamic equilibrium and overall 
magnetization becomes aligned with the static magnetic field. This relaxation 
generates a radio frequency signal which can be measured. [17]  
Different paramagnetic substances, which are characterized by unpaired electrons, 
e.g. Mn(II), Mn(III), Fe(III), Cu(II), and Gd(III), are applied in MRI to increase the 
signal strength and consequently the contrast [16]. Gadolinium with its high number 
of unpaired electrons (7 unpaired electrons) and its ability to efficiently influence 
nearby nuclei as well, is the most important element for MRI diagnostics [16].  
The electrons of the contrast agent are also influenced by the magnetic field applied 
in MRI. The magnetic moment of the electrons is aligned to the magnetic field. 
However, the magnetic moment of the electrons is ~680 fold larger than the one of 
protons [18]. Hence, protons in vicinity are influenced by the electrons. In case of 
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Gd(III), the unpaired electrons are inducing the relaxation of water molecules in MRI. 
By this, it decreases the spin-lattice relaxation time (T1) and spin-spin relaxation 
time (T2) [8]. The longitudinal and transverse relaxation rates (1/T1 and 1/T2, 
respectively) are both influencing the observed solvent relaxation rate (Tobs), as this 
is the sum of the diamagnetic (subscript dia) and paramagnetic spin (subscript 
para) [19]: 
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Gadolinium diagnostics are best suitable for T1 weighted imaging, as the percentage 
change in 1/T1 in tissue is greater than that in 1/T2 [5]. T1 weighted imaging is most 
prominent in MRI applications, as advances in MRI development have favored this 
method [5]. The paramagnetic fraction is dependent on the concentration of the 
paramagnetic species [19]: 
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Furthermore, paramagnetic relaxation enhancement is divided into two components, 
the inner-sphere and the outer-sphere relaxation [19]: 
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   (1.3) [19] 
For inner-sphere relaxation the water molecule has to be bound directly to the metal 
or via hydrogen bonds. Outer-sphere relaxation refers to molecules which pass the 
chelate (translational diffusion) [19]. The distance of the closest approach of 
outer-sphere water molecules and the diffusional correlation time of outer-sphere 
water molecules contribute, among others, to relaxivity, especially if the chelate 
contains no inner-sphere water molecules [16]. However, these contributions are 
usually very small when inner-sphere water molecules are present and are hence 
negligible for Gadolinium contrast agents [20]. Inner-sphere relaxation is influenced 
by factors such as the number of inner-sphere water molecules, residence life time of 
inner-sphere water molecules, and rotational tumbling time [16]. All of these factors 
are considered, when a ligand for chelating the Gd(III) is designed [20], to yield a final 
product which is sufficiently increasing relaxation rates and consequently enhancing 
contrast between healthy and ailing tissue.  
7 
 
1.3 Characteristics of Gadolinium-Diagnostics 
Information on the general properties on the gadolinium chelates was compiled. 
Other metal-ligand systems were investigated to enable a comparison between the 
different systems in order to deduct certain properties for the gadolinium chelates. In 
detail, stability of the chelates, which is of great importance for estimation of the 
toxicity and reactivity of the chelates, rate constants for the reaction of different 
metal-ligand systems with hydroxyl radicals and ozone have been compiled for 
comparison. This information is used to estimate behavior during the water treatment 
processes which are investigated. Hence, these data are required for the 
experimental design. These data are presented in Table 1.1. It is notable, that there 
is a difference between the thermodynamic stability constant and the conditional 
stability constant at a physiological pH (pH = 7.4) [5, 10]. The stability constants differ 
by pH dependency. The thermodynamic stability constant is defined as follows [21]:  
[M][L]
[ML]
KMLLM ML         (1.4) 
The conditional stability constant may be calculated, by using the dissociation 
constants (K1, K2, K3, ... , Kn) as follows [5]: 
 n
n21
2
211
ML
ML,
][H...KKK...][HKK][HK1
K
K
 
cond     (1.5) 
The conditional stability constant (at pH 7.4) is lower than the thermodynamic stability 
constant for the gadolinium chelates [5]. (For a comparison of thermodynamic and 
conditional stability constants cf. 1.6) 
Furthermore, data presented in Table 1.2 is of interest for characterization of the 
behavior of gadolinium diagnostics in medicine as well as in environment and water 
treatment. Data on osmolarity is of great importance for estimation of physiological 
complications which may appear due to administration of the chelates, e.g. 
intracellular dehydration, crenation of erythrocytes, and coma [8]. Relaxivity is the 
most important factor for description of the suitability as contrast agent 
(cf. chapter 1.2). In general, the contrast enhancing effect is increasing with 
increasing relaxivity. The octanol / water partitioning coefficient (POW) is important 
indicator for the description of environmental behavior. As this data was not available 
for the gadolinium chelates and estimations by calculations (based on SMILES 
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notations) are unreliable, especially for molecules containing amine groups, another 
partitioning coefficient is shown. The butanol / water partitioning coefficient 
(PButanol/Water) differs from the POW by the higher water solubility of butanol. Water 
solubility might be estimated by using the PButanol/Water. Furthermore it gives indices on 
molecules sorption affinity on various matters. 
Toxicity of gadolinium and its chelates is dependent on its speciation. In general, the 
toxicity of Gd(III) is decreasing by chelation. Also, the toxicity of the ligand is 
decreasing (e.g. LD50 for HP-DO3A is 0.1 mmol kg
-1 and 12 mmol kg-1 for 
Gd-HP-DO3A [8]). In Table 1.3 toxicity data on gadolinium and its chelates is 
presented. Additional to the LD50 also the half maximal Effective Concentration 
(EC50) for growth inhibition of fresh water algae and the No Observed Effect 
Concentration (NOEC) on the same algae are given. Both toxicological endpoints are 
recommended by the Organisation for Economic Co-operation and Development 
(OECD) for ecotoxicological assessment of chemicals [38].  
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In case of a lack of data on molecular properties, as well as on environmental 
behavior, different computational models are available to estimate such data. It has 
been considered to apply such models as the data on properties of the 
gadolinium chelates is incomplete. Popular tools for the estimation of substance 
properties and their behavior in the environment are 
Quantitative Structure-Activity Relationships (QSARs). Estimations made by these 
models include not only on physico-chemical properties, but also biological activity, 
biodegradation and –accumulation. The data provided are considered as reliable and 
have thus found their way into legal regulatory processes (e.g. EU Regulation 
concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals 
(REACH) recommends QSAR modeling for risk management). However, the 
essential input parameter for QSAR based models is the 
simplified molecular-input line-entry system (Smiles). This system enables to note 
any structure in a linear way, e.g. Diclofenac (cf. Figure 1.2). Yet, there is no rule for 
the notation of chelates which is accepted by common modeling programs such as 
EPIsuite (US EPA) or SPARC (ARChem). A notation of the ligand and the specific 
metal always results either in a covalent bond instead of a coordinated bond or the 
correct description is not accepted by the specific program. The suggested SMILES 
notation results in a wrongly displayed structure (cf. Figure 1.2). Hence, further 
estimations on toxicity and environmental processes by QSAR were not possible. 
Table 1.2: Physico-chemical data of gadolinium diagnostics; pKa is given for the ligands; *data are 
given for the medical solution which is different from the pure gadolinium chelate (excess ligand in 
formulation, e.g. (Omniscan: DTPA-BMA 12 g L
-1
 excess, Optimark: DTPA-BMEA 28.4 g L
-1
 excess, 
Magnevist (dimeglumine-Gd-DTPA): DTPA 0.4 g L
-1
 excess, Multihance: BOPTA 0.4 g L
-1
 
excess [39]), 
a
data given for a temperature of 37°C 
 
Osmolarity 
(mmol kg
-1
 
water) 
Relaxivity 
(T1 at 40°C 
and 20 MHz 
in mM
-1
s
-1
) 
Log 
PButanol/Water 
pKa (only for ligands)
 
GdCl3  11.3 [8]   
Gd-NTA    9.8, 2.6, 1.6 [40] 
Gd-EDTA  6.9 [41] -2.8 [42] 10.2, 6.1, 2.7, 2.6 [40] 
Gd-DTPA-BMA 789 [8]* 3.9 [8] -2.1 [8]* 9.4, 4.4, 3.3, 1.4 [43] 
Gd-HP-DO3A 630 [8]* 3.7 [8] -2.0 [5] 12, 9.4, 4.3, 3.3 [43] 
Gd-DOTA 1170 [8]* 3.5 [8]* -3.1 [8]* 11.4, 9.7, 4.5, 4.4 [43] 
Gd-DTPA 1940 [8]* 3.8 [8]* -3.2 [5]* 10.2, 8.6, 4.2, 2.9, 1.8 [43] 
Gd-DTPA-BMEA 1110 [1]* 4.7 [5]  9.3, 4.5, 3.3 [43] 
Gd-BOPTA 1970 [1]* 4.4 [44] -2.2 [5] 10.7, 8.3, 4.4, 2.8, 2.1 [44] 
Gd-BT-DO3A 1603 [1]* 3.7 [1] -2 [5]  
Gd-EOB-DTPA 688 [1]* 5.3 [1] -2.1 [5]  
Gd-MS325 825 [10]* 6.6 [5]
a 
-2.1 [5]  
Gd-DO3A  4.8 [5] -2.2 [42] 11.6, 9.2, 4.4, 3.5 [43] 
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Table 1.3: Toxicological data on different gadolinium chelates; *data are given for the medical solution 
which is different from the pure gadolinium chelate (excess ligand in formulation, e.g. (Omniscan: 
DTPA-BMA 12 g L
-1
 excess, Optimark: DTPA-BMEA 28.4 g L
-1
 excess, Magnevist 
(dimeglumine-Gd-DTPA): DTPA 0.4 g L
-1
 excess, Multihance: BOPTA 0.4 g L
-1
 excess [39]), 
a
 Data 
given for meglumine-Gd-EDTA; meglumine is an additive for some of the gadolinium diagnostics as 
well, e.g. Dotarem and Multihance 
Substance 
LD50 
mmol kg
-1
; mice 
EC50 
mg L
-1
 (mmol L
-1
); 
Algae test with 
Desmodesmus subspicatus 
NOEC 
mg L
-1
 (mmol L
-1
); 
Algae test with 
Desmodesmus subspicatus 
GdCl3 0.1 [8]  4.9 [18] 
DTPA 0.1 [8]   
DTPA-BMA 0.1 [8]   
DOTA 0.1 [8]   
HP-DO3A 0.1 [8]   
Gd-DTPA 5.6 (0.2) [30]* > 100 (0.18) [45]* 100 (0.18) [45]* 
Gd-DTPA-BMA 14.8 (0.7) [30]  20 (0.03) [18]* 
Gd-DOTA 15 [8]   
Gd-HP-DO3A 12 [8]  > 100 (0.18) [18] 
Gd-EDTA 0.3 (0.1) [30]
a 
  
Gd-DO3A 7-9 [5]   
Gd-BT-DO3A  > 937 (1.55) [45]* 937 (1.55) [45]* 
Gd-EOB-DTPA  > 500 (0.73) [45]* 120 (0.18) [45]* 
Gd-MS325  > 80 (0.08)[45]* 80 (0.08) [45]* 
 
 
 
Figure 1.2: Conversion of a metal chelate, in this case Gd-DTPA which is the active agent in 
Magnevist, into the SMILES notation and reconversion of the SMILES notation to the molecular 
structure by the same software (ChemDraw, Cambrige Software) 
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1.4 Water treatment processes 
1.4.1 Overview on water treatment processes 
Water treatment is generally divided into two major areas, drinking water treatment 
and wastewater treatment. Drinking water treatment processes are applied for raw 
waters of different quality. The matrix composition of the raw water mainly differs by 
the source of the raw water. In general, the use of ground water for drinking water 
production is preferred as surface waters are often more polluted. Important 
processes used for drinking water production are shown in Table 1.4. 
Table 1.4: Important processes in drinking water treatment 
Process Treatment objective 
Screening (Screen filters) Removal of solids 
Coagulation and flocculation Removal of colloids 
Filtration (Sand filtration or activated 
carbon filter, membrane filtration) 
Removal of suspended solids (inorganic and organic 
substances, including microorganisms, in case of activated 
carbon filtration also adsorption processes) 
Adsorption (activated carbon filtration) 
Adsorption of dissolved organic carbon (DOC), removal of 
color, odor, taste, micropollutants 
Oxidation (ozonation, chlorine 
treatment) 
Reduction of DOC, color, odor, taste, micropollutants and 
disinfection 
As an origin for surface water pollution the point source WWTP is of great 
importance. The treated wastewater is discharged into the receiving waters and all 
substances which are not retained by the wastewater treatment process enter the 
water cycle via this route. Important treatment steps which are applied in WWTPs are 
shown in Figure 1.3. In the last decades, detections of trace substances in surface 
and ground waters led to discussions on the efficiency of the wastewater treatment 
processes and subsequently additional treatment was proposed [46-48]. 
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Pharmaceuticals are of special concern as they have a biological effect. However, 
personal care products and industrial chemicals may also affect organisms. 
Endocrine disruptors are an example for such substances. The natural hormone 
17β-estradiol (E2) is one of the main female sex hormones. Its synthetic derivate 
17α-Ethinylestradiol (EE2) is used for contraception. EE2 has been found in the 
aquatic environment and concern about feminization of aquatic organisms arose [49, 
50]. However, not only EE2 was found to disrupt the endocrine systems of such 
organisms, but also other chemicals, such as nonylphenols, bisphenols, and 
polychlorinated biphenyls. These substances do not have an estrogenic effect as 
strong as the natural hormone which they mimic, but some are persistent and 
potentially accumulate in the environment [51, 52].  
 
Figure 1.3: Flow chart of a typical wastewater treatment plant 
It is discussed to retrofit wastewater treatment plants with advanced treatment steps 
to reduce concentrations of those substances with biological effects and / or 
persistent substances in surface waters [46-48]. Oxidative treatment steps, activated 
carbon treatment and membrane processes are discussed most widely [46, 48]. The 
application of these processes in drinking water production is common practice, 
especially ozonation and adsorption on activated carbon. The general mechanisms of 
these processes for the abatement of pollutants are the same for wastewater 
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treatment and raw water treatment for drinking water production. Yet matrix effects 
are far more relevant in wastewater treatment than in drinking water production, 
which has to be considered when such processes are designed. The application of 
ozone and generation of OH-Radicals via UV/Hydrogen peroxide are proposed for 
oxidative treatment. In some model WWTPs they are already in use, e.g.: 
 Application of ozone: 
In Duisburg-Vierlinden (Germany) with subsequent biological treatment in a 
turbulent fluidized bed; in Bad Sassendorf (Germany) with subsequent 
polishing pond 
 UV-treatment: 
Monschau-Kalterherberg (Germany); Einruhr (Germany) 
Dosage of powdered activated carbon (PAC) or filtration with granulated activated 
carbon (GAC) are proposed for treatment with activated carbon. In some model 
WWTPs both are already in use, e.g.: 
 PAC:  
Buchenhofen (Wuppertal, Germany) with removal via sand filtration; Lage 
(Germany) with no further treatment  
 GAC: 
Düren-Merken (Germany); WWTP Obere Lutter (Gütersloh, Germany)  
In some cases even a combination of both above presented treatment processes is 
applied, e.g.: 
 WWTP Schwerte (Germany): ozonation with a subsequent PAC dosage, 
recirculation to biological treatment step 
Also, the application of membrane bioreactors (MBR) is already established in some 
plants, e.g.: 
 WWTP Aachen-Soers (Germany) 
 WWTP Eitorf (Germany) 
In this study the behavior of gadolinium diagnostics in adsorptive water treatment 
steps has been studied, as well as the oxidation of the diagnostics by ozonation. 
Details for the evaluation of both processes are given in the following subsections.  
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1.4.2 Ozonation of water 
The treatment of drinking water by ozone is primarily used for disinfection purposes. 
Another important aspect is the oxidation of organic substances. In wastewater 
treatment, oxidation of micropollutants is usually the main aspect when applying 
ozone. Yet, in some cases the focus may also be on disinfection purposes. 
Application of ozone is characterized as advanced oxidation process (AOP) in such a 
matrix, as hydroxyl radicals are formed in situ [53]. Hence, it is necessary to 
investigate both reaction pathways for the evaluation of micropollutant oxidation in 
wastewater: the direct ozone reaction and the hydroxyl radical reaction pathway.  
One of the most important aspects for evaluation of oxidative treatment is the 
determination of reaction rate constants in order to be able to discriminate between 
feasible reactions in water treatment and such which are unlikely in the given time 
span for treatment. Calculations using the rate constant of the specific reactions may 
be performed to evaluate the process and estimate potential transformation of the 
probe compound. 
An oxidation reaction can be described by equation 1.6. The rate law presented in 
equation 1.7 can be derived from equation 1.6. If the reaction is first order, i.e., the 
reaction is only dependent on the concentration of one of the reactants, kOx may be 
derived by neglecting one of the reactants. 
products→Oxη+P Ox
k
       (1.6) 
]Ox[η×]P[×=
dt
]P[d
Oxk        (1.7) 
kOx = Second order reaction rate constant of the oxidation reaction 
[P] = Concentration of the probe compound 
[Ox] = Concentration of the oxidant 
η = Stoichiometric number 
  
16 
 
Small rate constants (< 1000 M-1 s-1) can be determined under (pseudo-)first order 
conditions for direct reactions with ozone [54]. This condition is achieved by applying 
an excess of probe compound to oxidant [54]. Hence, the probe compound 
concentration is constant during the process and the decay of oxidant can be 
monitored. Integrating equation 1.7 then yields: 
t×=t×]P[=
]Ox[
]Ox[
ln obsOx
0
kk --       (1.8) 
kobs = Observed pseudo-first order reaction rate constant of the oxidation reaction 
t = Time 
A plot of ln([Ox]/[Ox]0) versus time yields -kobs. Subsequently, kOx can be calculated 
from a rearranged equation 1.8. A prerequisite of this approach is that only one 
oxidant is present. However, hydroxyl radicals may be formed in ozone reactions 
which may react further with the probe compound and by this interfere with the rate 
constant determination [54]. To avoid such reactions, a radical scavenger is added to 
the reaction solutions. This radical scavenger is characterized by a low reaction rate 
constant with ozone and a high rate constant with hydroxyl radicals. Typically, 
aliphatic alcohols are used as radical scavengers [55]. In this work, this concept was 
applied for the determination of rate constants for the reactions with ozone. 
 
  
17 
 
Different concepts have been applied for the determination of rate constants with 
hydroxyl radicals. Hydroxyl radicals may be generated by different methods, some of 
which are summarized in Table 1.5. Due to the disadvantages of the 
Fenton-(like)-processes and the UV light based processes (cf. Table 1.5) only the 
peroxone and the pulse radiolysis method have been used for the generation of 
hydroxyl radicals. 
Table 1.5: Methods for the generation of hydroxyl radicals and their (dis)advantages concerning the 
applicability for determination of gadolinium chelate reaction rate constants 
Processes General mechanism Advantages Disadvantages 
Pulse radiolysis 
Hydroxyl radicals and 
hydrogen radicals are 
formed by applying 
ionizing radiation [56] 
 Considered as most 
reliable method [56] 
 Constant radical 
exposition 
 Availability of pulse 
generator 
UV-based 
processes 
(e.g. UV / H2O2) 
Generation of radicals via 
photolysis [57] 
 An economic method for 
laboratory experiments, 
as additionally direct 
photolysis reactions may 
be investigated 
 Glass ware to avoid light 
absorption → Gadolinium 
chelates and other 
chelates interact with 
glass [4, 58, 59] 
Fenton or 
Fenton-like-
processes 
Oxidation of a 
(transition-) metal by 
hydrogen peroxide, 
yielding 
hydroxyl radicals [60, 61]. 
 An economic method for 
laboratory experiments 
 Transmetalation may 
occur 
 The Fenton process is 
not fully understood by 
now [60] 
Peroxone 
Reaction of hydrogen 
peroxide with ozone 
yields 
hydroxyl radicals [62] 
 An economic method for 
laboratory experiments 
 No transmetalation by 
reactants 
 Interactions with glass 
may be avoided 
 Availability of ozone 
generator 
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The mechanism for radical generation via pulse radiolysis is presented in the 
following: 
H2O + ionising radiation → H2O
+ + e−      (1.9) 
H2O + ionising radiation → H2O*       (1.10) 
H2O
+ →

OH + H+         (1.11) 
H2O* →

OH + H

         (1.12) 
e− + nH2O → eaq
−         (1.13) 
eaq
− + N2O + H2O → 

OH + N2 + OH
−      (1.14) 
By the radiation, a water radical cation is formed (cf. eq. 1.9) which deprotonates to a 
hydroxyl radical (cf. eq. 1.11). Furthermore, the excited water molecule formed by 
radiation (cf. eq. 1.10) decomposes into a hydrogen and hydroxyl radical 
(cf. eq. 1.12). The electron which is formed in reaction 1.9 is solvated by water 
(cf. eq. 1.13) and forms in presence of dinitrogen oxide a further hydroxyl radical 
(cf. eq. 1.14). [54] 
The influence of hydrogen radicals, which are also formed by pulse radiolysis, is 
neglected due to the following reasons. First, the hydroxyl radical yield is 
considerably higher compared to the one of hydrogen radicals (9/1 ratio for 

OH / 

H) [54, 63]; secondly, hydroxyl radical reaction rate constants are by orders of 
magnitude higher than those of hydrogen radicals [54]. 
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As the peroxone process has been applied for the generation of hydroxyl radicals as 
well, this method is also described in more detail. In the peroxone process, it has to 
be differentiated between a mechanism which is commonly stated in literature 
(cf. eq. 1.15-1.19) and a more recently suggested one (cf. eq. 1.20-1.24) [54]. The 
new mechanism is an attempt to explain the experimentally observed yield of 
hydroxyl radicals which is only half of the one expected from the hitherto accepted 
mechanism (ratio ozone / hydroxyl radical 0.5 instead of 1) [54, 64]. 
HO2
- + O3 → HO2

 + O3
-        (1.15) 
HO2
 ⇌ O2
- + H+         (1.16) 
O2
- + O3 → O2 + O3
-        (1.17) 
O3
- + H+ ⇌ HO3

         (1.18) 
HO3

 → 

OH + O2         (1.19) 
The reaction sequence above (old mechanism), is started by an electron transfer 
reaction, yielding a hydroperoxyl radical and an ozonide radical anion 
(cf. eq. 1.15) [65]. The formed hydroperoxyl radical is in equilibrium with a hyperoxide 
anion and a proton (cf. eq. 1.16). The hyperoxide anion yields dioxygen and another 
ozonide radical anion by an electron transfer to ozone (cf. eq. 1.17). Protonation of 
the ozonide radical anion forms a hydrogen trioxide radical (cf. eq. 1.18). This 
decomposes into a hydroxyl radical and dioxygen (cf. eq. 1.19). Hence, the overall 
ratio ozone to hydroxyl radical is one (i.e., from two ozone molecules two ozonide 
radical anions are formed, yielding two hydroxyl radicals). [54] 
In contrast to the mechanism presented above, an ozone / hydroxyl radical ratio of 
0.5 is monitored in experiments which made a revision of the process necessary [54]. 
For such a revision, the following reactions are proposed [54, 64, 66]:  
HO2
- + O3 → HO5
-         (1.20) 
HO5
- → HO2

 + O3
-         (1.21) 
HO5
- → 2 3O2 + OH
-         (1.22) 
O3
- ⇌ O
- + O2         (1.23) 
O
- + H+ ⇌ 

OH         (1.24) 
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This reaction sequence is induced by formation of an ozone adduct (cf. eq. 1.20) 
which is slightly more exergonic than the electron transfer reaction 
(cf. eq. 1.15) [54].The formed adduct is transformed to a hydroperoxyl radical and an 
ozonide radical anion (cf. eq. 1.21) or into two triplet dioxygens and a 
hydroxide anion (cf. eq. 1.22). Both reactions occur equally. The 
ozonide radical anion is in equilibrium with the O
- and dioxygen (cf. eq. 1.23). 
Furthermore, the radical anion and hydrogen are in equilibrium with a hydroxyl radical 
(cf. eq. 1.24). Rather than the previously assumed reactions (cf. eq. 1.18 and 1.19), 
these equilibrium reactions take place. Overall two moles of ozone yield one mole of 
hydroxyl radicals. [54, 64] 
The differences in the mechanisms are important, as the radical yield is essential for 
a correct experimental set up. This is in particular the case in determinations of rate 
constants by competition kinetics, since the oxidant concentration has to be 
significantly lower than the one of probe compound and competitor (details given 
below). When applying the peroxone process, it is necessary to take the pKa of 
hydrogen peroxide (pKa = 11.8) into account. The dissociation rate of hydrogen 
peroxide is of importance because the reaction of hydrogen peroxide with ozone is 
slow compared to its anion (< 1 and 9.6 × 106 M-1s-1, respectively) [65]. 
The determination of rate constants using pseudo-first order conditions can be 
performed directly, when applying pulse radiolysis as method for generation of 
hydroxyl radicals. In this study, a different approach is used than the one described 
above for the determination of rate constants for the reaction with ozone. Instead of 
monitoring the decay of the oxidant, the decay of the probe compound is measured 
for several reactions with different excess concentrations of the probe compound. 
Following a first-order-law, where kobs = kOx × [P]0 (kobs in s
−1), equation 1.25 is 
obtained. A plot of kobs versus [P] yields a regular second-order rate constant kOx as 
the slope [54]. 
kOx × [Ox] × [P] = kobs ×  [P]        (1.25) 
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Another approach for determination of rate constants for the reaction with 
hydroxyl radicals was competition kinetics. Competition kinetics are generally applied 
when rate constants are > 1000 [67]. In competition kinetics, a competitor (C) with a 
well known rate constant has to be available. The occurring reactions are presented 
in equations 1.26-1.27. 
OxPOx+P
P,Ox
→
k
         (1.26) 
OxCOx+P
C,Ox
→
k
         (1.27) 
POx = Oxidation products of the probe compound 
COx = Oxidation products of the competitor 
kOx, P = Reaction rate constant of the oxidation of the probe compound 
kOx, C = Reaction rate constant of the oxidation of the competitor 
The degradation of both compounds is described by the following equation: 
C,Ox
P,Ox
00
×
]C[
]C[
ln=
]P[
]P[
ln
k
k
       (1.28) 
[P]0 = Initial concentration of the probe compound 
[C]0 = Initial concentration of the competitor 
By plotting ln([P]/[P]0) versus ln([C]/[C]0) a slope of kOx,P / kOx,C is obtained. However, 
another approach was used in this study, to avoid gadolinium species determination. 
At a ratio of [Ox] << [P] and [C] the following equation is valid: 
 
  ]P[]C[
]C[
C
C
PC
c
P
P
kk
k



        (1.29) 
 
  ]C[
]P[
1
]C[
]P[]C[
C
C
C
P
C
Pc
P
P
k
k
k
kk


       (1.30) 
[C]P = Concentration of competitor in presence of probe compound 
[C]-P = Concentration of competitor in absence of probe compound 
By plotting ([C-P]/[CP]) versus ([P]/[C]) the slope kOx,P / kOx,C is obtained, from which 
kOx,P can be calculated [54].  
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1.4.3 Adsorption processes in water treatment 
In drinking water production Adsorption on activated carbon is mainly used for the 
removal of dissolved organic carbon (DOC), color, taste, and odor. The great 
advantage of this method is the elimination of the substance from the water matrix 
without formation of any by-products, as the removed substances are bound to the 
carbon surface. 
For the description of sorption processes in general it is necessary to differentiate 
between adsorption and absorption [68]. In the case of sorption to activated carbon, 
in general, adsorption to the sorbent surface dominates and one generally applies the 
term adsorption [68]. The efficiency of the adsorption process may be described by 
determination of sorption isotherms. Sorption isotherms describe the equilibrium of 
sorption and desorption at constant temperature, i.e. the relationship of sorbed probe 
compound and dissolved probe compound [69]. The experimentally determined 
isotherms may have different shapes (cf. Figure 1.4), dependent on the types of 
sorbent and sorbate as well as on the concentration ratios [69]. The simplest type is a 
linear isotherm. This type applies to situations where partitioning into a homogeneous 
organic phase is dominating and/or at low sorbate concentrations where the 
strongest adsorption sites are by far not saturated [69]. More complicated are the 
Langmuir isotherm and the Freundlich isotherm, which apply both to a situation in 
which the extent of sorption is limited (cf. Figure 1.4).  
 
Figure 1.4: Examples for different shapes of isotherms, in detail, the Linear isotherm, Langmuir 
isothem and Freundlich isotherm 
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The Langmuir isotherm is based on the assumption that free energy, enthalpy and 
entropy change due to sorption is constant for all solid-phase concentrations, which 
is usually only the case for homogeneous surfaces [70]. Furthermore, sorption in 
monolayers is assumed [71]. Both assumptions are not fulfilled in adsorption 
processes on activated carbon in water treatment [69-71]. The equation of the 
Langmuir isotherm is presented in equation 1.31. The Freundlich isotherm 
(cf. eq. 1.32) may be derived from the Langmuir isotherm by taking a logarithmic 
decrease of the differential adsorption enthalpy with decreasing sorbent 
concentration in the liquid phase into account [72]. 
WL
WLmax
s ]P[×K+1
]P[×K×q
=]P[         (1.31) 
n
wFs )]P([×K=]P[          
 (1.32) 
[P]s = Concentration of the probe compound sorbed on solid phase 
[P]w = Concentration of the probe compound in liquid phase 
KL = Langmuir coefficient 
qmax = Maximal concentration of the sorbent on the solid phase 
KF = Freundlich coefficient 
n = Freundlich exponent 
The exponent in the Freundlich equation is a measure for diversity of free energy 
associated with sorption of the sorbate on a heterogeneous surface [69]. The 
Freundlich coefficient (KF) is a measure for sorption strength [71]. The Freundlich 
isotherm is widely used for description of adsorption processes on activated carbon 
in water treatment. Experimental data are often better described by the Freundlich 
approach than by the Langmuir isotherm, as the assumptions on which the Langmuir 
isotherm is based are not valid for sorption on activated carbon, in particular, 
energetic homogeneity of sorption sites and monomolecular coverage [70, 71]. 
However, in some cases the Langmuir isotherm was applicable, even though, the 
basic assumptions were clearly not fulfilled [71]. In fact, the Freundlich isotherm has 
become some type of standard equation for the characterization of adsorption 
processes [71]. Furthermore, the KF is often used for modeling of diverse sorption 
processes, e.g. the breakthrough behavior of filters [71].  
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1.5 Scope 
The behavior of gadolinium chelates throughout the water cycle is rather unknown. It 
is assumed that during environmental processes the chelates remain intact and none 
of the processes decreases the gadolinium concentration during the transport. These 
assumptions have not been validated sufficiently. Also, the influence of processes 
during water treatment has not been studied sufficiently up to date.  
This work is therefore focusing on two main goals: 
 Significance of gadolinium in the water cycle  
 Behavior during water treatment processes 
To investigate gadolinium chelates in water treatment it is important to develop a 
reliable analytical method. Factors which may influence analysis and speciation 
methods are discussed in chapter 2.  
The anthropogenic gadolinium in the environment may be best described by the so 
called gadolinium anomaly. Hence, a short introduction on the anomaly, its 
occurrence and its use as a pseudo-natural tracer is given in chapter 3. For a basic 
overview of occurrence of gadolinium throughout the watercylce two monitoring 
campaigns were carried out. One considered the input of gadolinium into the water 
cycle. To this end, samples from 75 European WWTPs effluents have been taken. In 
addition, drinking water samples have been taken in an urban agglomeration. This 
has been done in order to evaluate how much of the anthropogenic gadolinium 
reaches consumers’ tap water. Results of these monitoring campaigns are presented 
in chapter 3.  
Treatment steps which are of importance for both, drinking water treatment and 
wastewater treatment are of special interest for evaluation of behavior during water 
treatment. The focus was on ozonation as energetically and economically feasible 
oxidation process (cf. chapter 5) and adsorption on activated sorbents (cf. chapter 4). 
Wastewater treatment is of special interest as the concentration of the 
gadolinium chelates is higher than in raw water for drinking water production, e.g. 
due to dilution effects (if taking surface water as raw water). The concentration of the 
chelates approaches zero when ground water is used as raw water. Yet one has to 
consider that both advanced wastewater treatment steps are also applied for a long 
time in drinking water production. For waste water treatment and drinking water 
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treatment the same physico-chemical processes will take place. However, process 
parameters as, e.g., concentration of adsorbent / oxidant or matrix constitution and 
concentration differ and are strongly influencing the retention / oxidation of the 
substances. 
The advanced wastewater treatment steps are designed for the removal of organic 
trace substances. However, also other compounds will be affected as well. Up to 
date studies on organo-metallic compounds are very rare. However, ozonation, which 
is one of the favored steps for advanced wastewater treatment, is of special interest 
as a destruction of the gadolinium chelates may lead to a release of toxic, free 
Gd(III) ions. The oxidation of gadolinium chelates via ozone and hydroxyl radicals, 
which are generated by reactions of ozone with the matrix, is described in chapter 5. 
The application of activated carbon or other adsorbents for the removal of trace 
substances is proposed as an alternative to ozonation. Research on adsorption 
characteristics of chelates is rare. It is known, that these substances are in general 
poor adsorbable on activated carbon. Yet, knowledge on the specific behavior of 
gadolinium chelates in this treatment process has not been investigated up to date. 
The evaluation of gadolinium chelates adsorption on activated carbon and on an 
activated material based on spherical polymers is shown in chapter 4. The presented 
study includes adsorption behavior on powdered material as well as adsorption in 
fixed-bed filters. Furthermore, the breakthrough behavior was modeled to gain 
information on the relevant parameters influencing the adsorption in filters. 
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1.6 Supplement 
Table S 1.1: Comparison of thermodynamic and conditional stability constants for gadolinium chelates 
Chelate 
Thermodynamic stability constant 
log Kthern 
Conditional stability constant (pH 7) 
log Kcond 
Gd-EDTA 17.4 [22] 14.7 [5] 
Gd-DTPA 22.5 [22] 17.7 [10] 
Gd-DTPA-BMA 16.9 [32] 14.9 [10] 
Gd-DTPA-BMEA 16.6 [10] 15.0 [10] 
Gd-EOB-DTPA 23.8 [10] 18.7[10] 
Gd-DOTA 24.0 [26] 18.3 [5] 
Gd-BT-DO3A 21.8 [31] 14.7 [10] 
Gd-HP-DO3A 23.8 [10] 17.1 [10] 
Gd-MS-325 22.1 [10] 18.9 [10] 
Gd-BOPTA 22.6 [32] 18.4 [32] 
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2 Important aspects in the determination of gadolinium in aquatic 
samples 
2.1 Introduction 
For the determination of gadolinium in aquatic samples several aspects are of 
importance. The determination of total gadolinium or Gd(III) ions may be 
accomplished by elemental analysis, e.g.  
 atomic absorption spectroscopy (AAS) [1]  
 inductively coupled plasma (ICP) - optical emission spectrometry (OES) [2-4],  
 ICP - mass spectrometry (MS) [5, 6].  
 total reflection X-ray fluorescence (TXRF) [7],  
The method of choice for samples with high concentrations is TXRF as sample 
preparation is very fast [7]. However, ICP-MS methods are generally preferable in 
environmental analysis due to their very low limit of quantification (LOQ). Yet, if 
analyzing non-aquatic samples, sample preparation may be more extensive [8]. For 
drinking water or environmental samples, as well as those from wastewater treatment 
plants (WWTPs) ICP-MS is the method of choice. Nevertheless, it has to be 
considered that the methods presented above are only able to determine the total 
gadolinium concentration in a sample, whereas a separation and identification of 
single species is impossible. For determination of gadolinium species, several 
methods have been published, among others these are: 
 Capillary electrophoresis  (CE) - (electrospray ionization) ESI-MS [9, 10] 
 High-performance liquid chromatography (HPLC) with Ultraviolet (UV) / visible 
light (VIS) detection [2, 11] 
 Hydrophobic Interaction Liquid Chromatography (HILIC) – ICP - MS [4, 12, 13] 
 HILIC – ESI - MS [14, 15] 
 HPLC – ICP - MS [16] 
 HPLC – ICP - OES [17, 18] 
 Ion chromatography (IC) – ICP - MS [19-21] 
 Micellar electrokinetic chromatography (MEKC) - UV/VIS [22] 
 Size-exclusion chromatography (SEC) – ICP - MS [23] 
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In many of the methods presented above, a determination of only one 
gadolinium species was published, e.g., for CE-ESI-MS [10] and HPLC-UV/VIS [2] 
and sometimes separation of only two or three gadolinium species is possible, e.g., 
by HILIC-ESI-MS [15] and HPLC-UV/VIS [11]. 
Furthermore, it has to be noted that most published methods have been developed to 
investigate gadolinium species in biological samples to evaluate medical issues. An 
exception are the new HILIC-ICP-MS methods by Künnemeyer [4] and Raju [12]. In 
principle all other methods are also applicable for environmental, wastewater or 
drinking water samples. However, the LOQs of the methods are rather high and 
hence, quantification in such samples will not be accomplished without further 
improvements. The sensitive determination of the gadolinium species achieved by 
hyphenation of HILIC to ICP-MS is up to date the only method that provides LOQs 
which are low enough for analysis of samples from wastewater treatment and 
environment.  
Methods involving HILIC have been described by some authors for determination of 
metal species in trace amounts [24-26]. The retention mechanism of this 
chromatographic method is not fully characterized. However, it is assumed that 
different species can be separated according to partitioning between an immobilized 
water layer on the surface of the stationary phase and the mobile phase. Interactions 
between analyte and surface groups of the stationary phase contribute also to the 
retention mechanisms. In this regard ZIC-HILIC columns offer great selectivity due to 
their zwitterionic sulfobetaine surface groups bearing surface charges at high and low 
pH. These allow weak interactions with charged species [27, 28]. One disadvantage 
of the HILIC technique for ICP-MS is the need of a high organic content within the 
mobile phase, requiring addition of oxygen to the plasma gas to avoid carbon 
deposits within the interior of the MS device.  
A method for determination of gadolinium species by HILIC-ICP-MS was first 
published by Künnemeyer et al. [4] in 2009 and allowed the separation of: 
 Gadovist® / Gd-BT DO3A (macrocyclic, non-ionic) 
 Dotarem® / Gd-DOTA (macrocyclic, ionic) 
 Magnevist® / Gd-DTPA (linear, ionic) 
 Multihance® / Gd-BOPTA (linear, ionic) 
 Omniscan® / Gd-DTPA-BMA (linear, non-ionic)  
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The reported limit of detection (LOD) was 1 nM (determined by signal-to-noise 
method s/n = 3) and the corresponding LOQ was 3.3 nM (determined by signal-to-
noise method s/n = 10). This method was adapted and modified by Raju et al. [12]. 
Their modifications allowed LODs of 0.14 ± 0.03 nM (determined by signal-to-noise 
method s/n = 3) and correspondingly also lower LOQs (for Gd-BOPTA, Gd-DTPA, 
Gd-DOTA, Gd-DTPA-BMA and Gd-BT DO3A 71 nM, 92 nM, 57 nM, 60 nM and 
81 nM, respectively; determined by signal-to-noise method s/n = 10). In comparison 
to the method of Künnemeyer et al. [4], the flow rate was lower (0.1 mL min-1 instead 
of 0.3 mL min-1), injection volume was higher (5 µL instead of 4 µL) and pH was 
higher (pH 5.8 instead of 3.75). Furthermore, the composition of the eluent was 
modified, instead of using a 76/24 ratio of acetonitrile (ACN) / water with a 12.5 mM 
formate buffer, a 60/40 ratio of ACN / water with a 20 mM acetate buffer was applied. 
Total analysis time of the method presented by Raju et al. [12] was 25 min which is 
5 min less than the one of Künnemeyer et al. [4]. Both methods and combinations of 
both were tested in this study, to determine best operation parameters for the 
available HPLC-ICP-MS system. 
Concentrations of total gadolinium are in the lower ng L-1 range in environmental 
samples [29-31] as well as in drinking water (cf. chapter 3), [32]. In samples from 
wastewater treatment plants the concentration of total gadolinium is in the lower  
µg L-1 to medium ng L-1 range, depending on the sampling location (location of the 
WWTP and sampling point in the WWTP) (cf. chapter 3, [4, 6, 19]).  
Due to these low concentrations, preconcentration might be necessary for analysis of 
such samples. In addition to separation and quantification methods, also 
preconcentration methods for gadolinium species are described in literature. These 
involve solid phase extraction (SPE) [13, 33, 34] or simple evaporation 
approaches [12]. Preconcentration approaches are suitable for both, elemental 
analysis and species analysis. In methods based on SPE it has to be differentiated 
between methods which are only suitable for enrichment of ionic gadolinium based 
on ion exchange [33] and those that are also suitable for organic 
gadolinium species [13, 35]. Depending on the purpose of analysis both techniques 
might be suitable. SPE methods are faster than evaporation. However, these 
experiments are labor-intensive. Furthermore, SPE methods based on ion exchange 
might eliminate a relevant species. Only for the method described by Raju et al. [13] 
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it is possible to preconcentrate both, organic gadolinium species (neutral or ionic) and 
free Gd(III) ions. The method described by Möller et al. [35] has not been evaluated 
regarding this differentiation. For the overall aim of the studies presented in this work, 
all preconcentration methods are of interest.  
The development of a reliable analysis method (including preconcentration) for 
gadolinium (and its chelates) is presented in the following. Furthermore tests on 
suitability of equipment for such analysis are shown. These studies have been 
performed, to support the investigations of the overall scope of the work. 
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2.2 Methods 
2.2.1 Chemicals and Materials 
The chemicals used for the experiments are described in the following. As standard 
for ICP-MS measurements, a rare earth elements standard (ICP-Working Calibration 
Standard 4 from High Purity Standards, 10 mg L-1) and iridium (Iridium standard 
solution, CetriPur from Merck, 1000 mg L-1) as an internal standard have been used. 
For quality assurance, high purity single substance standards were used (gadolinium 
ICP-Standard (1000 mg L-1, CertiPur from Merck), cerium ICP-Standard       
(1000 mg L-1, High Purity Standards) and for quality assurance of the measurement 
method and indium ICP-Standard (1000 mg L-1, CetriPur from Merck) for quality 
assurance of the enrichment method via evaporization).  
For preconcentration experiments gadolinium chloride hexahydrate (99%, 
Sigma Aldrich) was used. The GdCl3 powder was dryed in a drying chamber (120°C) 
and afterwards stored until use in a desiccator. The gadolinium chelate standards 
were medical solutions (Gadovist® (Gd-BT-DO3A, 1.0 M, 
Bayer Schering Pharma AG); Omniscan® (Gd-DTPA-BMA, 0.5 M, 
GE Healthcare Buchler); Dotarem® (Gd-DOTA, 0.5 M, Guerbet), Multihance® 
(Gd-BOPTA, 0.5 M, Nycomed GmbH)), except for Gd-DTPA which was purchased as 
diethylenetriaminepentaacetic acid gadolinium(III) dihydrogen salt hydrate (97%) 
from Sigma-Aldrich. 
Formic acid (98-100% p.a., Merck), ammonium formate (p.a., Fluka), ammonium 
hydroxide solution (28% AnalaR NORMAPUR, VWR) and ammonium acetate 
(puriss., Merck) were used for buffer preparation for HILIC-ICP-MS. ACN (Rotisolv®, 
Ultra LC-MS, Roth, Germany) was used as eluent.  
Ultra pure water (Millipore: MilliQ Gradient / Elga: Purelab ultra; for both used ultra 
pure waters: R ≥ 18.2 MΩ) was used for experiments. HPLC water was further 
purified by filtration through a PP syringe filter (0.45 μm × 0.45 μm PP membrane). 
Nylon syringe filters (25 mm × 0.45 μm, nylon membrane) were used for filtration of 
the HILIC eluent and buffer. 
Stock and standard solutions were always prepared in PP-vials, if not stated 
elsewise, to avoid surface effects on glass, which will be described in the following 
(cf. chapter 2.2.4). PP-autosampler vials were used for HILIC-ICP-MS 
measurements. 
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2.2.2 ICP-MS 
For determination of rare earth element concentrations, measurements were 
performed with a Perkin Elmer ELAN DRC II ICP-MS equipped with an AS90 
autosampler. The ICP-MS instrument parameters are presented in Table 2.1. The 
integrated peristaltic pump (24 rpm) controlled the flow of washing solution (inlet tube 
PVC di = 1.143 mm, wall = 0.86 mm), sample solution (inlet tube: PVC di = 0.76mm, 
wall = 0.86 mm) and flow of the nebulizer waste (discharge tube: PVC di = 3.17 mm, 
wall = 0.86 mm). It is only necessary to determine REE* (rare earth elements 
excluding gadolinium) if the gadolinium anomaly has to be determined (cf. chapter 3). 
If not stated elsewise only two gadolinium isotopes (158Gd, 160Gd) and the 
corresponding internal standard (iridium, 192Ir) were measured. The devices were 
continuously rinsed between the single measurements with ultrapure water, acidified 
with 12.5 mL nitric acid (65% Suprapur®, Merck KGaA) and 45mL hydrochloric acid 
(30% Suprapur®, Merck KGaA) per liter (refered to as washing solution), to avoid any 
metal salt precipitation. The LOQs for all REEs were determined according to the 
US EPA guidelines [36] (cf.  chapter 3). For gadolinium the LOQ was 1.2 ng L-1. 
Table 2.1: Parameters for ICP-MS measurement of gadolinium and REE
*
 (e.g., for calculation of the 
gadolinium anomaly), including the internal standard iridium and the quality assurance standard 
indium 
Injector tube:  
Quartz glass, di = 1.85 mm (ball- and socket joint to spray 
chamber) 
Spray chamber:  Cyclone, quartz glass  
Nebulizer:  Meinhard, quartz glass  
Nebulizer gas flow:  0.9 L min
-1
  
ICP RF power:  1100 W  
Skimmer / sampler cone material:  Nickel  
Analysed mass traces [m/z]:  
140
Ce; 
141
Pr; 
142
Nd; 
143
Nd; 
144
Nd; 
147
Sm; 
149
Sm; 
152
Sm; 
153
Eu; 
158
Gd; 
159
Tb; 
160
Gd; 
161
Dy; 
163
Dy;
 165
Ho;
 166
Er; 
169
Tm;
 173
Yb; 
174
Yb;
 175
Lu; 
115
In; 
192
Ir 
Plasma / auxiliary / nebulizer gas: Argon (purity min. 4.6; inlet pressure = 7 bar) 
Software: Perkin Elmer Elan V 3.4 software 
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2.2.3 Spectral data 
For the three diagnostics, which were available as “pure substance” spectral 
absorbance was monitored from 190-800 nm. For this, stock solutions containing 
10 mM of the probe compound in pure water (Milli-Q (Elga)) were prepared. The 
diagnostics Gadovist (Gd-BT-DO3A) and Omniscan (Gd-DTPA-BMA) were medical 
solutions without addition of substances other than small quantities of NaCl (5% and 
0.1% respectively [37]) and Gd-DTPA (Magnevist) was available in 99% purity from 
Sigma Aldrich. The solutions were measured in 1 cm quartz glass cuvettes by a UV-
1650PC UV-VIS Spectrophotometer from Shimadzu. 
2.2.4 Interactions with glass 
To determine interactions of the chelates with sample vessels, stock solutions 
containing different concentrations of gadolinium as Gd-DTPA (100 ng L-1, 10 µg L-1 
and 1 mg L-1 as Gd) were stored in different types of vessels (PP, and glass vessels). 
Several replicates of low concentrated solutions (10 µg L-1 and 100 ng L-1 as Gd) 
have been prepared in the respective vessel type to yield sufficient sample volume 
for the complete sampling period. The 1 mg L-1 sample was prepared only once. 
Hence, for this concentration, samples were taken from one vessel over the whole 
sampling period. This was possible, as a 10-3 dilution previous to measurement had 
to be made. In contrast, sampling for other concentration levels had to be performed 
by taking solutions from different sampling vessels of the same material. 
 
Glass vials were tested without treatment and after a conditioning which is described 
in the following. To ensure that the glass was free of any complex forming agent 
which might interfere determination of gadolinium chelates, the glass was soaked for 
24 h with sodium hypochlorite solution (10 mM) and afterwards cleaned with 
ultrapure water. Then the vials were heated (550°C) for at least 12 h, to burn organic 
residues in the vessels. 
The gadolinium stock solutions were stored for 4 weeks. Samples were taken at least 
every second day. On the first day, samples were taken every hour, on the second to 
fifth day samples were taken every two hours. The samples were measured by 
ICP-MS. For a detailed measurement description cf. chapter 2.2.2. To shorten 
analysis time, only gadolinium isotopes have been analyzed, as for this purpose no 
determination of any other REE was necessary. 
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2.2.5 HILIC-ICP-MS 
For determination and quantification of gadolinium species, in this case the MRI 
diagnostics, two different methods, both HILIC-ICP-MS methods and combinations of 
both have been tested. These methods recently published by Künnemeyer et al. [14] 
and Raju et al. [12] differ mainly in the buffers’ pH and eluent solvent (cf. chapter 2.1) 
used.  
For chromatographic separations a Perkin Elmer Series 200 was used. In detail: 
autosampler, pump, vacuum degaser and a peltier column oven of this product line 
were coupled to a Perkin Elmer ELAN DRC II ICP-MS. Switching between the 
ICP-MS autosampler and chromatographic instruments to the inlet of the nebulizer 
was performed via a 6-way Rheodyne® valve (Index Science & Health). The coupled 
system was operated by Chromera Version 2.1.2.1752 software which controlled the 
Perkin Elmer Elan V 3.4 software, responsible for operation of the ICP-MS. 
The ICP-MS (details given in chapter 2.2.2) was configured for coupling to the HPLC. 
As in this case high concentrations of organic solvents had to be used, a PFA micro 
flow nebulizer and a spray chamber made of quartz glass in a cooling device (Peltier 
Cooled Cyclonic Chamber Model PC3, Elemental Scientific Inc. Omaha, U.S.) were 
connected via a ball- and socket joint to the injector tube (di = 0.9 mm). Furthermore, 
Platinum sampler- and skimmer cones (eSpec Sampler WE027802 and eSpec 
Skimmer WE027803 for Perkin Elmer Elan, Spectron Inc.) were used. To avoid 
carbon deposition of the organic solvents used in HPLC, oxygen (0.15 L min-1 (15% 
of plasma gas flow) was fed to the nebulizer gas stream and nebulizer gas flow was 
regulated to 0.6 L min-1. The speed of the peristaltic pump was kept.  
For separation of gadolinium species a zwitterionic ZIC-HILIC (SeQuant GmbH, Marl, 
Germany) was used, with di 2.1 mm, length 150 mm, particle size 3.5 μm and 
pore size 200 Å. A suitable ZIC-HILIC precolumn (SeQuant GmbH, Marl, Germany) 
with same inner diameter and pore size (length shortened to 20 mm and larger 
particle size (5 μm)) was used. Furthermore, a pre column filter (Supelco Pre Column 
Filter 1/16” Peek, 2 μm frit) was tested. Regeneration of the column was achieved by 
rinsing it with 30 column volumes (, which is 15.6 ml) of ultrapure water, followed by 
30 column volumes of a 0.5 M NaCl solution. Afterwards rinsing with 30 column 
volumes of ultrapure water was repeated.  
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2.2.6 Sample preconcentration 
For preconcentration of the samples different methods have been tested. 
 Evaporation: Simple preconcentration method, without any further advantages 
 SPE: For preconcentration of gadolinium and for a differentiation of complexed 
gadolinium and Gd(III) ions 
The preconcentration of the samples is necessary as in most environmental samples 
and especially in drinking water samples the concentration of the rare earth elements 
including gadolinium is very low. Hence, to be able to get a reliable result, e.g., in the 
case of a gadolinium anomaly determination, it is necessary to preconcentrate the 
sample to be within the working range of the analytical method. 
2.2.6.1 Preconcentration via evaporation 
Preconcentration of the samples by evaporation is a very easy, however, time 
consuming approach. Samples in the PP vessels were heated up to 65°C in an 
aerated drying chamber. Higher temperatures were avoided due to limited long-term 
thermal stability of the vessels. Sample volume was decreased from 40 mL to 10 mL 
within 5 d. 
The initial sample was spiked with indium, to evaluate the enrichment process. 
Furthermore, to verify the results a certified standard (SPS-SW2, Batch 24 from 
Spectrapure Standards: [La], [Ce], [Pr], [Nd], [Sm], [Eu], [Gd], [Tb], [Dy], [Ho], [Er], 
[Tm], [Yb], [Lu] each 2.5 µg L-1) was used. After enrichment the samples were 
measured as described in chapter 2.2.2.  
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2.2.6.2 Preconcentration via SPE 
For preconcentration via SPE different methods were discussed: 
 SPE cartridges for removal of organic moieties (cartridges with 
Poly(styrenedivinylbenzene-comethylmethacrylate as base material with 
benzene rings as functional groups) 
 Anion exchangers 
 Cation exchangers 
 Chelation of cations 
Methods based on chelation for preconcentration were rejected, as potentially the 
ligands may be exchanged during this process and hence, a differentiation between 
chelated cations and free cations is not possible.  
Cation exchange is only possible for preconcentration of free Gd(III) ions. Even 
though focus was on enrichment of the organic species this method was tested, to be 
able to enrich Gd(III) which might be liberated from ligands, e.g. due to 
transmetallation or oxidation. As pH of the sample might influence the binding sites of 
the SPE material, a strong ion exchanger (sulfonic acid) was chosen, as in these 
materials the speciation of the binding sites is functional for exchanging purposes at 
pH ≤ pKa [38]. 
Anion exchange is only possible for negatively charged species. Also, for this 
method, a strong ion exchanger (alkyl trimethyl ammonium chloride) was chosen. 
The extraction methods for both ion exchange SPEs have been adapted from 
manufacturer’s information (SCP Science). They are presented in the following. 
For conditioning, anion SPE cartridges (DigiSep Red (500 mg / 6 mL cartridges from 
SCP Science) were rinsed with 1.5 mL 2 M HNO3 solution. After a vacuum drying 
step the cartridge was rinsed with 2.5 mL ultra pure water, then dryed again and 
rinsed with 2.5 mL NaOH (1 M NaOH). After another vacuum drying step, the 
cartridge was rinsed with 2.5 mL ultra pure water and finally vacuum dried again. 
After these conditioning steps, the sample was applied (10 mL) and subsequently the 
cartridge vacuum dried. This sample flushed through the SPE was kept for analysis 
(“sample flush” in the following). For removal of positively charged (in this case 
Gd(III) ions) or neutral substances, the cartridge was rinsed with 2.5 mL ultrapure 
water and vacuum dried This impurity removal flush was kept for analysis as well 
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(“impurity removal” in the following). For elution of the analyte, the cartridge was 
rinsed with 0.5 mL HNO3-solution and vacuum dried. This step is repeated 3 times. 
The flow rates for all steps described above were set to 1 mL min-1. For regeneration, 
the same steps are repeated with the same flow rates as for initial conditioning.  
As samples for anion exchange, Gd-DOTA and Gd(III) solutions were prepared in 
ultrapure water. The following sample compositions have been tested: 50, 5 and 
0.5 µM Gd as Gd-DOTA, 50 µM Gd as GdCl3 and a mixture of 50 µM Gd as GdCl3 
and 50 µM Gd as Gd-DOTA. 
 
For conditioning, cation SPE cartridges (DigiSep Green (500 mg / 6 mL cartridges 
from SCP Science) were rinsed with 1.5 mL of 2 M HNO3 solution and after a 
vacuum drying step rinsed with 2.5 mL ultra pure water. As last step for conditioning 
the cartridge was vacuum dried again. The sample was applied (10 mL) and 
afterwards the cartridge was vacuum dried again. The sample flushed through was 
kept for analysis (again referred to with “sample flush”). For removal of impurities, the 
cartridge was rinsed with 2.5 mL ultrapure water and vacuum dried afterwards. Also, 
this flush was kept for further analysis (sample is named “impurity removal”). For 
analyte elution, rinsing with 0.5 mL HNO3 solution and vacuum drying was repeated 
3 times. The flow rates for all steps were 1 mL min-1. For regeneration, the 
conditioning steps were applied with the same flow rates.  
For cation exchange Gd-DTPA and Gd-BT-DO3A samples were prepared in 
ultrapure water and drinking water, to detect matrix effects. The tested concentrations 
of the samples (spiked with only a single substance) were 10 ng L-1and 1 µg L-1. 
All samples for cation and anion exchange were tested in triplicate and measured 
with ICP-MS as described in chapter 2.2.2. 
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2.3 Results and discussion 
2.3.1 Spectral data 
The spectral data obtained are presented in Figure 2.1.The absorbance maxima of 
the chelates are 195 nm for Gd-BT-DO3A, 200 nm for Gd-DTPA: 200 nm and 
210 nm for Gd-DTPA-BMA. Due to the maxima in the middle to lower UV range, it is 
not possible to determine gadolinium species in trace concentrations by HPLC-UV 
methods using organic solvents, as the absorbance maxima of these solvents are 
usually in the same range. The detection of high concentrations of 
gadolinium species is possible and also in experiments where no organic solvents 
are necessary, e.g. pulse radiolysis experiments (cf. chapter 5), it is possible to 
determine species concentrations via absorbance monitoring. 
2.3.2 Interactions with glass 
Experimental results for determination of interactions with glass are shown in    
Figure 2.2. The concentration of total gadolinium in the sample in relation to the total 
gadolinium concentration at the start of the experiment is increasing step wise over 
time for 10 µg L-1 in PP vials and decreasing step wise for 10 µg L-1 in glass vessels 
(cf. Figure 2.2 b) and d)). This is concluded to be due to measurement of samples 
from different original preparations, which were made to obtain sufficient sampling 
volume for the whole monitoring period (cf. chapter 2.2.4) and comparison of the 
result to the one preparation which was measured at the beginning of the sampling 
period. Hence, the stepwise increase / decrease may be an artifact due to differences 
in concentrations in the single original preparations rather than due to a chemical 
processes over time. For the other tested samples such a trend is not detectable 
(cf. Figure 2.2 a) and c)). Hence, it is concluded, that the changes in total 
concentration are negligible. If interactions with glass are due to sorption processes, 
as described previously for gadolinium chelates [4] a decrease of total gadolinium 
should have been observed. If interactions with glass are due to transmetalation 
effects as described for other chelates [39], no change in total gadolinium 
concentration should be measurable. From the presented results it is concluded, that 
the described interactions [4, 12] are more likely to be based on transmetalation 
processes. However, to verify this statement, further experiments would be 
necessary that are beyond the scope of this study. 
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Figure 2.1: UV/VIS-spectra of gadolinium diagnostics (10mM), which were available as “pure” 
substances, in the relevant wavelength range. The insert displays the full spectra 
 
 
  
Figure 2.2: Behaviour of Gd-DTPA in different concentrations during storage in different materials, 
[Gd] = 1 mg L
-1
 for a) and c), [Gd] = 10 µg L
-1
 for b) and d), storage vessel material was PP for c) and 
d) and glass for a) and b); marked by black bars: Change of sampling vessels 
 
b) a) 
d) c) 
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2.3.3 Determination of complexes with HILIC-ICP-MS 
For the application of a HILIC separation, prior to ICP-MS analysis, a complete 
modification of the sample introduction system is necessary. Hence, a first test has 
been performed to check the quality of hyphenation for the different devices.  
For this test, a validated method for platinum species analysis (for method description 
cf. chapter 2.5) was used. To this end, the ZIC-HILIC column was exchanged by a 
Discovery HS F5 (Supelco) and to avoid high background noises by platinum the 
cones, sampler and skimmer cones of the ICP-MS were substituted by nickel cones. 
Beside these minor necessary changes for a validation of the instrument setup, the 
instrumental setup for use of HILIC remained identical. A modification compared to 
the validated method was the injector tube size. The one used for the HILIC method 
featured an inner diameter of 0.9 mm instead of 1.85 mm in the validated method. 
This injector tube was kept for the test. The achieved chromatogram (cf. Figure 2.3) 
showed the same retention times as in the validated method. However, lower 
intensities were observed which is due to the smaller inner diameter of the injector 
tube. This gave evidence of successful hyphenation. Thus, method development for 
determination of gadolinium species via HILIC-ICP-MS was continued. 
 
Figure 2.3: Separation of cis-, carbo- and oxali-platin using the LC-ICP-MS system setup for organic 
solvents as eluents (same setup used as for HILIC-ICP-MS measurements) 
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First qualitative tests for hyphenation of HILIC to the ICP-MS were performed for the 
use of the method described by Künnemeyer et al. [4] (cf. chapter 2.1). These 
involved injection of a single gadolinium species (Gd-BT-DO3A), to verify if signal 
detection with the instrument setup was possible. For this, 5 µL Gd-BT-DO3A 
solution ([Gd] = 10-8 M) was injected with an eluent flow of 0.1 mL min-1 which is less 
than the 0.3 mL min-1 used by Künnemeyer et al. [4], to avoid high pressure and 
leakage in the sensitive system. The ACN / water ratio of the eluent was 76/24 
ACN / water, formiate buffer concentration was 12.5 mM and pH set to 3.5, which are 
the same conditions used by Künnemeyer et al. [4]. By application of this method a 
signal for the injected gadolinium species was detectable. However, no reproducible 
results could be obtained. This effect may not be explained by the lowered flow rate. 
However, it may be due to hardware problems which ocured throughout the whole 
period of method development. The same effect was observed for the method 
published by Raju et al. [12]. Adjustments to both methods (flow rates, buffer strength 
and pH and ACN / water ratio) were made and combinations of both methods have 
been tested to identify the suitable method for the available, sensitive system. 
An adjustment of both flow rate and ACN / water ratio was necessary to obtain 
narrower peaks and a reproducible retention time. The flow was increased gradually 
from 0.1 mL min-1 to 0.3 mL min-1, which was the flow rate stated by 
Künnemeyer et al. [4]. Furthermore, the ACN / water ratio was increased from 
60/40 to 80/20 at buffer strength of 10 mM formiate yielding a pH of 3.5. Increasing 
ACN content led to delayed elution and increasing water content to a significant 
narrowing of the peaks. By a variation of the Künnemeyer method to a ACN / water 
ratio of 70/30 at a buffer strength of 15 mM (formiate buffer), a pH = 3.5 and a flow 
rate of 0.3 mL min-1, sufficient retention and narrow peaks without coelution were 
obtained (cf. Figure 2.4). Furthermore, the influence of the buffer has been tested, as 
Raju et al. [12] used higher buffer concentrations and higher pH than Künnemeyer et 
al. [4] (20 mM acetate buffer at pH = 5.8 and 12.5 mM formiate buffer at pH =3.8, 
respectively). Three different buffers were applied, as gadolinium species are 
charged differently and hence, ionic strength as well as pH are of importance. Two 
formic acid / formiate buffer systems adjusted to pH = 3.5 and pH = 3.8 (buffer 
strength varied for both pHs between 5 and 50 mM), respectively and an acetic acid / 
acetate buffer at pH = 5.1 (buffer strength varied between 1 and 30 mM) were tested. 
The long-term use of formiate buffers resulted in hardware problems (pressure 
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increase, clogging at different places of the system) and higher gadolinium 
background concentration, due to lower purity of these buffer reagents. Using the 
acetate buffer fewer problems occurred and reproducible signal intensities and 
retention times were obtained. Additionally, the background concentration of 
gadolinium was lower, when using the acetate buffer.  
 
Figure 2.4: Chromatogram of 5 × 10
-8
 M Gd-BT-DO3A in ultrapure water (70/30 ACN / water, 15 mM 
formiate buffer, flow rate: 0.3 mL min
-1
) 
Changing buffer concentration led to different behaviour of gadolinium species. The 
neutral species Gd-BT-DO3A and Gd-DTPA-BMA showed no buffer concentration 
dependency in the tested concentration range, but for the negatively charged 
Gd-DTPA significant changes in retention time were observable, due to modifications 
in buffer strength. This effect has been reported by Raju et al. as well [12]. For all 
tested buffer systems (acetate and formiate buffer) higher concentrations of the 
buffer led to earlier elution of Gd-DTPA. Furthermore, Gd-DTPA peaks were sharper, 
with less tailing, when higher acetate buffer concentrations were used. 
The best separation has been obtained for the buffer-independent species 
Gd-BT-DO3A and the buffer-dependent species Gd-DTPA at an ACN / water ratio of 
70/30 with a flow rate of 0.2 mL min-1 in an acetate buffered system (30 mM, 
pH = 5.1) (cf. Figure 2.5). In this case Gd-DTPA was eluted earlier than 
Gd-BT-DO3A. Quality of the separation is mainly influenced by buffer strength. A 
higher buffer concentration led to a better separation of the two peaks. A separation 
using the same LC conditions except exchange of buffer (formiate buffered system, 
c = 30 mM, pH = 3.81) was not possible (cf. Figure 2.6) which corroborated the 
hypothesis that the separation also depends on pH. The order of elution was the 
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same as for the method published by Raju et al. [12] (Gd-DTPA is eluted before 
Gd-BT-DO3A). Künnemeyer et al. [4] stated another order of elution. For comparison, 
the elution order described by Raju et al [12] is Gd-BOPTA > Gd-DTPA > 
Gd-DOTA > Gd-DTPA-BMA > Gd-BT-DO3A, whereas the elution order described by 
Künnemeyer et al. [4] is Gd-BOPTA > Gd-DTPA-BMA > Gd-BT-DO3A > Gd-DOTA > 
Gd-DTPA. The change in the order of elution is proposed to be due to the increased 
buffer strength in the method used by Raju et al. [12], as this leads to an earlier 
elution of ionic gadolinium species. 
 
Figure 2.5: Signals for a 10
-7
 M Gd-DTPA and 10
-7
 M Gd-BT-DO3A sample (70/30 ACN / water, 
30 mM acetate buffer, flow rate: 0.2 mL min
-1
) 
 
 
Figure 2.6: Chromatogram for a mixed 10
-7
 M Gd-DTPA and 10
-7
 M Gd-BT-DO3A sample (70/30 
ACN / water, 30 mM formiate buffer, flow rate: 0.2 mL min
-1
) 
  
Gd-BT-DO3A Gd-DTPA 
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2.3.4 Sample preconcentration  
For preconcentration two different methods were tested. An evaluation of this method 
is simply obtained by calculation of the recovery rate, which is defined as deviation of 
the measured concentration from the target value.  
A very simple approach for preconcentration is evaporation of the sample. For this, 
tap water samples, spiked with indium as internal quality standard have been 
investigated. The samples were enriched by a factor of 4. For comparison, a 
synthetic sample in pure water was tested as well. 
The recovery rates of a synthetic sample (1.5 µg L-1 REE standard solution           
with 4 µg L-1 indium standard in ultrapure water) for REE isotopes and indium as 
internal quality control standard are presented in Table 2.2. The resulting recovery 
rates were excellent. Hence, further tests were performed with drinking water 
samples. The resulting recovery rates are presented in Table 2.3. Also, with these 
samples good recovery rates could be achieved, with exception of cerium. However, 
cerium analysis is interfered by oxide generation (cf. chapter 3). For analysis of the 
total element concentration of REEs this enrichment method is reliable and easily 
applicable. 
Table 2.2: Recovery rates of the measured analytes after preconcentration via evaporation for a 
synthetic sample in ultra pure water 
Isotope Recovery rate  Isotope Recovery rate 
115
In 103% 
 
158
Gd 107% 
139
La 108% 
 
159
Tb 109% 
140
Ce 109% 
 
160
Gd 109% 
141
Pr 111% 
 
161
Dy 111% 
142Nd
 112% 
 
163
Dy 112% 
143
Nd 110% 
 
165
Ho 111% 
144
Nd 111% 
 
166
Er 112% 
147
Sm 111% 
 
169
Tm 111% 
149
Sm 112% 
 
173
Yb 113% 
152
Sm 112% 
 
174
Yb 111% 
153
Eu 112% 
 
175
Lu 111% 
 
53 
 
Table 2.3: Recovery rates for the determination of REE after preconcentration via evaporation; mean 
of 10 drinking water samples 
Isotope Recovery rate  Isotope Recovery rate 
140
Ce 70% 
 159
Tb 105% 
141
Pr 96% 
 160
Gd 97% 
142Nd
 92% 
 161
Dy 95% 
143
Nd 84% 
 163
Dy 102% 
144
Nd 88% 
 165
Ho 91% 
147
Sm 86% 
 166
Er 99% 
149
Sm 86% 
 169
Tm 96% 
152
Sm 104% 
 173
Yb 108% 
153
Eu 104% 
 174
Yb 99% 
158
Gd 97% 
 175
Lu 101% 
As an alternative to the slow evaporation method SPE methods were tested. The 
advantage of SPE is that additional to preconcentration, a separation of ionic 
gadolinium species from other gadolinium species is possible. Furthermore 
enrichment factors of max. 200 may be achieved for the tested SPE cartridges.  
For anion exchange, solutions with an anionic gadolinium species (Gd-DOTA) in 
different concentrations, a solution containing only Gd(III) and a solution with a 
mixture of both have been tested. The recovery rates for the respective samples are 
presented in Table 2.4. The obtained recovery rates are > 90% for Gd-DOTA 
samples. These recovery rates are excellent for an SPE method. Yet it has to be 
considered that the tested matrix was pure water, with no competition effect by any 
other ions. For a mixture of anionic and cationic gadolinium species a lower recovery 
rate was achieved. Nevertheless, this method is a very promising approach for 
differentiation and preconcentration of anionic gadolinium species. 
Table 2.4: Recovery rates for SPE samples, using an anion exchange resin 
Gadolinium species [Gd] / µM Recovery rate 
Gd-DOTA 50 98% 
Gd-DOTA 5 93% 
Gd-DOTA 0.5 98% 
Gd-DOTA and Gd(III) 50 both 79% 
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For cation exchange, solutions with an anionic gadolinium species (Gd-DTPA) and a 
non-ionic species have been tested in different concentrations and matrices. For 
evaluation of this method a mass balance has been performed (cf. equation 2.1). In 
this equation (cf. eq. 2.1) the mass of gadolinium in the eluate should be equal to 
zero as no analyte is supposed to be retarded by the SPE material. Hence, 
equation 2.2 is resulting. 
Masssample = Masssample flush + Massimpurity removal + MassEluate   (2.1) 
Masssample = Masssample flush + Massimpurity removal     (2.2) 
The results are presented in Table 2.5. The recovery of gadolinium species in sample 
flush and the flush for impurity removal is quite well, with exception for low 
concentrations of Gd-DTPA. Yet the presented results are only triplicate experiments 
in used and regenerated SPE cartridges. For a comprehensive study, further 
experiments are necessary. 
Table 2.5: Mass balance results for cation exchange experiments; different concentrations of 
Gd-DTPA (anionic) and Gd-BT-DO3A (neutral) in ultrapure water and a drinking water matrix 
Matrix 
Gadolinium 
species 
[Gd] / µg L
-1 Masssample / (Masssample flush 
+ Massimpurity removal) in % 
Masssample / (Masssample flush + 
Massimpurity removal + MassEluate) in 
% 
U
lt
ra
p
u
re
 
w
a
te
r 
Gd-DTPA 0.01 75 122 
Gd-DTPA 1 107 109 
Gd-BT-DO3A 0.01 124 197 
Gd-BT-DO3A 1 98 109 
D
ri
n
k
in
g
 w
a
te
r Gd-DTPA 0.01 68 94 
Gd-DTPA 1 95 94 
Gd-BT-DO3A 0.01 97 98 
Gd-BT-DO3A 1 103 104 
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2.4 Conclusions 
From experiments presented in this chapter important aspects for the further 
proceeding have been revealed. The absorbance spectra of gadolinium chelates 
have been determined for application in further experiments, e.g. pulse radiolysis 
experiments for the determination of reaction rate constants. 
In literature, a decrease of gadolinium species concentration is described, when 
glass ware is used for storage [4, 12]. It has been proposed, that this effect is due to 
sorption [4]. However, a sorption processes would lead to a decrease of the total 
gadolinium concentration. In the presented experiments no significant decrease of 
the total gadolinium concentration has been detected. Hence, it is assumed, that 
transmetalation processes occur. Transmetalation processes have been proposed for 
other chelates when using glass ware [39]. However, for a final elucidation whether 
sorption effects or transmetalation is responsible for the decrease of gadolinium 
species, further experiments are necessary. Yet use of glassware for other 
experiments is omitted.  
Preconcentration of gadolinium via evaporation of the sample is a feasible, but a time 
consuming method with low enrichment factors. The separation of Gd-DOTA from 
other gadolinium species by anion exchange SPE is also feasible. However, this 
method is in comparison to the simple evaporation method very work intensive. 
Furthermore, by this method it is only possible to preconcentrate anionic 
gadolinium species and a separation of these from the matrix is possible. Other 
gadolinium species are also charged negatively, such as Gd-DTPA-2, Gd-BOPTA-2, 
Gd-EOB-DTPA-2 and Gd-MS-3253-, hence, a preconcentration of at least those four 
and Gd-DOTA is possible via this method. Other SPE methods might be used to 
preconcentrate the cationic and neutral gadolinium species. However, these SPE 
methods are only able to discriminate between charged and neutral species and not 
between the single species. Hence, it is not possible to perform SPE previous to 
ICP-MS measurements for determination of single gadolinium species. 
HILIC-ICP-MS is able to discriminate and quantify single gadolinium species. The 
coupling of HILIC to ICP-MS is extensive and involves a complete modification of the 
sample introduction system. This is only feasible for an ICP-MS system which is used 
in long term for determinations, that require such a sample introduction system. 
Hence, further developments of the very promising method have been restricted. Yet 
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a system in which a single species has to be detected is only necessary for 
evaluation of processes in real water samples. Previous experiments under 
laboratory conditions do not necessarily need a separation method for evaluation 
since they are carried out with single substances. 
The information gained from the results presented in this chapter give necessary 
information and tools for successful analysis applications in the further proceeding of 
the study.  
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2.5 Supplement 
The method for determination of platinum species, which was used to test 
hyphenation of the HILIC system to ICP-MS, is described in the following. The 
described method is validated according to the standards given in DIN EN 
ISO/IEC 17025. 
For analysis of platinum species, instrumental setup is changed only minor compared 
to the one used for gadolinium species analysis (cf. chapter 2.3.3). However, in the 
validated reference method, a larger injector tube (di = 1.85 mm) is used and a glass 
nebulizer in a non-cooled spray chamber. The separation column is a Discovery HS 
F5 HPLC Column 15 cm × 2.1 mm, 3 µm (Supleco) with a Discovery HS F5 Guard 
Column (2 cm × 2.1 mm, 3 µm (Supleco)). Furthermore, a Pre-Column Filter (1/16’’ 
Peek 2 µm Frit Sigma Aldrich) is used. The eluent is ammonium formiate buffer 
(20 mM in 4 vol% methanol, pH = 3.75) /water (50/50). Flow rate is set to 0.3 ml min-1 
with a total run time of 8 min. LOQ of the validated method is 0.3 µg L-1 for all three 
species (cis-, carbo- and oxali-platin). 
 
  
58 
 
2.6 Literature 
1. Kimura, J., T. Ishiguchi, J. Matsuda, R. Ohno, A. Nakamura, S. Kamei, K. 
Ohno, T. Kawamura, and K. Murata, Human comparative study of zinc and 
copper excretion via urine after administration of magnetic resonance imaging 
contrast agents. Radiation Medicine - Medical Imaging and Radiation 
Oncology, 2005. 23(5): 322-326. 
2. Weinmann, H.J., M. Laniado, and W. Mützel, Pharmacokinetics of 
GdDTPA/dimeglumine after intravenous injection into healthy volunteers. 
Physiological chemistry and physics and medical NMR, 1984. 16(2): 167-172. 
3. Hagan, J.J., S.C. Taylor, and M.F. Tweedle, Fluorescence detection of 
gadolinium chelates separated by reversed-phase high-performance liquid 
chromatography. Analytical Chemistry, 1988. 60(6): 514-516. 
4. Künnemeyer, J., L. Terborg, B. Meermann, C. Brauckmann, I. Möller, A. 
Scheffer, and U. Karst, Speciation analysis of gadolinium chelates in hospital 
effluents and wastewater treatment plant sewage by a novel HILIC/ICP-MS 
method. Environmental Science and Technology, 2009. 43(8): 2884-2890. 
5. Bau, M. and P. Dulski, Anthropogenic origin of positive gadolinium anomalies 
in river waters. Earth and Planetary Science Letters, 1996. 143(1-4): 245-255. 
6. Lawrence, M.G., J. Keller, and Y. Poussade, Removal of magnetic resonance 
imaging contrast agents through advanced water treatment plants. Water 
Science and Technology, 2010. 61(3): 685-692. 
7. Telgmann, L., M. Holtkamp, J. Künnemeyer, C. Gelhard, M. Hartmann, A. 
Klose, M. Sperling, and U. Karst, Simple and rapid quantification of gadolinium 
in urine and blood plasma samples by means of total reflection X-ray 
fluorescence (TXRF). Metallomics, 2011. 3(10): 1035-1040. 
8. Telgmann, L., M. Sperling, and U. Karst, Determination of gadolinium-based 
MRI contrast agents in biological and environmental samples: A review. 
Analytica Chimica Acta, 2013. 
  
59 
 
9. Künnemeyer, J., L. Terborg, S. Nowak, L. Telgmann, F. Tokmak, B.K. Krämer, 
A. Günsel, G.A. Wiesmüller, J. Waldeck, C. Bremer, and U. Karst, Analysis of 
the contrast agent Magnevist and its transmetalation products in blood plasma 
by capillary electrophoresis/electrospray ionization time-of-flight mass 
spectrometry. Analytical Chemistry, 2009. 81(9): 3600-3607. 
10. Campa, C., M. Rossi, A. Flamigni, E. Baiutti, A. Coslovi, and L. Calabi, 
Analysis of gadobenate dimeglumine by capillary zone electrophoresis 
coupled with electrospray-mass spectrometry. Electrophoresis, 2005. 26(7-8): 
1533-1540. 
11. Vora, M.M., S. Wukovnig, R.D. Finn, A.M. Emran, T.E. Boothe, and P.J. 
Kothari, Reversed-phase high-performance liquid chromatographic 
determinationof gadolinium-diethylenetriaminepentaacetic acid complex. 
Journal of Chromatography A, 1986. 369(C): 187-192. 
12. Raju, C.S.K., A. Cossmer, H. Scharf, U. Panne, and D. Lueck, Speciation of 
gadolinium based MRI contrast agents in environmental water samples using 
hydrophilic interaction chromatography hyphenated with inductively coupled 
plasma mass spectrometry. Journal of Analytical Atomic Spectrometry, 2010. 
25(1): 55-61. 
13. Raju, C.S.K., D. Luck, H. Scharf, N. Jakubowski, and U. Panne, A novel solid 
phase extraction method for pre-concentration of gadolinium and gadolinium 
based MRI contrast agents from the environment. Journal of Analytical Atomic 
Spectrometry, 2010. 25(10): 1573-1580. 
14. Künnemeyer, J., L. Terborg, S. Nowak, A. Scheffer, L. Telgmann, F. Tokmak, 
A. Günsel, G. Wiesmüller, S. Reichelt, and U. Karst, Speciation analysis of 
gadolinium-based MRI contrast agents in blood plasma by hydrophilic 
interaction chromatography/electrospray mass spectrometry. Analytical 
Chemistry, 2008. 80(21): 8163 - 8170. 
15. Telgmann, L., C.A. Wehe, J. Künnemeyer, A.C. Bülter, M. Sperling, and U. 
Karst, Speciation of Gd-based MRI contrast agents and potential products of 
transmetalation with iron ions or parenteral iron supplements. Analytical and 
Bioanalytical Chemistry, 2012: 1-9. 
60 
 
16. Frenzel, T., P. Lengsfeld, H. Schirmer, J. Huetter, and H.-J. Weinmann, 
Stability of gadolinium-based magnetic resonance imaging contrast agents in 
human serum at 37 °C. Investigative Radiology, 2008. 43(12): 817-828. 
17. Kahakachchi, C.L. and D.A. Moore, Speciation of gadolinium in gadolinium-
based magnetic resonance imaging agents by high performance liquid 
chromatography inductively coupled plasma optical emission spectrometry. 
Journal of Analytical Atomic Spectrometry, 2009. 24(10): 1389-1396. 
18. Mazzucotelli, A., V. Bavastello, E. Magi, P. Rivaro, and C. Tomba, Analysis of 
gadolinium polyaminopolycarboxylic complexes by HPLC-ultrasonic nebulizer-
ICP-AES hyphenated technique. Analytical Proceedings including Analytical 
Communications, 1995. 32(5): 165-167. 
19. Telgmann, L., C.A. Wehe, M. Birka, J. Künnemeyer, S. Nowak, M. Sperling, 
and U. Karst, Speciation and isotope dilution analysis of gadolinium-based 
contrast agents in wastewater. Environmental Science and Technology, 2012. 
46(21): 11929-11936. 
20. Pfundstein, P., D. Flottmann, C. Martin, W. Schulz, K.M. Ruth, A. Wille, T. 
Moritz, and A. Steinbach, Gadolinium-based MRI contrast agents: IC-ICP/MS 
analysis. G.I.T. Laboratory Journal Europe, 2011. 15(7-8): 31-33. 
21. Pfundstein, P., C. Martin, W. Schulz, K.M. Ruth, A. Wille, T. Moritz, A. 
Steinbach, and D. Flottmann, IC-ICP-MS analysis of gadolinium-based MRI 
contrast agents. LC-GC Europe, 2011: 16-18. 
22. Andra¡si, M., A. Gaspar, O. Kovacs, Z. Baranyai, A. Klekner, and E. Brücher, 
Determination of gadolinium-based magnetic resonance imaging contrast 
agents by micellar electrokinetic capillary chromatography. Electrophoresis, 
2011. 32(16): 2223-2228. 
23. Loreti, L. and J. Bettmer, Determination of the MRI contrast agent Gd-DTPA 
by SEC–ICP–MS. Analytical and Bioanalytical Chemistry, 2004. 379: 1050-
1054. 
  
61 
 
24. Falta, T., G. Koellensperger, A. Standler, W. Buchberger, R.M. Mader, and S. 
Hann, Quantification of cisplatin, carboplatin and oxaliplatin in spiked human 
plasma samples by ICP-SFMS and hydrophilic interaction liquid 
chromatography (HILIC) combined with ICP-MS detection. Journal of 
Analytical Atomic Spectrometry, 2009. 24(10): 1336-1342. 
25. Hemström, P., Y. Nygren, E. Björn, and K. Irgum, Alternative organic solvents 
for HILIC separation of cisplatin species with on-line ICP-MS detection. 
Journal of Separation Science, 2008. 31(4): 599-603. 
26. Nygren, Y., P. Hemstroem, C. Astot, P. Naredi, and E. Bjoern, Hydrophilic 
interaction liquid chromatography (HILIC) coupled to inductively coupled 
plasma mass spectrometry (ICPMS) utilizing a mobile phase with a low-
volatile organic modifier for the determination of cisplatin, and its 
monohydrolyzed metabolite. Journal of Analytical Atomic Spectrometry, 2008. 
23(7): 948-954. 
27. Hao, Z., B. Xiao, and N. Weng, Impact of column temperature and mobile 
phase components on selectivity of hydrophilic interaction chromatography 
(HILIC). Journal of Separation Science, 2008. 31(9): 1449-1464. 
28. Ikegami, T., K. Tomomatsu, H. Takubo, K. Horie, and N. Tanaka, Separation 
efficiencies in hydrophilic interaction chromatography. Journal of 
Chromatography A, 2008. 1184(1-2): 474-503. 
29. Kulaksiz, S. and M. Bau, Contrasting behaviour of anthropogenic gadolinium 
and natural rare earth elements in estuaries and the gadolinium input into the 
North Sea. Earth and Planetary Science Letters, 2007. 260(1-2): 361-371. 
30. Lawrence, M.G. and D.G. Bariel, Tracing treated wastewater in an inland 
catchment using anthropogenic gadolinium. Chemosphere, 2010. 80(7): 794-
799. 
31. Verplanck, P.L., H.E. Taylor, D.K. Nordstrom, and L.B. Barber, Aqueous 
stability of gadolinium in surface waters receiving sewage treatment plant 
effluent Boulder Creek, Colorado. Environmental Science and Technology, 
2005. 39(18): 6923-6929. 
62 
 
32. Kulaksiz, S. and M. Bau, Anthropogenic gadolinium as a microcontaminant in 
tap water used as drinking water in urban areas and megacities. Applied 
Geochemistry, 2011. 26(11): 1877-1885. 
33. Hennebrüder, K., R. Wennrich, J. Mattusch, H.J. Stärk, and W. Engewald, 
Determination of gadolinium in river water by SPE preconcentration and ICP-
MS. Talanta, 2004. 63(2): 309-316. 
34. Möller, P., P. Dulski, M. Bau, A. Knappe, A. Pekdeger, and C. Sommer-Von 
Jarmersted, Anthropogenic gadolinium as a conservative tracer in hydrology. 
Journal of Geochemical Exploration, 2000. 69-70: 409-414. 
35. Möller, P., P. Dulski, and J. Luck, Determination of rare earth elements in 
seawater by inductively coupled plasma-mass spectrometry. Spectrochimica 
Acta Part B: Atomic Spectroscopy, 1992. 47(12): 1379-1387. 
36. Analytical detection limit guidance & laboratory guide for determining method 
detection limits, in PUBL-TS-056-96, Wisconsin Department of Natural 
Resources. 1996. 
37. Idee, J.M., M. Port, I. Raynal, M. Schaefer, S. Le Greneur, and C. Corot, 
Clinical and biological consequences of transmetallation induced by contrast 
agents for magnetic resonance imaging: A review. Fundamental and Clinical 
Pharmacology, 2006. 20(6): 563-576. 
38. Camel, V., Solid phase extraction of trace elements. Spectrochimica Acta Part 
B: Atomic Spectroscopy, 2003. 58(7): 1177-1233. 
39. Ulanski, P., E. Bothe, K. Hildenbrand, J.M. Rosiak, and C. von Sonntag, 
Hydroxyl-radical-induced reactions of poly(acrylic acid); a pulse radiolysis, 
EPR and product study. Part I. Deoxygenated aqueous solutions. Journal of 
the Chemical Society, Perkin Transactions 2, 1996(1): 13-22. 
 
 
63 
 
3 Occurrence of gadolinium in the water cycle 
3.1 Introduction 
The gadolinium anomaly was first discovered by Bau and Dulski in 1996 [1]. It was 
the first time that anthropogenic gadolinium had been detected in the environment. 
The anomaly describes elevated concentrations of gadolinium which have been 
found in environmental aquatic samples all over the world by now.  
The anomaly is calculated as the ratio of the expected total gadolinium concentration 
in a sample and the measured concentration. The geogenic gadolinium 
concentration, which is the expected concentration, can be derived from an 
interpolation of normalized concentrations of other REEs (cf. chapter 3.2). Hence, the 
anomaly describes the factor by which the non-geogenic fraction of gadolinium is 
higher than the geogenic one.  
The anomaly is assumed to be originated from gadolinium chelates [1-3] which are 
extremely stable (log K > 16) and used as diagnostics in Magnetic Resonance 
Imaging (MRI) (cf. chapter 1). This assumption was made, because no other 
application is introducing gadolinium in relevant concentrations to water bodies [1]. It 
is assumed that they are excreted unmetabolized by the patients [4]. Hence, the 
chelates reach wastewater treatment plants (WWTPs) via the sewage system. There, 
the chelates are retained insufficiently [5].  
The chelates are classified as not readily biodegradable [6]. This is explained by their 
chemical stability (cf. chapter 4.2.2.1). Microbial degradation of gadolinium chelates 
is not of any importance in the aquatic environement [6]. This is an important factor 
for the persistence of the chelates during wastewater treatment. The chelates which 
are not retained in the wastewater treatment plant reach the recipient waters without 
any modification [5]. The soluble and stable chelates differ strongly from natural 
gadolinium in their reactivity and hence, an amplification and transfer of the 
gadolinium anomaly has been proposed [1]. This statement has been corroborated 
by subsequent studies on the gadolinium anomaly [7, 8]. An summary of important 
studies reporting on the anomaly in different water bodies is presented in Table 3.1. 
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Table 3.1: Occurrence of the gadolinium anomaly; MUQ is Mud from Queensland, PAAS is Post 
Archaean Australian shale, NASC is North American Shale Composite; concentrations of Gdanthropogenic 
and values for the anomaly are not given, due to the varity of the sampling locations (amongst others 
to avoid comparison of river water data which are differently influenced by WWTP plumes) 
Place Water bodies Year 
Reference 
material 
Author 
Australia River, semi-enclosed shallow bay 2009 MUQ Lawrence [3] 
Australia River, WWTP 2009 MUQ Lawrence and 
Bariel [9] 
Australia WWTP, surface water, tap water 2009 MUQ Lawrence et al. [10] 
Austria River, WWTP 2005, 
2007 
PAAS Kulaksiz and Bau [8] 
Czech 
Republic 
WWTP, river, tap water, spring 2002 PAAS Möller et al. [11] 
Czech 
Republic 
WWTP, river, raw water, tap water, 
spring, 
2006 PAAS Morteani et al. [12] 
England River, tap water 2009 PAAS Kulaksiz and Bau [8] 
France River, lagoon 2002 NASC Elbaz-Poulichet et 
al. [13] 
France River, wells and springs for drinking 
water supply, WWTP effluent 
2003 -
2004 
NASC Rabiet et al. [14] 
France River, wells for drinking water supply, 
WWTP effluent 
2004 NASC Rabiet et al. [14] 
Germany River, tap water, WWTP 1996 PAAS Bau und Dulski [1] 
Germany River 2000 PAAS Möller et al. [2] 
Germany River, groundwater, tap water 2004 -
2011 
PAAS Kulaksiz and Bau [8] 
Germany Lake, river, WWTP 2005 PAAS Knappe et al. [15] 
Germany WWTP, river, estuary, sea 2007 PAAS Kulaksiz and Bau [7] 
Germany River, wells for drinking water supply 2009 PAAS Schwesig and 
Bergmann [16] 
Germany Hyporheic zone water of a river, 
groundwater 
2010 PAAS Lewandowski et 
al. [17] 
Italy River 2003 PAAS Möller et al. [18] 
Japan River 1996 PAAS Bau und Dulski [1] 
Japan River, estuaries 1996 PAAS Nozaki et al. [19] 
Japan River 2000 PAAS Möller et al. [2] 
Japan River, coastal sea water 2001 PAAS Zhu et al. [20] 
Japan River, surface sea water,  2006 Local silicic 
rock 
Ogata and 
Terakado [21] 
Luxembourg River, wells for drinking water supply 2009 PAAS Schwesig and 
Bergmann [16] 
Sweden Lake, coastal semi-closed basin 1996 PAAS Bau und Dulski [1] 
Sweden River 2000 PAAS Möller et al. [2] 
USA WWTP 2005-
2007 
NASC Verplanck et al. [22] 
USA River, WWTP effluent 2005 NASC Verplanck et al. [23] 
USA River 2006 NASC Barber et al. [24] 
USA River, lake 2006 PAAS Bau et al. [25] 
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Soon after the first detection of the gadolinium anomaly, it has been proposed to use 
the anomaly as pseudo-natural tracer for the anthropogenic influence on a water 
body [2]. To investigate if, e.g., a deep well is contaminated with water originated 
from a WWTP, it is possible to determine the anomaly. Furthermore, it may be 
determined, how great such an influence is. In detail, by determination of the 
anomaly not only in the water body of interest, but also in surrounding water bodies, 
the mixing ratio may be determined [2, 9, 16]. The gadolinium anomaly has also been 
used for verification of biodegradation studies [17]. In this study [17], water samples 
from the hyporheic zone of a eutrophic river have been taken in different depths and 
concentrations of different micropollutants, such as ibuprofen and diclofenac, have 
been determined. These concentrations were decreasing with sampling depth. 
However, also the concentration of borate and the gadolinium anomaly which were 
used as indicators for wastewater contact were decreasing. By the determination of 
these tracers a wrong interpretation of the data has been prevented. It has been 
possible to distinguish between samples that were in contact with wastewater and in 
which a biodegradation took place and such samples that have never been in contact 
with wastewater. 
For the application of the gadolinium anomaly as tracer it is not necessary to know 
the speciation of the gadolinium present in the sample, as only the total concentration 
of gadolinium has to be determined [1]. Natural gadolinium which is ionic or weakly 
inorganic chelated binds to particles and is affected by mixing and sedimentation 
processes, or by environmental flocculation processes [3, 7]. Organic and highly 
stable chelates like the medical diagnostics are not affected by such processes [3, 7]. 
Hence, the transfer and amplification of the anomaly is based on different 
environmental behavior of the geogenic gadolinium and anthropogenic gadolinium [3, 
7]. Consequential, if the speciation of the anthropogenic gadolinium is changed, this 
will also influence the gadolinium anomaly. 
However, to use gadolinium as tracer it is necessary to determine the gadolinium 
anomaly and not only the total gadolinium concentration [1, 11, 13, 16, 19, 20, 23, 25, 
26]. The determination of the anomaly is required as high total gadolinium 
concentrations are not necessarily only due to anthropogenic gadolinium but may 
also be caused by a high geogenic background, which will be described in the 
following. The gadolinium anomaly describes how much higher the concentration of 
66 
 
the measured gadolinium is compared to the one expected from the distribution 
pattern of other rare earth elements (REE). To determine the anomaly, the 
concentration of the relevant REEs in a sample is measured and normalized to a 
reference material. This normalized concentration is plotted versus the atomic 
number of the elements, and the resulting graph is fitted with a (linear or exponential) 
function. If the sample contains only geogenic gadolinium, the data point of the 
normalized gadolinium concentration is close to the interpolated function. Yet, if a 
sample contains non-geogenic gadolinium (e.g. from wastewater), the normalized 
gadolinium concentration will be higher than the expected one. The 
gadolinium anomaly can be calculated by dividing the normalized measured 
gadolinium concentration by the normalized expected 
concentration (cf. chapter 3.2.3). Consequently, the gadolinium anomaly describes 
the factor by which the actual gadolinium concentration is above the geogenic level.  
The relevance of the anomaly determinations for description of anthropogenic 
influence is presented in the following. It is not possible to identify an anthropogenic 
influence by determination of the total elemental concentration of gadolinium only. A 
complete determination of the gadolinium anomaly has to be performed as shown in 
the following examples. In Figure 3.1 the calculation of the anomaly for a sample 
from a deep well is presented. In this sample, the total elemental concentration of 
gadolinium is extremely high ([Gd]total = 4470 ng L
-1), even higher as one might 
expect in wastewater treatment plants (, which is usually ≤ 1 µg L-1). Hence, one 
might falsely conclude that this sample is influenced by human activity, if only 
considering the total element concentration. However, based on the determination of 
the gadolinium anomaly (, which is in this case < LOQ), this conclusion has to be 
rejected. The gadolinium concentration is not any higher than one might expect by 
comparing it to other REE concentrations. The high concentrations of REEs in this 
sample are probably due to the acidity of the water (pH = 4.7). The acidic water must 
have leached the metals from the surrounding bedrock. 
The importance of the anomaly calculation can be supported by an example of 
another extreme (cf Figure 3.2). The sample was taken from a wastewater plant in 
Finland.  
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Figure 3.1: Plot of the concentration of the REEs normalized to PAAS (as reference material) vs. the 
atomic number for the determination of the gadolinium anomaly in a deep well sample; filled 
diamonds: mass traces used for the determination of the anomaly; open triangles: mass traces not 
used for determination of the anomaly and / or the determination of the isotope is interfered; marked 
with a star: normalized gadolinium concentration 
 
 
Figure 3.2: Plot of the concentration of the REEs normalized to PAAS (as reference material) vs. the 
atomic number for the determination of the gadolinium anomaly in a sample from a wastewater 
treatment plant effluent in Finland; filled diamonds: mass traces used for the determination of the 
anomaly; open triangles: mass traces not used for determination of the anomaly and / or the 
determination of the isotope is interfered; marked with a a star: normalized gadolinium concentration 
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Even though the gadolinium concentration seems to be rather low (23.6 ng L-1), by 
determination of the anomaly (gadolinium anomaly = 8.3) it is evident that a large 
fraction of this gadolinium is of non-geogenic origin and as there are no relevant 
applications of gadolinium other than MRI contrast agents which may have an 
influence on the gadolinium concentration in water, the determined gadolinium must 
derive from such applications.  
Since the end of the 1990ies gadolinium anomalies have been detected in natural 
water systems and attributed to the influence of wastewaters from medical 
applications of gadolinium compounds (cf. Table 3.1). In this chapter, the extent of 
gadolinium emission and its relevance in the water cycle from wastewater treatment 
to tap water is described. This was done to verify that gadolinium chelates are 
present in notable high concentrations, making it necessary to investigate the effects 
of water treatment on the chelates. 
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3.2 Experimental 
The relevance of anthropogenic gadolinium in the water cycle was determined by 
identification of the gadolinium anomaly in two different water matrices. WWTPs 
effluents were studied to investigate the impact of gadolinium on surface waters, as 
well as the spatial distribution of the anomaly in Europe to verify that the emission of 
gadolinium has become by now a problem, independent from the countries 
development status. As gadolinium emissions are generally originated by health care, 
a correlation of gadolinium data and data from a health care systems ranking has 
been performed, to verify not only a qualitative, but also a semi-quantitative 
dependency. 
Tap water samples have been taken to study how great the impact of anthropogenic 
gadolinium on drinking water is which implies how great the uptake of gadolinium is 
by drinking tap water. Furthermore these investigations give a hint on the removal 
rates during water treatment. 
 
3.2.1 Sampling 
Tap water samples in households in the Ruhr area in Germany were collected 
according to German drinking water standards for metal ion determinations [28]. Prior 
to sampling the tap water was run until a constant temperature of approx. 10-15°C 
was reached. Then samples were taken in Vials (PP) and acidified when they arrived 
in the laboratory (4 ml HNO3 (65%, ultrapure) per liter).  
Deep well samples were taken according to the DIN 38402-13 [29] and also acidified 
when they arrived in the laboratory (4 ml HNO3 (65%, ultrapure) per liter). 
The samples from the waste water treatment plants were taken as random samples 
according to DIN 38402-11 [30]. Samples were cooled during transport and acidified 
when they arrived in the laboratory (4 ml HNO3 (65%, ultrapure) per liter). 
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3.2.2 Instrumentation 
For the determination of the rare earth elements’ concentrations, measurements 
were performed with a Perkin Elmer ELAN DRC II ICP-MS that was equipped with an 
AS90 autosampler. The ICP-MS method parameters are presented in Table 2.1 
(cf. chapter 2). It is necessary to determine also other REEs to be able to differentiate 
between geogenic and non-geogenic gadolinium). The limit of quantification for all 
REEs was determined according to the US EPA guidelines [27] (cf. Table 3.2).  
Table 3.2: Limit of quantification for each measured m/z in the gadolinium anomaly method and 
possible interferences in the determination 
Isotoppe LOQ [ng L-1] Abundance 
[%] 
Isobaric interferences 
(abundance [%]) 
Molecule interferences 
(abundance of Ba isotope [%]) 
140
Ce 2 88.5 - - 
141
Pr 2 100.0 - - 
142
Nd 3 27.1 
142
Ce (11.1) - 
143
Nd 3 12.2 - - 
144
Nd 5 23.8 
144
Sm (3.1) - 
147
Sm 4 15.0 - - 
149
Sm 5 13.8 - - 
152
Sm 5 26.7 
152
Gd (0.2) 
136
BaO (7.9) 
153
Eu 2 52.2 - 
137
BaO (11.2) 
158
Gd 1 24.8 
158
Dy (0.1)  
159
Tb 1 100.0 -  
160
Gd 1 21.9 
160
Dy (2.3)  
161
Dy 3 18.9 -  
163
Dy 3 24.9 -  
165
Ho 1 100.0 -  
166
Er 3 33.6 -  
169
Tm 1 100.0 -  
173
Yb 3 16.1 -  
174
Yb 1 31.8 
174
Hf (0.2)  
175
Lu 1 97.4 -  
 
3.2.3 Calculation of the anomaly 
The calculation of the anomaly is performed according to Bau and Dulski [1]. As 
reference material the Post Achaean Australian Shell (PAAS) was chosen as well. 
The calculation of the anomaly is presented in the following. First molar 
concentrations of the REEs are normalized to the PAAS: 
]M[PAASinionconcentratREE
]M[ionconcentratREEmeasured
=ionconcentratREEnormalized      (3.1) 
The normalized concentrations are ploted vs. the atomic number (cf. Figure 3.3). The 
resulting plot is fitted to an (usually) exponential curve. 
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Figure 3.3: Determination of the gadolinium anomaly; PAAS-normalized REE concentration vs. the 
atomic number; filled diamonds: isotopes used for calculation of the anomaly; open triangles: 
determination of isotopes interfered and / or isotopes not used for calculation; measured gadolinium 
isotopes marked with a star; gadolinium concentration which would be expected marked with a dot; 
sample type: Tap water from a household in Kerken, Germany 
 
The normalized geogenic gadolinium concentration is defined by this fitted function. 
Hence, it is possible to calculate this “expected” normalized gadolinium concentration 
by use of the function.  
Once the expected normalized gadolinium concentration is known, as well as the 
measured normalized gadolinium concentration, one is able to calculate the 
gadolinium anomaly: 
ionconcentratgadoliniumnormalizedectedexp
ionconcentratgadoliniumnormalizedmeasured
=anomalygadolinium  (3.2) 
  
[Gd]expected 
[Gd]measured 
expected[Gd]
measuredGd][
 =  Anomaly Gd
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3.3 Results 
The determination of the gadolinium anomaly in the effluent of wastewater treatment 
plants in Europe has shown that there is an enormous input of non-geogenic 
gadolinium to water resources all across Europe. The results are presented in   
Figure 3.4 (detailed results are presented in Table S 3.1). 
 
Figure 3.4: Results of a pan-European monitoring study: gadolinium anomaly plotted vs. the sample 
number; b) Zoom, to show the value for a normal distribution of the rare earth elements in a water 
sample 
a) 
b) 
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The gadolinium anomaly is independent on the economic development status of the 
country (cf.  Figure S 3.1). Non-geogenic gadolinium may be found in any wastewater 
treatment plant receiving water from a hospital or doctor’s office applying gadolinium 
based contrast agents or from patient’s households. 
Interestingly, the gadolinium anomaly may be correlated with the performance of the 
health care system of the specific country (cf. Figure 3.5). The quartile average 
(average of the first and third quartile) was taken to reduce the influence of the lowest 
anomalies, as no or very low anomalies may be found in wastewater treatment plants 
which do not receive water from any MRI using facility. 
DALE and independent from this, expenditure (both taken from the WHO ranking 
“performance of the health system” [31]), were also correlated with gadolinium 
anomaly. Best fit (r2 = 0.87) was obtained vs. the complete ranking (performance of 
the health system).  
The ranking of the health system in 2000 was performed by the 
World Health Organization (WHO). The performance of a health care system is a 
combination of two factors: 
 health (here, expressed in disability-adjusted life expectancy (DALE)) 
which is established by several factors, also by such which are not manageable 
by a health system (good nutrition, work, climate, war, etc) and  
 expenditure (private and public) for the health care system 
(, including costs for MRI diagnostics as one factor) [31] 
The DALY (disability-adjusted life year) which is usually used for burden of disease 
estimation, was not used as more parameters are necessary for its calculation than 
for calculation of DALE [32]. For estimation of the DALE following information is 
necessary:  
 fraction of the population surviving certain age (calculated using birth and death 
rates); 
 prevalence disability types at all ages;  
 Type of disability is weighted sometimes with age (dependents on the type of 
disability). [32] 
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Gadolinium in diagnostic is not directly linked to the health of a population. Yet, good 
diagnostics are necessary to find correct cures for the specific disability and hence, to 
decrease the mortality assigned to the specific disability. However, the correlation 
between those data sets (DALE and gadolinium anomaly) is rather poor. The 
interdependency between expenditure and gadolinium data did not lead to a better 
correlation, as one might have expected. The expenditure for the health care systems 
is very complex and diagnostics are only a small part of the complete system. 
Eventhough MRI diagnostics are considered as one factor in overall expenditure, it is 
composed of several different parameters which contributing to different (larger) 
extend to the overall expenditure [31]. 
Considering the remarks above (health is not dependent on the use of MRI contrast 
agents, nor are MRI contrast agents influencing costs as single most factor,) it is 
comprehensible that the best correlation is found when considering the complete 
ranking. 
 
Figure 3.5: Results of the pan-European study: Gadolinium anomaly in the effluent of 75 European 
wastewater treatment plants plotted vs. the position of the specific country in the 2000 WHO ranking of 
the performance of the health system (rank 1-10: Italy, Spain, Austria (n = 10), rank 11-20: Portugal, 
Greece, Netherlands, Ireland, Switzerland (n = 22), rank 21-30: Belgium, Cyprus, Germany (n = 24), 
rank 31-40: Finland, Slovenia (n = 7), rank 41-50: Czech republic (n = 7), rank 51-60: Hungary (n = 2), 
rank 71-80: Lithuania (n = 3)); circled quartile average was used for linear regression 
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Results from a drinking water monitoring campaign in the densely populated Ruhr 
area (5.15 million inhabitants [33]) are presented in Figure 3.6 (detailed results in 
chapter 3.5.2). In the Ruhr area a great proportion of the drinking water supply is 
based on bank filtration from the Ruhr River and also most of the wastewater 
treatment plants discharge their effluent into the Ruhr River. The area surrounding 
Ruhr River is very densely populated (cf. Figure 3.6) and hence, the wastewater load 
in the river is higher than in the Lippe River, which is used for drinking water 
production in the northern part of the Ruhr area. Due to high population density also 
hospital density is higher. Centralization of the health system is a factor contributing 
to increased influence of pharmaceuticals in the Ruhr River. Patients are referred to 
specialists in hospitals in urban centers, for special examinations and therapies. 
Hence, pharmaceuticals, which are used for these special treatments, are discharged 
into the urban wastewater. This applies also for gadolinium diagnostics, as there are 
remarkably fewer MRI facilities in less densely populated regions. 
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Next page: 
Figure 3.6: Results from drinking water monitoring in the Ruhr area; orange bars: [Gd]total, value above 
is the concentration in  ngL
-1
; yellow (and bright yellow) bars: [Gd]geogenic,; < LOQ = [Gd]total < LOQ; 
n.d. = not determined ([REE] too low); n.q. = not quantified (anomaly < 1.5), for both cases (n.d. and 
n.q.) it is assumed that [Gd]total = [Gd]geogenic; brown circles: wastewater treatment plant; blue squares: 
drinking water treatment plant; red circles: city center with population > 100000; grey area: building 
covered area; black lines: drinking water distribution area (2012, LANUV NRW) NOTE: drinking water 
distribution areas may be variable and drinking water is not necessarily from one specific supplier, only 
a certain water quality is described by the drinking water distribution area 
 
 
  
Gadolinium anomaly 
in drinking water in the Ruhr Area 
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Yet, in the northern part of the region water supply is provided by the Lippe River and 
to a greater extent (compared to the southern and central Ruhr Area) ground water is 
used. The anthropogenic influence on the Lippe River is less pronounced than on the 
Ruhr River. Hence, it has been assumed, that the non-geogenic fraction of 
gadolinium should be higher in the region close to the Ruhr River and lower in the 
northern part of the Ruhr area. The results shown in Figure 3.6 corroborate this 
assumption. Only few exceptions have been found, which may be explained by the 
variable sources of the drinking water. This variability of drinking water is described 
by the drinking water supply areas (also displayed in Figure 3.6) that describe areas 
in which a certain composition of drinking water is supplied. The samples from 
Bottrop- Mitte, Mülheim-Styrum and Oberhausen-Sterkrade do not show an anomaly, 
even though they are directly located in the densely populated region. However, 
these sampling locations were in other drinking water distribution areas than the 
neighboring samples, with high gadolinium anomalies. 
The sample from Recklinghausen is located in the same drinking water supply area 
as the samples from Gelsenkirchen-Buer, Gelsenkirchen-Horst and Marl-Sinsen. 
However, it is the only sample in this area that does not show an anomaly. This might 
be due to the variability of the drinking water supply areas. The drinking water does 
not necessarily have to be from one supplier at all times. 
Sampling time (samples were taken on different days of the week), has also been 
assumed to contribute to the variations. This assumption has been disproved by a 
sampling campaign at three different sampling locations (Duisburg-Duissern, 
Essen-Steele and Oberhasuen-Sterkrade) over a period of at least 10 days. The 
results are presented in Figure 3.7. Due to a lower concentration in the samples of 
Oberhausen-Sterkrade and Duisburg-Duissern it was necessary to preconcentrate 
the samples to be able to determine not only gadolinium, but also other REEs. The 
preconcentration by evaporation of the samples (1:4 enrichment (cf. chapter 2.2.6.1) 
yielded recovery rates of 80%. The low concentration of the REE`s may be explained 
by lower flow rates (due to seasonal variations) in the river used for bank filtration 
which leads to less turbulences. These turbulences are responsible for transport of 
particle-bound REEs [34]. 
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Figure 3.7: Monitoring of the gadolinium anomaly at three sampling locations over a period of 10 
days; the geogenic gadolinium concentration in ng L
-1
 is colored; the non-geogenic fraction of the 
gadolinium concentration is grey; deviation is higher for OB-Sterkrade and Du-Duissern as a 
preconcentration of the samples by evaporation was necessary to be able to quantify not only 
gadolinium but also concentrations of the other REEs 
The results presented in Figure 3.7 cleary show that a daily variation of the 
gadolinium anomaly in drinking water is not given. However, a variation might be 
detectable in a broader time range, e.g. connected to the seasonal variation. The 
small differences of [Gd]non-geogenic presented in Figure 3.7 may be explained by other 
factors. Gadolinium, discharged from a wastewater treatment plant travels different 
distances until it reaches drinking water production. Every gadolinium discharge into 
the river increases the gadolinium load in this specific river. However, one has to 
consider also the dilution by rivers, creeks and wastewater treatment plants not 
carrying gadolinium. Furthermore, also the ratio of former wastewater in the raw 
water which is used for the drinking water production for the specific tap water is 
variable, as well as the residence time in soil. All these factors may contribute to the 
small variations of the anomaly.  
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Another important result from this monitoring campaign is the dimension of the 
anomaly compared to other urban areas. A recent study from Berlin has shown a 
non-geogenic concentration of 18 ng L-1 as maximum (additional to a geogenic 
background of 0.54 ng L-1), with an average non-geogenic concentration of 3.7 ng L-1 
(additional: average geogenic background of 2 ng L-1). For the Ruhr area the 
maximum non-geogenic concentration is 35.1 ng L-1 (additional geogenic 
background = 2.1 ng L-1), with an average non-geogenic concentration of 16.4 ng L-1 
(additional average geogenic background = 7.3 ng L-1).  
Considering only the non-geogenic fraction of the total gadolinium concentration, the 
concentrations in the Ruhr area are almost twice as high. This may have several 
reasons:  
- Emission of gadolinium diagnostics in the Ruhr area is of importance for the 
whole area since 1988, in Berlin this is only the case for the western part until 
the reunion and the following reconstruction years. 
- Less inhabitants in Berlin (3.5 million people in Berlin [Amt für Statistik Berlin-
Brandenburg, Stichtag 31.12.2011]; 5.15 million people in the Ruhr area [33]) 
- Higher “re-use-rate” of the water in the Ruhr area: The percentage of 
wastewater treatment plants in the Ruhr region that use a water body which 
serves as raw water source for drinking water production is higher than for 
wastewater treatment plants in Berlin (cf. Figure 3.6 and [8]) 
- Steady increase in use of gadolinium diagnostics for MRI: campaign in Berlin 
was in 2010 [8]; results of the Ruhr area in this study are from 2012 
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3.4 Conclusion 
The results of both drinking water monitoring campaigns in urban areas show that 
anthropogenic gadolinium reaches drinking water. It is concluded, that the 
anthropogenic gadolinium is not substantially removed by any of the treatment 
processes. Yet the speciation of gadolinium in the drinking water is unknown. 
Consumers of drinking water are highly concerned, when even such low 
concentrations of anthropogenic chemicals are detected in the water. Recently it has 
been shown that transmetalation occurs during flocculation steps in drinking water 
treatment (with Fe(III)) [35, 36]. However, the extent of this process and speciation of 
gadolinium which reaches consumers’ tap has not been evaluated. It is possible, 
however unlikely, that gadolinium is present in its free and toxic form. The LD50 of 
GdCl3 · 6 H2O is 100-200 mg kg
-1 for mice [37]. For an acute intoxication with 
gadolinium from drinking water a mice had to drink 100 m3 (assumptions: 30 ng L-1 
Gdtotal in drinking water present as Gd(III), typical house mouse 20 g). Humans would 
need even higher amounts. Nevertheless, long-term effects of low (chelated or ionic) 
gadolinium dosages are not known [8]. 
Even though research in this area has increased in the past years, a great part of the 
processes in the environment and in water treatment are still unknown [5, 8, 35, 36, 
38, 39]. In this study it could be demonstrated, that gadolinium emission via WWTPs 
into the aquatic environment is relevant all across Europe. The amount of 
anthropogenic gadolinium is not directly linked to an economic development status of 
the country, however, to the development status of the health care system in that 
specific country.  
In other studies, it could be shown that non-toxic gadolinium chelates enter the 
wastewater treatment plants and approx. one third enter the recipient waters [5]. In 
general it is unknown which processes are important for the removal of the 
gadolinium species whether in its original (chelated) form or as newly generated 
chelate or in its free ionic form. However, it is known that the gadolinium 
concentration (as chelated form and [Gd]total) decreases right after a sedimentation 
step [5]. Hence, it was considered that sorption on organic matter is an important 
factor [5]. However, this may only apply to ionic, non-chelated gadolinium, as results 
of adsorption on activated carbon filters have shown no significant removal of 
[Gd]non-geogenic in a biologically active filter (cf. chapter 4). It is not known if 
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transmetalation occurs during transport in the environment, eventhough there are 
hints that Cu(II) and Ni(II) exchange Gd(III) during soil passage [40]. Sorption 
processes in the environment are also hitherto poorly studied. It is known that, that 
anthropogenic gadolinium is not retained by soil passage [39-41]. However, 
processes during transport in the environment may influence the speciation of 
gadolinium and may also lead to a reduction of gadolinium in the water phase. A 
crucial factor for evaluation of these processes is an analytical method for speciation 
which is highly sensitive [42]. 
The presence of anthropogenic gadolinium in drinking water, which could be 
demonstrated in this study analogue to previous studies [8] and its occurrence in 
WWTPs all across Europe could demonstrate the necessity of research on the 
behavior of gadolinium chelates during water treatment processes. Due to insufficient 
removal during the treatment processes for wastewater and drinking water, 
processes which are of importance for both treatment processes have been 
investigated. Hence, activated carbon treatment (cf. chapter 4) and oxidative 
processes (cf. chapter 5) were evaluated to provide insight in their behavior. 
However, to fully understand the life cycle of gadolinium, further research is 
necessary.  
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3.5 Supplement  
3.5.1 Detailed results of the pan-European study 
Table S 3.1: Detailed results of the pan-European study; gadolinium anomaly in the effluent of 
wastewater treatment plants 
Country 
[Gd] / 
ng L
-1
 
 
G
d
 a
n
o
m
a
ly
 
N
o
n
-g
e
o
g
e
n
ic
 G
d
  
/ 
%
 
[G
d
] n
o
n
-g
e
o
g
e
n
ic
  
/ 
n
g
 L
-1
 
[G
d
] g
e
o
g
e
n
ic
  
 /
 n
g
 L
-1
 
Performance of health systems WHO ranking 
R
a
n
k
in
g
 o
f 
h
e
a
lt
h
 
le
v
e
l 
(D
A
L
E
) 
R
a
n
k
in
g
 o
f 
h
e
a
lt
h
 
le
v
e
l 
p
e
rf
o
rm
a
n
c
e
1
 
R
a
n
k
in
g
 o
f 
h
e
a
lt
h
 
e
x
p
e
n
d
it
u
re
 p
e
r 
c
a
p
it
a
 i
n
 i
n
te
rn
a
ti
o
n
a
l 
d
o
lla
rs
2
 
O
v
e
ra
ll 
ra
n
k
in
g
 o
f 
p
e
rf
o
rm
a
n
c
e
 o
f 
th
e
 
h
e
a
lt
h
 s
y
s
te
m
 
Austria 275 678 100 274 0.4 17 15 6 9 
Greece 247 301 100 246 0.8 7 11 30 14 
Netherlands 237 292 100 237 0.8 13 19 9 17 
Greece 204 281 100 204 0.7 7 11 30 14 
Austria 58.2 275 100 57.9 0.2 17 15 6 9 
Belgium 15.7 186 99 15.6 0.1 16 28 15 21 
Finland 711 153 99 706 4.6 20 44 18 31 
Belgium 154 140 99 153 1.1 16 28 15 21 
Germany 441 137 99 438 3.2 22 41 3 25 
Cyprus 52.5 135 99 52.1 0.4 25 22 39 24 
Switzerland 66.4 134 99 65.9 0.5 8 26 2 20 
Belgium 419 132 99 416 3.2 16 28 15 21 
Netherlands 211 121 99 209 1.7 13 19 9 17 
Austria 118 101 99 117 1.2 17 15 6 9 
Netherlands 227 92.5 99 225 2.4 13 19 9 17 
Netherlands 115 90.9 99 114 1.2 13 19 9 17 
Belgium 59.3 83.1 99 58.6 0.7 16 28 15 21 
Finland 101 80.2 99 99.2 1.2 20 44 18 31 
Switzerland 92.0 79.8 99 90.9 1.1 8 26 2 20 
Cyprus 41.1 75.8 99 40.5 0.5 25 22 39 24 
Netherlands 305 75.8 99 301 4.0 13 19 9 17 
Czech 
Republic 
115 63.1 98 113 1.8 35 81 40 48 
Germany 719 60.9 98 708 12 22 41 3 25 
Czech 
Republic 
43.9 58.8 98 43.2 0.7 35 81 40 48 
Netherlands 84.1 53.0 98 82.5 1.6 13 19 9 17 
Slovenia 49.6 42.2 98 48.5 1.1 34 62 29 38 
                                            
1
 Ranking of comparison of actual attainment and attainment which a system should be able to accomplish (best results, which 
2
 international dollar: hypothetical currency with the same purchasing power as the U.S. dollar in the United States 
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Netherlands 223 41.2 98 218 5.3 13 19 9 17 
Finland 232 38.2 97 227 5.9 20 44 18 31 
Austria 24.7 36.6 97 24.0 0.7 17 15 6 9 
Belgium 219 35.7 97 213 6.0 16 28 15 21 
Spain 19.3 35.1 97 18.7 0.5 5 6 24 7 
Czech 
Republic 
56.4 33.7 97 54.7 1.6 35 81 40 48 
Switzerland 33.9 33.6 97 32.9 1.0 8 26 2 20 
Belgium 390 28.8 97 375 13 16 28 15 21 
Finland 208 27.9 97 200 7.2 20 44 18 31 
Netherlands 43.7 26.6 96 42.1 1.6 13 19 9 17 
Switzerland 10.7 22.5 96 10.2 0.5 8 26 2 20 
Netherlands 122 22.4 96 117 5.2 13 19 9 17 
Finland 95.0 22.2 96 90.9 4.1 20 44 18 31 
Belgium 17.5 21.5 96 16.7 0.8 16 28 15 21 
Spain 33.6 20.6 95 32.0 1.6 5 6 24 7 
Austria 21.0 19.7 95 19.9 1.0 17 15 6 9 
Belgium 59.5 17.2 95 56.2 3.3 16 28 15 21 
Belgium 155 15.0 94 145 9.7 16 28 15 21 
Czech 
Republic 
5.7 14.6 94 5.3 0.4 35 81 40 48 
Netherlands 90.1 13.3 93 83.7 6.3 13 19 9 17 
Lithuania 16.8 13.0 93 15.6 1.2 63 93 71 73 
Netherlands 146 11.2 92 134 12 13 19 9 17 
Germany 58.7 10.2 91 53.5 5.2 22 41 3 25 
Lithuania 46.6 10.0 91 42.3 4.2 63 93 71 73 
Belgium 105 9.2 90 94.2 10 16 28 15 21 
Finland 23.6 8.3 89 21.0 2.5 20 44 18 31 
Belgium 219 8.0 89 194 24 16 28 15 21 
Austria 25.1 7.6 88 22.1 2.9 17 15 6 9 
Belgium 83.6 7.3 88 73.4 10 16 28 15 21 
Lithuania 16.1 6.3 86 13.9 2.2 63 93 71 73 
Ireland 32.6 5.7 85 27.7 4.8 27 32 117 19 
Czech 
Republic 
91.3 5.7 85 77.6 14 35 81 40 48 
Ireland 3.0 3.4 77 2.3 0.7 27 32 117 19 
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Czech 
Republic 
1.8 2.9 74 1.3 0.5 35 81 40 48 
Belgium 54.2 2.9 74 40.2 14 16 28 15 21 
Czech 
Republic 
2.3 2.7 73 1.7 0.6 35 81 40 48 
Switzerland 2.5 2.5 72 1.8 0.7 8 26 2 20 
Belgium 34.5 2.4 70 24.3 10 16 28 15 21 
Belgium 127 2.2 68 86.8 40 16 28 15 21 
Belgium 35.0 2.1 67 23.6 11 16 28 15 21 
Belgium 16.9 < 2 ≤ 66 0.0 17 16 28 15 21 
Belgium 46.1 < 2 ≤ 66 0.0 46 16 28 15 21 
Belgium 16.1 < 2 ≤ 66 0.0 16 16 28 15 21 
Hungary 55.6 < 2 ≤ 66 0.0 56 62 105 59 66 
Hungary 65.1 < 2 ≤ 66 0.0 65 62 105 59 66 
Italy 231 < 2 ≤ 66 0.0 231 6 3 11 2 
Italy 15.7 < 2 ≤ 66 0.0 16 6 3 11 2 
Portugal 49.5 < 2 ≤ 66 0.0 50 29 13 28 12 
Spain 3.5 < 2 ≤ 66 0.0 3.5 5 6 24 7 
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Figure S 3.1: Results of the pan-European study: Gadolinium anomaly in the effluent of 75 European 
wastewater treatment plants plotted vs. the position of the specific country in the 2011 United 
Nations (UN) ranking of the gross domestic product per capita at nominal value; rank 1-5: no country; 
rank 5-10: Switzerland (n = 5); rank 11-15: Netherlands and Austria (n = 17); rank 16-20: Belgium, 
Finland, and Ireland (n = 27); rank 21-25: Germany and Italy (n = 5); rank 26-30: Spain, Cyprus, and 
Greece (n = 7); rank 31-35: Portugal and Slovenia (n = 2); rank 36-40: Czech republic (n = 7); 
rank 41-45: none; rank 50-55: Hungary (n = 2); rank 56-60: Lithuania (n = 3) 
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3.5.2 Detailed results of the gadolinium anomaly in the Ruhr area 
Table S 3.2: Gadolinium anomaly in the Ruhr area, detailed results; geogenic results in grey: Anomaly 
< LOQ, hence, it is assumed that [Gd]geogenic = [Gd]total 
Place 
Gd 
in ng L-1 
Gd anomaly 
Gdnon-geogenic 
[%] 
[Gd]non-geogenic in 
ng L-1 
[Gd]geogenic in 
ng L-1 
Bo-Ehrenfeld 29 5.0 80 4.7 24 
Bot-Batenbrock 23 19 95 1.2 22 
Bot-Boy 23 24 96 0.9 22 
Bot-Mitte < LOQ n.d. n.d. n.d. n.d. 
Bo-Wattenscheid 31 5.4 82 4.9 27 
Do-Buschei 15 8.4 88 1.6 14 
Do-Mitte 23 7.4 86 2.7 20 
Du-Dellviertel 5.6 5.3 81 0.9 4.7 
Du-Duissern 4.3 5.1 80 0.7 3.6 
Du-Homberg 24 9.4 89 2.3 21 
Du-Meidereich 23 5.8 83 3.4 20 
D-Wersten 11 4.7 79 1.9 8.8 
E-Altenessen 28 11 91 2.4 26 
E-Frohnhausen 36 16 94 2.1 34 
E-Heisingen 30 12 91 2.3 27 
E-Kettwig 35 13 92 2.4 32 
E-Steele 24 13 92 1.8 22 
Ge-Buer 17 3.6 72 3.8 14 
Ge-Horst 18 3.5 71 4.0 14 
Hattingen 37 9.9 90 3.4 33 
Her-Horsthausen 22 5.6 82 3.4 19 
Her-Mitte 33 10 90 3.0 30 
Kerken 16 7.1 86 2.0 14 
Marl-Sinsen 27 6.5 85 3.6 24 
Mh-Broich 37 28 96 1.3 36 
Mh-Mitte 34 19 95 1.7 33 
Mh-Styrum 31 n.d. n.d. 0 31 
Moers 4.3 < 2 n.q 0 4.3 
Alt-Oberhausen 30 25 96 1.2 30 
Ob-Sterkrade 27 n.d. n.d. 0 27 
Ratingen-Mitte < LOQ n.d. n.d. n.d. n.d. 
Recklinghausen 26 4.7 79 4.6 22 
Schwerte 21 7.1 86 2.6 18 
Velbert 14 4.9 80 2.4 12 
Witten 22 5.9 83 3.3 19 
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4 Adsorption of gadolinium-based diagnostics in water treatment 
4.1 Introduction 
New treatment steps for advanced wastewater treatment are discussed for municipal 
treatment plants [1] and hospital wastewaters [2]. Most promising of currently 
discussed additional wastewater treatment steps are oxidative treatment by ozone 
and adsorption on activated carbon (AC) [3]. The advantage of adsorption is that no 
transformation products or byproducts are formed that may exhibit toxicological 
relevance [4-6]. A strong disadvantage of activated carbon treatment are costs for 
removal and / or regeneration. Furthermore, adsorption on activated carbon is very 
generally speaking, not a suitable process for (very) large substances (if molecular 
size is so large that pores cannot be entered and hence, available sorption sites are 
not reached) and very hydrophilic substances. Other factors are influencing 
adsorption characteristics of a substance as well. A good adsorption of the 
gadolinium chelates has not been expected. However, gadolinium chelates will be 
affected simultaneously with other substances, if such an adsorption process is 
applied in wastewater treatment. Hence, it was investigated to which (small) extend 
the chelates will be retained in an adsorption step. 
The use of activated carbon is a well-known drinking water treatment technology. In 
Germany it is usually used as granulated activated carbon (GAC) in fixed-bed filters. 
GAC is also used for the treatment of industrial wastewater, in particular for the 
removal of dyes.  
Generally speaking, the higher the surface of an AC the higher is the Freundlich 
constant (KF). Another crucial factor for adsorption efficiency is the character of the 
surface groups. Competitive adsorption is one of the limiting factors and therefore a 
challenge especially for removal of micropollutants from wastewater matrices. For 
wastewater treatment a dosage of 10 - 20 mg L-1 powdered activated carbon 
(PAC) [1, 7] has been proposed. GAC fixed-bed filters may be preferred depending 
on the specific needs and existent equipment in wastewater treatment plants 
(WWTPs).  
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Adsorption equilibrium constants are most relevant for the design of the process in 
practice [1, 8]. Adsorption on activated carbon is often described by a Freundlich 
isotherm, as it considers inhomogeneous distribution of binding site energy [9]. 
Especially for modeling, e.g. of breakthrough behavior in fixed-bed filters, Freundlich 
constants are necessary [10, 11]. 
Focus of this study was to evaluate adsorption behavior of gadolinium chelates on 
different sorbents. The use of gadolinium in magnetic resonance imaging (MRI) for 
medical diagnostics is increasing [12, 13]. The paramagnetism of gadolinium is used 
to enhance the contrast of images by reducing the relaxation time [14]. As, the free 
gadolinium(III) ion is toxic (LD50 = 100-200 mg L
-1 [15]), it is complexed for medical 
purposes. Gadolinium, in its ionic form, as well as in its chelated form is not regulated 
by any environmental or waste- / drinking water standard, but its increasing medical 
use leads to detectable input of these compounds into the aquatic environment via 
waste water. Hence, the behaviour of these compounds during waste water 
treatment processes becomes of interest. Some of the most commonly used 
gadolinium-based diagnostics are presented in Figure 4.1. 
 
Figure 4.1: Structures of the gadolinium diagnostics investigated and their molar weight 
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The used gadolinium chelates are very stable (log K[GdL]/[Gd][L] > 15) and it is assumed 
that these diagnostics are excreted un-metabolized from the human body and hence 
enter the sewage system unmodified [14]. In WWTPs, these diagnostics are not 
removed sufficiently [16, 17]. Künnemeyer et al. [16] estimated a reduction of the 
concentration in the final treated water up to approx. two third of the inflow 
concentration. Recently, these findings based on random samples have been verified 
in a follow-up study [17]. A typical effluent concentration of gadolinium from WWTPs 
in Europe is 120 ng L-1 [mean of 75 samples; cf. chapter 3]. Yet a speciation of 
gadolinium has not been performed. This would be important as transmetalation of 
the diagosnstics (e.g. exchange of Gd(III) with Fe(III)) may be possible as it has been 
shown for drinking water [18].  
Recently, several investigations revealed elevated concentrations of gadolinium in 
the aquatic environment [19-21]. It is possible to determine the non-geogenic fraction 
of the gadolinium concentration in a sample by comparison of concentrations with 
those of the other rare earth elements (REE) and taking into account the natural 
abundance of each element [19]. To do this, concentrations of the REEs are 
normalized to a reference material and plotted versus the atomic number of the 
elements, and the resulting graph is fitted with a function. The gadolinium anomaly, 
which is the ratio of the normalized measured gadolinium concentration and the 
expected normalized concentration, describes the factor by which the gadolinium 
concentration is above the geogenic level. Hence, gadolinium may be used as a 
tracer in hydrogeology [21]. It is assumed that adsorption of the chelates on soil is not 
relevant, yet adsorption behavior of the gadolinium diagnostics on activated carbon 
and other man-made sorbents has not been studied yet. 
As advanced wastewater treatment, with e.g. activated carbon, will increase in the 
next years, it is important to have a complete view on the behavior of relevant 
substance classes affected by this treatment. Also, poorly adsorbing substances are 
retained by application of activated carbon, however, to a minor extent. Especially for 
the gadolinium-diagnostics it is important to know about the removal efficiency as 
chelates are generally assumed to be retained poorly. In contrast, metal ions are 
assumed to adsorb well on AC.  
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4.2 Experimental 
4.2.1  Chemicals and Materials 
For determination of adsorption isotherms, two different PACs were used. 
Norit SA UF® and Chemviron Pul Sorb RD 90®. Both have a small medium particle 
size (cf. Table 4.1), relatively high capacity and fast adsorption kinetics. Also, 
adsorption on two different GACs was determined (Norit 830 EN and 
Jacobi AquaSorb 5000). In comparison to PACs, they exhibit only marginal 
differences concerning iodine number and BET surface area (cf. Table 4.1). 
Furthermore, two different synthetic sorbents were tested (Blücher GmbH, Erkrath, 
Germany: Saratech 1 and Saratech 2). The raw material for these synthetic 
adsorbents is a spherical polymer which is carbonized and activated in a special 
procedure. Characteristic for these adsorbents are considerably higher iodine 
numbers and surface areas than in conventional activated carbons (cf. Table 4.1). As 
previous experiments have shown [unpublished results], these spherical polymers 
seem to be able to bind more hydrophilic substances than activated carbons. 
Table 4.1: Comparison of the used sorbents (manufacturers’ data); 
1
for PAC: Particle Size (D50) [µm]; 
for GAC and synthetic sorbents: Particle size distribution > 95% [µm] 
 PAC GAC Synthetic sorbents 
Parameter 
Norit 
SA UF 
Chemviron 
Pul Sorb  RD 90 
Jacobi 
AquaSorb 
5000 
Norit 
830 EN 
Blücher 
Saratech 1 
Blücher 
Saratech 2 
Iodine number 
[mg g
-1
] 
 1100  1100  1100  1000 1730 – 1780 1380 – 1480 
Density 
(stamped) 
[kg m
-3
] 
225 250 300 450 408 562 
Inner surface 
(BET) [m
2 
g
-1
] 
1200 1100  1150 1150 1920 1486 
Size
1
 
 
5 10 2360 – 600 2380 – 800 315 – 580 315 – 580 
 
  
99 
 
For determination of adsorption isotherms the two GACs as well as synthetic 
sorbents were pulverized with a planetary mill (Pulverisette 7 (Fritsch), Zirconium 
oxide beakers, 7 zirconium oxide balls (Ø 20 mm), 20 min at 90% power; resulting 
size ≤ 45 µm). Suspensions were prepared from the pulverized sorbents in drinking 
water after drying of carbon for at least 24 h at 110°C.  
Stock solutions of gadolinium diagnostics ([Gd] = 6.36 µM = 1 mg L-1) were prepared 
with ultrapure water in polypropylene (PP) vessels. PP-vessels were used to avoid 
any interaction with glass surfaces (cf. chapter 2). Stock solutions were prepared 
from Gd-DTPA (powdered, Sigma-Aldrich), Gadovist® (1 M, medical solution from 
Bayer) and Omniscan® (1 M, medical solution from GE Healthcare). 
 
4.2.2 Adsorption experiments 
Adsorption isotherms were determined in triplicate experiments in drinking water 
(Mülheim tap water for PACs and Duisburg tap water for GACs and synthetic 
sorbents, for both tap waters ([Gd] < level of quantification (LOQ) and 
DOC = 0.72 mg L-1 (Mülheim), DOC = 0.54 mg L-1 (Duisburg)) with an initial 
concentration of [Gd]0 = 6.36 × 10
-3 µM = 1 µg L-1 for PAC isotherms and 
[Gd]0 = 6.36 × 10
-2 µM = 10 µg L-1 for GAC and synthetic sorbents in the water 
phase. Bottle point isotherms for the determination of isotherms were performed in 
tap water to take direct competitive adsorption of gadolinium chelates with DOC of 
the tap water into account [22]. By this it is possible to evaluate general adsorption 
characteristics of the gadolinium chelates. The concentration of AC and the synthetic 
sorbents varied between 5 – 50 mg L-1 (10 equidistant points). Aliquots of the sorbent 
suspension (preparation described above) were withdrawn under continuous stirring, 
to prevent sedimentation of activated carbon, and introduced to the sample solutions 
in PP-vessels. Samples were shaken continuously with 140 rpm (horizontally). After 
an equilibration time of at least 24 h, samples (10 mL) were taken with a syringe and 
filtered through a syringe filter (PP, Ø 25 mm, 0.45 μm PP membrane). The samples 
were acidified right after filtration with HNO3 (65% suprapur, Merck) to yield an acid 
concentration of 0.4 M for stabilization purposes.  
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Concentration of gadolinium in the aqueous phase was determined by ICP-MS 
measurements. From this result the load q was calculated and isotherms were 
determined and evaluated using the Freundlich approach (cf. Equation 4.1).  
          (4.1) 
KF → Freundlich coefficient 
n → Freundlich exponent 
 
4.2.2.1 Fixed-bed filter experiments 
To investigate behavior of gadolinium chelates during filtration processes which may 
be used as an alternative to the dosage of PAC, lab scale filter experiments were 
performed. Due to limited resources experiments were carried out in drinking water 
(same as in the batch experiments for determination of the isotherms) and only for 
one of the diagnostics. The use of spiked tap water as feed for the filters is feasible 
and as isotherms for gadolinium chelates and for DOC were determined in the same 
tap water it should be possible to use these data for description of the breakthrough 
behavior of gadolinium chelates in a fixed-bed filter with a mathematical model such 
as the LDF model.  
To ensure that effects will be observable, only the diagnostic which revealed the 
highest affinity to activated carbon was chosen as test adsorbate, in this case 
Gd-BT-DO3A (cf. Table 4.3).The characteristics of the filters are presented in     
Table 4.2. As filter media the two GACs and the two synthetic sorbents were used 
(for characteristics cf. Table 4.1). Gadolinium diagnostics are not readily 
biodegraded [23]. Generally speaking the more nitrogen atoms substituted with 
carboxylic groups are present, the more stable is the complex [24, 25]. Gd-BT-DO3A 
with four amino groups and three carboxy substituents is particularly stable. Even 
though, one sorbent (Saratech 1) was tested twice, in order to ensure that during the 
several weeks of experiment duration no microbial activity biased the results of the 
experiment. To the feed of the second filter with Saratech 1 the biocide 
sodium azide (50 µg L-1) was added. 
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Table 4.2: Characteristics of the lab scale filters 
Feed Drinking water 
Flow  20 L h
-1 
Filter velocity  (filter) 10 m h
-1 
Layer height 7 cm 
Inner diameter di 5 cm 
Samples from feed and filtrate were taken over a period of 6 weeks (at least one 
sample per day) to determine the breakthrough of Gd-BT-DO3A.  
To gain a first insight on behavior of gadolinium chelates during activated carbon 
treatment in a wastewater matrix, AC filters in a WWTP (for operation procedure and 
basic data cf. chapter 4.5.1) were studied. The filter experiment was scaled up from 
pilot plant (pilot scale filter (PSF)) to full scale (large scale filter (LSF), both PSF and 
LSF fixed-bed filters were operated with real wastewater). In the WWTP the so called 
Biofor®-process was used as final treatment step, before establishing the AC filters, 
and was operated further, parallel to the full scale filter during the monitoring period. 
In the Biofor®-process the wastewater is filtered through a Biolite™ filter media in 
bottom-up direction. Particles are retained during the filtration process and biofilms 
on the surface of the Biolite™ filter material reduce nitrogen and carbon concentration 
in the filtrate. The lower region of the filter bed is aerated, to enhance aerobic 
biodegradation. 
One of these Biofor®-process basins was modified in such a way that it could be used 
for the full scale fixed-bed adsorber. This large scale filter (LSF) was operated in 
upward flow direction. As the Biofor®-process was used in parallel it was possible to 
compare both treatment steps, the Biofor®-process, which is based on particle 
removal and biodegradation and the activated carbon filtration, in which as additional 
removal process adsorption takes place. The LSF (filter area = 40 m²) consisted of a 
support layer (0.5 m) of Jacobi AquaSorb 5000 and a 2.0 m fixed-bed consisting of 
the same type of activated carbon, however, granulated more finely. During the 
monitoring period, filter velocity was 2 m h-1, to yield high contact time (at vf = 2 m h
-1 
empty bed contact time = 75 min) and hence maximal adsorption efficiency. Samples 
were taken at the influent and effluent of the filter bed. 
The third filter, a pilot scale filter (PSF), running in the WWTP was the basis for 
up-scaling to the LSF. The cylindrical filter column (di = 190 mm; Ai = 0.0283 m²) was 
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operated in downward flow. Bed height was likewise 2.5 m of finely granulated 
AquaSorb 5000, as the support layer could be omitted. Filter velocity was set to 
10 m h-1 to yield an empty bed contact time of 15 min. Sampling was also performed 
at the influent and effluent and of the filter bed. Due to the higher velocity, saturation 
loading is achieved faster as number of bed volume throughputs per time is 
increased.  
 
4.2.3 Measurements 
Concentration of gadolinium in the aquatic phase was determined by ICP-MS (ELAN 
DRC II). The detection limit calculated is according to german standard 
DIN 32645 [26] 0.8 ng L-1. The limit of quantification is as low as 2.4 ng L-1 (RSD 
≤ 3%). Because of this sensitive analytical method it was possible to determine 
isotherms in a concentration range which is close to the expected concentrations in 
WWTPs (< 1 µg L-1, cf. chapter 2 and 3).  
Determinations of iopromide and carbamazepine were performed by SPE-HPLC-MS2 
respectively GC-MS. The limit of quantification for both substances is 400 ng L-1. 
 
4.2.4 Modeling of fixed-bed filters 
For modeling of fixed-bed filters two programs were used, to confirm the results: 
 LDF and AdsAna program, Version 2.6 (© E. Worch 2009); based on the 
linear driving force model (LDF) and the ideal adsorbed solution theory 
(IAST) [9] 
 FAST 2.0 (© A. Sperlich and S. Schimmelpfennig, 2008 [27]); in this software 
two different approaches were used: The homogeneous surface diffusion 
model (HSDM) and the LDF model. 
HSDM is a combination of film and surface diffusion and Freundlich equation as 
equilibrium relationship (incorporating dispersion).  
The linear driving force model is considered as valuable alternative to HSDM. It is a 
simplified surface diffusion model in which instead of Fick`s law a linear driving force 
(LDF) is used for the mass transfer equation for film diffusion. [9] 
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For calculations with both programs KF and n from bottle point isotherm experiments 
[28] were used and dimensions of the filter as well as operation parameters given 
above were used. The LDF program provides an estimation tool for the diffusion 
coefficient (DL), the liquid-phase mass transfer coefficient (kF) multiplied with the 
external adsorbent particle surface area related to the adsorbent volume (av) and the 
surface diffusion coefficient multiplied with av. These calculated diffusion coefficients 
were adopted in the FAST program. In the FAST program only 
single-solute adsorption modeling is possible. 
Modeling was used to gain insight in the characteristics of the adsorption process in 
fixed-bed adsorbers. Of special interest were competitive adsorption effects of 
gadolinium chelates with the water matrix, i.e., the natural organic matter which was 
measured by DOC, as it is assumed to be one of the main factors influencing 
adsorption processes in wastewater treatment. 
The AdsAna model is a mathematical approach to describe adsorption behavior of an 
unknown mixture of organic substances in water. For this, a DOC isotherm is 
measured and the DOC is divided into different groups of compounds with different 
adsorption behavior (different Freundlich parameters). The AdsAna software allows 
calculation of the competitive adsorption between the different groups of compounds. 
Variation of the Freundlich coefficients of the different groups allows the fitting of 
calculated DOC isotherm to the measured values. 
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4.3 Results and discussion 
Adsorption isotherms of the gadolinium diagnostics on the two PAC used are 
presented in Table 4.3. The Freundlich coefficients of Gd-BT-DO3A on all tested 
sorbents are presented in Table 4.4.  
Table 4.3: Freundlich isotherms of Gd(III) and gadolinium chelates on different PACs 
([Gd]0 = 6.36 × 10
-3
 µM ; n.d. = not determined) 
Substance Parameter 
PAC 
Norit SA UF 
Chemviron
®
 Pul Sorb 
RD 90 
Gd-BT-DO3A 
(Gadovist
®
) 
KF [(µmol kg
-1
) (L µmol
-1
)
1/n)
] 0.256 1.34 × 10
-2 
n 0.376 0.400 
r
2
 0.984 0.960 
Gd-DTPA-BMA 
(Omniscan
®
) 
KF 
 [(µmol kg
-1
) (L µmol
-1
)
1/n)
] 
0.035 5.9 × 10
-3
 
n 0.300 0.404 
r
2
 0.944 0.959 
Gd-DTPA 
(Magnevist
®
) 
KF [(µmol kg
-1
) (L µmol
-1
)
1/n)
] 0.035 7 × 10
-6
 
n 0.176 0.245 
r
2
 0.827 0.808 
GdCl3 
KF  
[(µmol kg
-1
) (L µmol
-1
)
1/n)
] 
0.282 n.d. 
n 0.690 n.d. 
r
2
 0.952 n.d. 
 
Table 4.4: Freundlich coefficients of Gd-BT-DO3A for different sorbents ([Gd]0 = 6.36 × 10
-6
 µM ) 
Sorbent 
KF 
[(µmol kg
-1
) (L µmol
-1
)
1/n)
] 
n r
2
 
GAC 
Jacobi
®
 
AquaSorb 5000 
0.071 0.131 0.894 
Norit
®
 
830 EN 
0.016 0.421 0.967 
Synthetic 
sorbent 
Blücher
®
 Saratech 1 2.83 0.298 0.959 
Blücher
®
 Saratech 2 0.11 0.395 0.934 
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KF values of all diagnostics on all tested sorbents are very low. For instance, the KF 
for Gd-DTPA-BMA (, which is sorbing in the middle range of all tested diagnostics) of 
1.26 [(mmol kg-1) (L mmol-1)1/n)] is approximately the same as the one of iopromide 
(1.92 [(mmol kg-1) (L mmol-1)1/n)] [28]) on Norit SA UF. Iopromide is considered as a 
substance insufficiently removable by activated carbon [3]. The results of the 
experiments show clearly that adsorption of the diagnostics on activated carbon is 
low with an exemplary removal efficiency of 41% (Gd-DTPA-BMA) for a dosage of 
10 mg L-1 Norit SA UF.  
Adsorption in general depends on several different characteristics of both adsorbates 
(e.g. structure and size) and adsorbent (e.g. surface characteristics), as well as on 
different matrix dependent effects (e.g. pH, temperature, concentration and 
composition). One of the aspects influencing adsorption is water solubility and 
hydrophilicity of the adsorbate. In general it is assumed that substances with high 
hydrophilicity, which may be described by the POW, are adsorbed less efficient than 
those with a low hydrophilicity. This has been described by Zwiener, who found that 
substances with a log POW >10
3 have a removal efficiency of 75 - 100% with activated 
carbon [29]. Gadolinium chelates are characterized by high water solubility and 
extremely low POW values (e.g., log POW = 10
-5.4 for Gd-BT-DO3A, Gadovist®), like 
most metal chelates. Hence, a low KF has been expected.  
In literature it is furthermore discussed whether complexation of metals improves or 
decreases adsorption of metal ions on activated carbon [30]. In general, adsorption of 
metals increases with increasing pH [30, 31] and chelation with organic ligands 
decreases adsorption at all pHs relevant for water treatment [32]. Hence, it was 
assumed that the Gd(III) ion is sorbing better than any of the gadolinium chelates. 
This assumption has been confirmed by experimental results (cf. Table 4.3).  
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Another important factor for describing adsorption is the surface of the adsorbent. 
This has been shown by a comparison of conventional activated carbons with 
synthetic sorbents. The spherical sorbents are mainly characterized by a very high 
BET, up to almost 2000 m2 g-1 (for Saratech 1). The higher the surface area of the 
sorbents the higher is KF. The results of isotherm determinations (cf. Table 4.4) and a 
comparison of the results of filter experiments (cf. Figure 4.2) indicate that the 
surfaces of the spherical synthetic sorbents are better capable of adsorbing these 
hydrophilic compounds, than the ACs. As shown in Figure 4.2, filter breakthrough for 
the sorbent with highest inner surface area (Saratech 1) is occurring last.  
 
Figure 4.2: Adsorption of Gd BT DO3A, spiked in drinking water on different sorbents in a fixed bed 
reactor; [Gd]influent = 6.36 × 10
-5
 mM 
Comparing the two synthetic sorbents with the activated carbons, it is clear that 
breakthrough of the filters is fastest for Norit carbon and slowest for the Saratech 
sorbent with the highest inner surface. Nevertheless, Jacobi AS 5000 is more 
efficient for removal of gadolinium chelate from the tested drinking water matrix than 
Saratech 2. Comparing BET surface area and iodine number, one has to consider 
that no maximum values are given for Jacobi AS 5000. Nevertheless, BET surface 
and iodine number are not the only values for a complete characterization of 
adsorption capacity for an adsorbent. Further properties like wettability, accessibility 
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of the total pore system, and the kind of surface groups on all surfaces of the 
adsorbent may influence removal efficiency. However, a more indepth 
characterization of adsorbents was not in focus of this study. 
Calculation of breakthrough curves for Saratech 1, based on both model approaches 
used (LDF and FAST program) are shown in Figure 4.3 (for input parameters 
cf. chapter 4.5.2).  
 
Figure 4.3: Comparison of experimental breakthrough data (lab scale experiments, 
[Gd-BT-DO3A]0 = 6.36 × 10
-5
 mM in drinking water matrix without sodium azide) and model predictions 
(LDF program and FAST program) for Saratech 1 
To ensure that the effect of competitive adsorption is considered, all adsorption 
isotherms were determined in tap water. However, when using data from these batch 
experiments to model filter breakthrough instead of using isotherm data from single 
solute experiments, a comparison of fixed-bed experimental data and modeled data 
shows a clear deviation (cf. Figure 4.3).  
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Figure 4.4: Breakthrough curves of Gd BT DO3A (6.36 × 10
-5
 mM in drinking water matrix); lab scale 
experiments with Norit 830 EN (model predictions (LDF program, input parameters, c.f. chapter 4.5.2) 
and experimental data) 
Thus, to describe early breakthrough a simple approach was tested. For this, in 
addition to the Freundlich data for the gadolinium chelate in tap water - taking into 
account competitive adsorption in batch – Freundlich data for three different groups 
of virtual DOC compounds resulting from adsorption analysis with the AdsAna 
Software were used in the LDF model. Results of this calculation are shown in  
Figure 4.4. It is shown that the calculated breakthrough curve on basis of the 
mentioned procedure leads to a quite good description of the measured values. Also, 
desorption after reaching a maximum may be explained by competitive adsorption of 
DOC and gadolinium chelate. Gadolinium chelates which have already adsorbed can 
be displaced from adsorption sites by components of the DOC, resulting in a higher 
effluent than initial concentration.  
Filter experiments in a WWTP corroborate results obtained in lab scale experiments 
and modeling. The results (cf. Figure 4.5) show that adsorption of gadolinium is very 
low.  
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Figure 4.5: Removal of different substances in the PSF in the WWTP; white bars: carbamazepine; 
hatched bars: iopamidole; black bars: total gadolinium. (Carbamazepine and iopamidole where below 
limit of quantification (LOQ) (for carbamazepine and iopamidole LOQ = 0.04 µg L
-1
) in the effluent of 
the filter until a throughput of 3744 bed volumes (BV), influent concentrations: 
Carbamazepine = 1.3 µg L
-1
; iopamidole = 0.2 µg L
-1
; gadoliniumtotal = 0.5 µg L
-1
 
As it can be seen in Figure 4.5, gadolinium will be one of the first substances which 
can be detected in the filter effluent. The effluent concentration of iopamidole, which 
is supposed to adsorb very poorly on activated carbon [3], is reduced to a greater 
extent than the one of gadolinium. Information of a differentiation of anthropogenic 
and geogenic gadolinium removal during the filtration process is given in the 
supplement (cf. chapter 4.5.3). 
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Figure 4.6: Comparison of the removal of carbamazepine and gadolinium in the Biofor
® 
process and 
the large scale filter (LOQcarbamazepine = 400 ng L
-1
) in a WWTP 
The comparison of the Biofor®-process and adsorption on activated carbon shows 
that the reduction of carbamazepine is not possible by biological degradation. 
However, adsorption on activated carbon eliminates carbamazepine completely. 
Gadolinium is also not reduced by biological treatment. Adsorption in the activated 
carbon filter is reducing gadolinium by more than 90% in this short operating period. 
In a worst case scenario for operating fixed-bed filters in wastewater treatment (i.e. 
removal of 70% of diclofenac, a poorly adsorbing substance, and a median removal 
of 80% for all other substances from a hospital wastewater matrix with 
c(DOC) = 10 mg L-1), up to 7500 BV can be treated before the carbon has to be 
exchanged [33]. Based on the presented data for gadolinium a smaller breakthrough 
volume of only 6400 BV would result in such a scenario.  
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4.4 Conclusion 
To evaluate adsorption of gadolinium chelates first determination of isotherms in 
bottle point experiments were performed. To this end, tap water was used to include 
the effect of competitive adsorption, which is of importance for any water matrix to be 
treated. Isotherm data already revealed that adsorption of the chelates is highly 
inefficient, as it has been assumed. The poor adsorption may be demonstrated as 
follows: For a 90% removal of 6.4 nM Gd-DTPA from a drinking water matrix 
50 mg L-1 Norit SA UF are necessary. Yet, only an addition of 10-20 mg L-1 PAC is 
discussed for advanced wastewater treatment [1, 7] in which the competitive 
adsorption will take place to an even greater extent than in a drinking water matrix. 
Hence, an additional treatment step in WWTPs utilizing PAC adsorption will hardly 
affect gadolinium chelates at effluent concentrations.  
Preliminary lab scale experiments assessing breakthrough behavior of the chelates in 
fixed-bed filters have been performed. The early breakthrough could be calculated 
using the LDF model. In this case it has been possible to differentiate between a 
direct competitive adsorption and an additional competitive adsorption in the filter by 
the DOC of the used drinking water. 
Investigations on adsorption of gadolinium in WWTPs activated carbon filtration 
showed that adsorption is even poorer than assumed. A comparison of results from 
lab scale filtration and results from filtration in the WWTP show that a 70% 
breakthrough occurs much quicker in the PSF. The treated BV of the filters in the 
WWTP are by a factor of ~100 lower for a 70% breakthrough than in the lab scale 
filters. It has to be considered that adsorption on activated carbon in general is not a 
suitable process for the removal of metal chelates. But since additional treatment 
steps for wastewater treatment may include adsorption on activated carbon it is 
nevertheless necessary to investigate their behavior in such a scenario.  
Yet one might take into consideration to use gadolinium as indicator for the quality of 
the filtration processes in a WWTP. Gadolinium analysis is cheap compared to 
analysis of most organic trace substances. The LOQ is low and the analysis method 
is very robust. During water treatment by activated carbon or other adsorption based 
treatment steps, the gadolinium anomaly could be monitored to indicate breakthrough 
of organic trace substances in filters. Due to poor adsorption of gadolinium 
diagnostics breakthrough detection is possible earlier than by monitoring of other 
commonly used organic substances, like atrazine.   
112 
 
4.5 Supplement 
4.5.1 Description of the wastewater treatment plant 
 Size: 380000 population equivalents (connected: 185000 population equivalents 
(ca. 75000 citizens + 110000 population equivalents) 
 Dry weather volume: 18000 m³/day 
 Maximal volume: 60000 m³/day 
 65% highly poluted industrial waste water 
 Treatment steps: 
 Bar screening 
 Grit chamber, including grease removal  
 Primary treatment (3000 m³) 
 1. Biological step (including Bypass, 5000 m³ reactor volume and 5880 m³ 
settling volume) including intermediary treatment 
 2. Biological step (9.200 m³ reaktor volume and 12480 m³ settling volume) 
including intermediary treatment 
 Fixed-bed denitrification as a 3. Biological step (8 chambers each 
Af = 37.5 m²) 
 Flocculation-filtration (Biofor®-process, 10 chambers each Af = 40 m², filter 
material: Biolit (siliceous diabase)) 
 Polishing ponds (42640 m³) 
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4.5.2  Modeling input parameters 
Table S 4.1: Input parameters for modeling the breakthrough of two different filters with both used 
programs (LDF program and FAST program); NOTE: Isotherm data are given in mg L
-1
 as the 
program needs input data in this specific unit; kFav and kSav both calculated by the LDF program, the 
resulting diffusion coefficients were used for FAST program. 
Sorbent 
Input 
parameter 
Value Sorbent 
Input 
parameter 
Value 
N
o
ri
t 
8
3
0
 E
N
 
c
0, Gd-BT-DO3A
 0.038 mg L
-1 
S
a
ra
te
c
h
 1
 
c
0, Gd-BT-DO3A
 0.038 mg L
-1
 
K
F , 
Gd-BT-DO3A
 22.2 [g kg
-1
] / [mg L
-1
]
1/n
 
K
F , 
Gd-BT-DO3A
 65.5 [g kg
-1
] / [mg L
-1
]
 1/n
 
n
Gd-BT-DO3A
 0.4 n
Gd-BT-DO3A
 0.3 
V
F
 10 m h
-1 V
F
 10 m h
-1 
T 15°C T 15°C 
ɛ 0.4 ɛ 0.4 
d
P
 1.6 mm d
P
 0.4475 mm 
m
adsorbent
 0.05538 kg m
adsorbent
 0.04777 kg 
V 0.02 m
3
 h
-1 
V 0.02 m
3
 h
-1 
p 500 kg m
-3
 p 500 kg m
-3
 
c
0, DOC 1
 0.04 mg L
-1 Yielded 
kFav
 1.93 × 10
-1
 s
-1
 
K
F , DOC 1
 5 [g kg
-1
] / [mg L
-1
]
1/n
 
Yielded 
kSav 
3.96 × 10
-6
 s
-1
 
c
0, DOC 2
 0.06 mg L
-1 
  
K
F , DOC 2
 25 [g kg
-1
] / [mg L
-1
]
1/n
   
c
0, DOC 3
 0.26 mg L
-1 
  
K
F , DOC 3
 60 [g kg
-1
] / [mg L
-1
]
1/n
   
n
DOC
 0.2   
Yielded 
kFav
 2.71 × 10
-2
 s
-1
   
Yielded 
kSav 
2.24 71 × 10
-6
 s
-1
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4.5.3 Use of the gadolinium anomaly in filter experiments in a wastewater treatment 
plant 
Overall in an adsorption process, the total gadolinium concentration is decreasing but 
the fraction of geogenic gadolinium is decreasing stronger than the non-geogenic 
fraction, resulting in an increasing deviation between [Gd]total and the 
gadolinium anomaly (cf. Figure S 4.1).  
 
Figure S 4.1: Figure for description of the anomaly increase after a filtration process; black line and 
black diamond represent the normalized REE concentrations vs. atomic number before a filtration 
process; dashed line and hollow diamond represent the normalized REE concentration vs. atomic 
number after a filtration process 
For a better understanding of this one has to consider that: 
geogenicnon
Gd
geogenic
GdGd total 
       (4.2) 
More precisely: 
[ ] [ ] [ ]Gd×b+Gd×a=Gd total         (4.3) 
In which b > a 
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In adsorption processes the geogenic fraction is adsorbing better than the non-
geogenic fraction. In a filtration process, which is working well, one might represent 
this as: 
[ ] [ ] [ ]Gd×)cb(+Gd×)da(=Gd total --        (4.4) 
In which c > d. 
In a filtration process, which is reaching breakthrough, both gadolinium fractions are 
adsorbing less, until a total breakthrough is reached, described by [Gd] / [Gd]0 = 1. 
The gadolinium anomaly is defined as presented above (cf. equation  4.3). Revising 
this definition by incorporating the filtration process as presented in (cf. eq. 4.4) 
yields:  
[ ] [ ]
[ ]Gd×)da(
Gd×)cb(+Gd×)da(
=AnomalyGadolinium
-
--
    (4.5) 
The relation of [Gdtotal]after filtration to [Gdtotal]0, which is the total gadolinium 
concentration before filtration is reaching no values > 1. However, the quotient of 
gadolinium anomaly after the filtration process (gadolinium anomaly) to anomaly 
before an filtration process (gadolinium anomaly0) might reach values > 1. As in this 
case not concentrations are related, however, a relation to a reference value 
([Gdexpected]) that may be decreased to a greater extent than the target value 
([Gdtotal]). Hence, it is possible, that the anomaly increases at a certain time in 
comparison to the initial value (gadolinium anomaly0), as the concentration of the 
geogenic REEs decreases stronger than the concentration of the non-geogenic 
gadolinium: 
[ ] [ ]
[ ]
[ ] [ ]
[ ]Gd×a
Gd×b+Gd×a
Gd×)da(
Gd×)cb(+Gd×)da(
-
--
       (4.6) 
Solving equation 4.6 leads to: 
a
b
+1
ca
db
+1
-
-
         (4.7) 
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Regarding the assumptions made above (Gdanthropogenic > Gdgeogenic → b > a) and 
adsorption of Gdgeogenic > adsorption of Gdanthropogenic → c > d), the term presented in 
equation 4.6 is greated than 1. 
 
Figure S 4.2: Correlation of [Gdtotal] / [Gdtotal]0 to (Gd anomaly) / (Gd anomaly)0 in a fixed-bed activated 
carbon filter in a wastewater treatment plant (details given in 4.2.2.1); the number of treated bed 
volumes for the given data point is presented in the diagram; linear equation: 
(Gd anomaly) / (Gd anomaly)0 = 0.566 [Gdtotal] / [Gdtotal]0 + 0.0166 with r
2
 = 0.996 
The quotient of (gadolinium anomaly) / (gadolinium anomaly)0 and [Gdtotal] / [Gdtotal]0 
increases during the course of filtration as [Gdtotal] / [Gdtotal]0 will approach 1, whereas 
(gadolinium anomaly) / (gadolinium anomaly)0 will increase less than 
[Gdtotal] / [Gdtotal]0. This is indicated by the slope < 1 (cf. Figure S 4.2). 
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5 Reaction of Gadolinium Chelates with Ozone and 
Hydroxyl Radicals 
5.1 Introduction 
Ozone and / or hydroxyl radical treatment processes are long known for disinfection 
and removal of trace substances in drinking water treatment [1-3]. In recent years, 
these processes have been discussed for the application in wastewater treatment 
and are in some places already established in full-scale [4]. This is due to frequent 
detections of trace substances in surface and ground waters [5, 6]. The removal of 
these substances is often inefficient in conventional wastewater treatment plants 
(WWTP). According to the European water framework directive the water quality shall 
reach a “good chemical status” as well as a “good ecological status” [7]. This aim is 
threatened by the presence of several of these traces substances, especially those 
with biological activity such as (xeno-)hormones, antibiotics, and other 
pharmaceuticals. For further elimination of such compounds in an additional 
treatment step, the application of ozone is one of the preferred methods. Ozone 
action in wastewater can be divided in two reaction pathways [8, 9]. Mainly it reacts 
with the wastewater matrix forming hydroxyl radicals to substantial yields[3, 8, 10, 
11]. In wastewater the application of ozone generates 13 mol % hydroxyl radicals of 
the applied ozone dose [10]. In competition to the hydroxyl radical forming reaction, 
ozone-reactive target compounds are oxidized directly. In many cases, the biological 
activity of the target compounds is eliminated upon a single ozone attack [3]. Ozone 
refractory compounds can also be transformed via hydroxyl radicals formed by the 
matrix. However, again competition between wastewater matrix and target 
compounds is a limiting factor. The hydroxyl radical rate constants are strongly 
influencing the efficiency of target compound oxidation [3, 11]. To understand the 
oxidation of target compounds in a wastewater matrix it is necessary to investigate 
both the reaction via ozone and hydroxyl radicals separately. 
The reactions of chelates with ozone and hydroxyl radicals are rarely studied [12]. 
There are few studies on the reaction of metal EDTA complexes [13-16] and on 
metal DTPA complexes [17, 18], but to the authors’ knowledge, no other chelates are 
covered in such studies. Here, we focus on gadolinium chelates (cf. Figure 5.1), used 
as contrast agents in magnetic resonance imaging. They have a very high complex 
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stability, and are excreted without metabolization [19], hence reaching WWTPs 
without any modification. Conventional wastewater treatment does not remove them 
substantially [20]. They remain intact, and no free Gd(III) is released.  
This may be different in oxidative (waste)water treatment processes which are 
potentially able to destroy gadolinium chelates and Gd(III) ions, which are toxic in 
contrast to the chelated form ((LD50 in mice for GdCl3 = 0.1 mmmol kg
-1 and for 
Gd-DTPA-BMA = 12 mmmol kg-1) [21], may be liberated. Hence, not only reactivity of 
the chelates has been analyzed in this work, but also toxicity of reaction products has 
been studied. Similar toxicity studies were performed with triclosan containing 
wastewater before and after oxidative wastewater treatment [22]. 
 
 
Figure 5.1: Molecular structures of tested gadolinium chelates including trade names and molar 
weights, marked as circles: examples for the reactive center for the reaction with hydroxyl radicals, 
marked as square: examples for the reactive center for the reaction with ozone 
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5.2 Experimental 
5.2.1 Reagents 
For the generation of ozone an oxygen-fed ozonator (BMT 802X, BMT Messtechnik, 
Berlin) was used. Ozone was bubbled through 0.5 L ultrapure water (Elga: 
Purelab ultra) for 30-60 min. The ozone concentration in this solution was determined 
spectrophotometrically at 260 nm (ε260 nm = 3300 M
-1 cm-1). Hydrogen peroxide 
(Sigma Aldrich, p.a.) stock solution of 5 mM was prepared for the generation of 
hydroxyl radicals by the peroxone process.  
The gadolinium chelate stock solutions of 10 mM were prepared in ultrapure water 
from the medical solutions (Gd-BT-DO3A as Gadovist from Bayer-Schering and 
Gd-DTPA-BMA as Omniscan from GE Healthcare), with exception of Gd-DTPA 
which was purchased from Sigma-Aldrich as diethylenetriaminepentaacetic acid 
gadolinium(III) dihydrogen salt hydrate. The stock solutions were prepared in PFA- or 
PP-vessels to avoid effects on the chelates by contact with glass. Such effects of 
chelates are suggested to be due to sorption [20] or transmetalation. [23]. 
The buffer solution was prepared from dipotassium hydrogen phosphate and 
potassium dihydrogen phosphate (both purchased from Sigma Aldrich, p.a.) in Elga 
water to yield a concentration of 100 mM and a pH of 7 ± 0.5. A stock solution of 
400 mM tert-butanol (tBuOH) (Sigma Aldrich p.a.) prepared in ultrapure water was 
diluted to the specific concentration necessary for the use as radical scavenger 
(20 mM in the reaction solution) or as competitor (1 µM in the reaction solution). 
The para-chlorobenzoic acid (pCBA) and para-nitrobenzoic acid (pNBA) (both 
purchased from Sigma Aldrich, p.a.) stock solutions (4 mM) were prepared in 
ultrapure water alkalinized with sodium hydroxide (Sigma Aldrich, p.a.) to yield pH 7 
in the reaction solutions. At this pH pCBA and pNBA is present in its dissociated form 
(pKa = 3.99 [24] and 4.03 [25], respectively. This has been considered for calculation 
of the rate constants. 
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5.2.2 Rate constants 
Rate constants of the chelates with ozone and hydroxyl radicals have been 
determined. Rate constants for the reaction with ozone have been determined under 
pseudo-first-order conditions. Ozone decrease was followed by the indigo 
method [26]. As radical scavenger tBuOH was used and the reaction was buffered 
with phosphate (100 mM) at pH = 7. Ozone rate constants were calculated by plotting 
the reaction time against the natural logarithm of the ratio of the residual ozone 
concentration vs. the initial ozone concentration.  
 
The hydroxyl radical rate constants were determined by pulse radiolysis experiments, 
which is the ultimate reference method for the determination of hydroxyl radical 
rate constants. Very reliable values, within an error margin of < 10%, are obtained for 
well soluble compounds that form intermediates with high molar absorption 
coefficients in a convenient wavelength region (250 – 600 nm). All three 
gadolinium chelates show transient spectra in the region of interest (cf. Figure S 5.1).  
Pulse radiolysis experiments were carried out by using 5 ns electron pulses from a 
10 MeV linear accelerator (ELEKTRONIKA, Toriy Corp., Moscow) of the Leibniz-
Intitut für Oberflächenmodifizierung (IOM), Leipzig. All solutions were bubbled for 
10 min prior to the measurement with N2O. The dose per pulse (~18 Gy) was 
determined using the thiocyanate dosimeter system [27]. The optical detection 
system consisted of a pulsed 1000 W xenon lamp, Suprasil cell (light path 1 cm), 
high-intensity grating monochromator (Acton Research Corp., SP275), R 928 
photomultiplier (Hamamatsu) and a fast transient recorder (Tektronix, TD5034B). 
Four signals were averaged for each kinetic trace at a defined wavelength. Linear 
accelerator operation and data acquisition were computer controlled. 
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In brief, the free radicals 

OH, H
 and solvated electrons (eaq
) are generated in a 
short electron beam pulse (cf. reaction 5.1) The radiation-chemical yields of the 
primary radicals are G(

OH)  G(eaq
) = 2.8 × 10-7 mol J-1 and            
G(H

) = 0.6 × 10-7 mol J-1 [28]. The hydrated electrons are readily converted into 
further hydroxyl radicals (cf. reaction 5.2) by saturating the solution with N2O 
(k2 = 9.1 × 10
9 M-1 s-1 [29]), thus G(

OH) becomes ~ 5.6 × 10-7 mol J-1.  
H2O + ionizing radiation  

OH, eaq
, H

, H+, H2O2, H2    (5.1) 
eaq
 + N2O + H2O  

OH + N2 + OH

      (5.2) 

OH + Gd chelates  products absorbing at ~250 - 400 nm   (5.3) 
  SCN¯ 
OH + SCN¯  OH¯ + SCN2

¯ (absorbing at 475 nm) (5.4) 
The gadolinium chelates react with hydroxyl radicals (cf. reaction 5.3), forming a well 
observable transient species (cf. Figure S 5.1). H• atoms may also react with the 
compounds. However, in N2O-saturated solutions their concentration is only about 
10% of the hydroxyl radical concentration (see above) and their reaction is usually 1 
to 3 orders of magnitude slower compared to hydroxyl radical reactions, thus a 
contribution to the observed spectra and kinetics can be neglected.  
For further confirmation of the measured rate constants, competition with a good 
hydroxyl radical scavenger with well known rate constant and spectrum was applied. 
In presence of gadolinium chelate and the competitor  SCN¯        
(kOH = 1.1  10
10 M-1 s-1 [29], both compounds react with 

OH (cf. reactions 5.3 
and 5.4). Further experimental details are provided in chapter 5.5.1. 
Pulse radiolysis is due to availability of pulse generators not possible in most cases. 
Hence, another method for the determination of hydroxyl radical rate constants has 
been tested. For this, competition kinetics were applied using pCBA 
(kOH = 5.5  10
9 M-1s-1 [4]) (monitoring the decrease) and tBuOH (monitoring product 
formation) as competitors. Hydroxyl radicals were in this case generated by the 
peroxone process (~200 µM O3 / 100 µM H2O2). This process has been chosen to 
avoid interferences from transmetalation of gadolinium by other metals, as in the 
Fenton-Process Fe(II) is used and in Fenton like processes other metals like Cu(II) 
may be used for the generation of hydroxyl radicals. UV-based processes for the 
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generation of hydroxyl radicals have to be performed in glass, which should be 
avoided when working with (gadolinium) chelates [20, 23]. The pH was set to 7 by 
addition of NaOH (purchased from Sigma Aldrich, p.a.) to the pCBA stock solution. 
The determination of the formed product (formaldehyde from tBuOH) as well as the 
determination of the decrease of the competitor (pCBA) was performed by HPLC-UV 
(Agilent). The ratio of gadolinium vs. competitor concentration ranged from 1:1 to 
1:1000, depending on the metal chelate and the competitor used. All samples were 
prepared in PFA-bottles, to avoid reaction of ozone with PP and to avoid any effects 
due to glass contact [20, 23]. 
To prove the concept of the competition method applied for the determination of 
hydroxyl radical rate constants of gadolinium chelates the rate constant of pNBA was 
determined in the same way. pNBA was choosen as its rate constant is also known 
(kOH = 2.6  10
9 M-1s-1 [29]) and in the same range as the ones of the chelates. The 
degradation of pCBA in the presence of different ratios of pNBA was determined by 
HPLC-UV.  
 
The competition kinetics plot for the determination of the hydroxyl radical 
rate constants using pCBA as reference substance was modified. Instead of plotting 
([pCBA reaction product; without Gd chelate addition] / [pCBA reaction product; with addition of Gd chelate]) - 1 on 
the y-axis against the relation of gadolinium chelate to reference substance (pCBA) 
on the x-axis as it is the usual for such competition plots [30], ([pCBA initial] - [pCBA 
without addition of Gd chelate]) / ([pCBA initial] – [pCBA with addition of Gd chelate]) - 1 was used for the 
y- axis, to determine k OH, Gd chelate.  
Determinations of rate constants with tBuOH, another standard reference compound, 
where performed to verify results. For this method, another modification was 
necessary since in the reaction of gadolinium chelates with hydroxyl radicals, 
formaldehyde is formed as well as [unpublished results] in the reaction of tBuOH with 
hydroxyl radicals. Hence, a plot of another reaction product 
(2-hydroxy-2-methylpropanal) of tBuOH was chosen for the competition plot. It has to 
be noted, that peak areas were used instead of concentrations as there is no 
commercially available standard of 2-hydroxy-2-methylpropanal. 
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5.2.3 Toxicity tests 
Toxicity tests were performed for mixtures of all reaction products of each chelate. 
The chelates (0.1 mM) were treated with either ozone only (0.1 mM) or ozone 
(0.1 mM) and H2O2 (0.05 mM). Excess H2O2 was removed by addition of catalase 
from bovine liver, Sigma Aldrich (0.01 mg L-1 ~ 20-50 units). 
 
For cytotoxicity tests of reaction products from the reaction with 

OH, a well 
established mammalian cell line (Chinese hamster ovary (CHO-9)) was used. These 
cells were cultured in Ham’s F-12 medium (c.c.pro GmbH) supplemented with 10% 
fetal calf serum (FCS), 0.5% L-glutamine, and 0.5% gentamycin at 37°C under 5% 
CO2 and 95% humidity conditions. For cytotoxicity and estrogenity test (for 
experimental and results of estrogenity tests cf. 5.5.2) of reaction products from the 
reaction with ozone another mammalian cell line T47D cells (human breast 
carcinoma cells) were used. T47D cells were cultured in Dulbecco's Modified Eagle's 
Medium (DMEM) with phenol red supplemented with 41 mL FCS, 5 mL non-essential 
amino acids, and 3 mL gentamycin were used. Genotoxicity tests were performed 
with CHO-9 cells. 
 
For cytotoxicity tests, the inner wells of a 96 well plate were filled with 200 µL 
medium containing 104 CHO-9 or T47D cells per well. Outer wells were filled with 
200 µL PBS (Phosphate Buffered Saline) and afterwards the plates were incubated 
at 37°C for 24 h. For exposure, the medium was removed and 180 µL fresh medium 
and 20 µL sample were added to the cells which were further incubated at 37°C for 
another 24 h. After exposure, the medium was removed and 100 µL fresh medium as 
well as 10 µL MTT solution (0.5 mg 3-(4-dimethylthiazol-2-yl)-2,5-diphenyl-
tetrazoliumbromid dissolved in 1 mL PBS) were added. Cells were again incubated at 
37°C for 2 h. Then the supernatant was removed from the wells and 100 µL lysis 
solution (99.4 mL DMSO (dimethylsulfoxide), 0.6 mL acetic acid (100%) and 10 g 
SDS (Sodium dodecyl sulfate)) were added per well followed by 5 min incubation at 
room temperature and 5 min shaking. Afterwards absorbance was measured at 
595 nm with a TECAN GENios platereader (TECAN; Crailsheim, Germany). Triton-X 
100® in a ration of 1:10 into medium was used as a positive control. 
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For genotoxicity testing, 5  105 CHO-9 cells per 10 mL were seeded into 75 cm2 cell 
culture flasks and incubated at 37°C over night. Then cells were exposed to the 
negative control (1 mL sterile water, 9 mL medium, 10 µL Cytochylasin B), positive 
control (20 µL Mitomycin C, 9.98 mL medium, 10 µL Cytochylasin B) and samples 
(1 mL sample, 9 mL medium, 10 µL Cytochylasin B) for 24 h at 37°C, 5% CO2 and 
95% humidity. Afterwards the medium was removed and 10 mL new medium 
containing 10 µL Cytochylasin B was added for another 20 h before cells were 
washed with PBS, trypsinated and 8  104 cells were seeded on microscope slides 
covered with 4 mL of medium. After the cells attached to the microscope slide, the 
medium was removed and 5 mL of 0.075 M KCl solution were added for 5 min. 
Microscope slides were afterwards transferred to cooled methanol (-20°C) and stored 
at -20°C over night. For analysis, the DNA was stained with 
2-(4-carbamimidoylphenyl)-1H-indol-6-carboximidamid (DAPI). The Metafer 4 
software (MetaSystems; Altussheim, Germany) was used for the detection of 
micronuclei. Three individual tests were performed for each sample. 
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5.3 Results and discussion: 
The result of the determination kOzone, Gd-chelate is shown in Table 5.1 (detailed 
experimental results shown for Gd-BT-DO3A in Figure 5.2). The reaction of all three 
chelates is rather slow (< 50 M-1 s-1 cf. Table 5.1). A degradation via this pathway in 
wastewater treatment is thus of minor importance. A comparison of the results with 
the complex stability (cf. Table 5.1) shows that with decreasing stability of the 
chelates the rate constant for the reaction of the chelates with ozone increases. 
Hence, the more stable the gadolinium chelate, the slower the reaction with ozone. 
This is due to the nature of the complexes: The gadolinium ion binds to the free 
electrons in the carboxyl- and amino-groups of the ligand. Accordingly electrons are 
withdrawn from these groups. In a reaction with ozone, the amino groups are usually 
attacked due to their high electron density. Hence, the more stable the chelate, the 
more of the electron density is withdrawn from the amino groups and the less 
probable is an ozone attack. 
 
Figure 5.2: Results of the determination of the rate constant for the reaction of Gd-BT-DO3A 
(Gadovist) with ozone in a triplicate experiment (kobs = observed rate constant, η = stoichiometric 
coefficient for gadolinium in the reaction, kOzone = rate constant) 
Slope = - kobs  = ηkozone [Gd] = -0.0123  
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The rate constant for the reaction of the chelates with hydroxyl radicals was 
determined by four different methods: 
1. Generation of hydroxyl radicals by pulse radiolysis and determination of the 
rate constant by direct measurement of the degradation of the chelates 
(monitoring absorbance of transient products from the reaction of  
gadolinium chelates) 
2. Generation of hydroxyl radicals by pulse radiolysis and determination of the 
rate constant by competition kinetics using SCN¯ as competitor (monitoring 
the decrease of SCN2

¯ at 475 nm) 
3. Generation of hydroxyl radicals by the peroxone process and determination of 
the rate constant by competition kinetics with pCBA as reference substance 
4. Generation of hydroxyl radicals by the peroxone process and determination of 
the rate constant by competition kinetics with tBuOH as reference substance 
The results for the rate constant determination of Gd-BT-DO3A with hydroxyl radicals 
using the third method with pCBA as reference compound are shown in Figure 5.4. 
Results for the same compound using method 1 are shown in Figure 5.3. 
Furthermore, Figure 5.3 shows the absorption spectra and the time dependence of 
the absorbance at 270 nm for different molar gadolinium concentrations in case of 
Gd-DTPA. From a plot of the observed decay rate against the molar Magnevist 
concentration (cf. Figure 5.3) a rate constant of 2.6 ± 0.2 × 109 M-1 s-1 can be derived 
for the reaction with hydroxyl radicals. In a similar manner, rate constants of 
1.9 ± 0.7 × 109 and 4.3 ± 0.2 × 109 M-1 s-1 were derived for Gd-DTPA-BMA and 
Gd-BT-DO3A, respectively (for detailed calculations cf. chapter 5.5.1). 
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Figure 5.3: a) Transient absorption spectra observed after electron irradiation of N2O-saturated 
aqueous solutions of Gd-DTPA (Magnevist); concentration given in M. Inset: time dependence of the 
absorbance at 270 nm, for 5 different concentration levels of Gd-DTPA; b) Plot of kobs against 
Magnevist concentration. The slope yields a bimolecular rate constant of 2.6  0.2  10
9
 M
-1
 s
-1
 for the 
reaction hydroxyl radicals with Gd-DTPA (for a discussion of competition kinetics cf. 5.5.1)  
From competition kinetics in pulse radiolysis experiments, slope of the plot of 
(A0/A)475nm – 1 vs. [Gd]/[SCN¯] and the given rate constant of 

OH with SCN¯ the rate 
constant of Gd-DTPA with hydroxyl radicals,  
kOH + Gd-DTPAcomp = (2.4 ± 0.5) × 10
9 M-1 s-1 is obtained in good agreement with the 
direct determination. In similar manner, rate constants of 3.1 ± 0.5 × 109 and 
4 ± 0.5 × 109 M-1 s-1 were derived for Omniscan and Gadovist, respectively (for more 
details cf. chapter 5.5.1).  
In Figure 5.4 results for the rate constant determination of Gd-BT-DO3A with 
hydroxyl radicals in the peroxone process using pCBA as reference compound are 
presented. Rate constants of the other gadolinium chelates are presented in Table 
5.1. For Gd-DTPA further experiments were carried out using tBuOH as reference 
compound in the same processes. The determined rate constants using tBuOH 
(kOH + Gd-DTPA = 3.55 ± 1.75  10
6 M-1 s-1 ) differs greatly from the one determined by 
using pCBA as reference compound and determinations in pulse radiolysis 
experiments. 
Method 3 and 4 are very prone to errors, among others these are: 
 Variable exposure to hydroxyl radicals due to variation of the concentration of 
the ozone stock solution and dosage issues 
 Complex formation of (transformation products of) reference compounds with 
gadolinium 
 Further reaction of transformation products of reference compound and / or 
gadolinium chelates with hydroxyl radicals 
b) a) 
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The determined rate constants using the peroxone process differ by a factor of ~5 for 
Gd-DTPA and Gd-BT-DO3A from the ones obtained from pulse radiolysis studies for 
these chelates (cf. Table 5.1). Only for Gd-DTPA-BMA kOH is determined within the 
margin of error equally in all three methods. The correlation of the competition plot, 
as well as the deviation is rather low (cf. Figure 5.4). The residual standard deviation 
(RSD) for the determination of kOH for Gd-BT-DO3A and Gd-DTPA is 0.137, 
whereas for the determination of kOH + Gd-DTPA-BMA RSD is even higher (0.517). This is 
due to inconstant exposure to hydroxyl radicals. Variability of the ozone concentration 
(variation in concentration of the stock solution due to outgasing / temperature or 
dosage errors) in the sample vessels lead to inconstant yields of hydroxyl radicals 
and hence, in higher scattering of the measuring points. 
 
Figure 5.4: Results of the determination of the rate constant for the reaction of Gadovist with 
hydroxyl radicals (generated by peroxone process) by the use of pCBA as reference compound in a 
triplicate experiment; only the concentration of pCBA was determined and (([pCBAinitial]-[pCBAwithout 
addition of Gd chelate]) / ([pCBAinitial] – [pCBAwith addition of Gd chelate])) -1 was plotted instead of using ([pCBAreaction 
product; without Gd chelate addition] / [pCBA reaction product; with addition of Gd chelate]) -1 on the y-axis against the relation of 
gadolinium chelate to reference substance (pCBA) on the x-axis 
  
k•OH+ pCBA = 5  10
9
 M
-1 
s
-1
 
slope  = kOH + Gd-BT-DO3A / kOH, pCBA   =   0.1707 
kOH + Gd-BT-DO3A = 8.54 ± 1.17  10
8
 M
-1 
s
-1 
r
2
 = 0.974 
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In general, pulse radiolysis is the method of choice for determination of rate 
constants and both methods using pulse radiolysis yield the same rate constants. 
Therefore, it has been assumed that the results produced by method 1 and 2 (pulse 
radiolysis) are more reliable than those of methods 3 and 4 (peroxone based 
competition). To exclude that reaction products and / or pCBA form complexes with 
gadolinium which might lead to an underestimation of pCBA, experiments have been 
performed in which gadolinium chelate was added after the reaction of pCBA with 
hydroxyl radicals (equal pCBA concentration with and without addition of 
gadolinium chelate). These experiments have shown that no such transmetalation 
reactions have occurred, as the decrease of the pCBA concentration was the same 
with and without addition of gadolinium chelates (cf. Figure S 5.5). 
Owing to the deviation of results from pulse radiolysis and peroxone use, the concept 
to determine the rate constant of gadolinium by only monitoring the decrease of a 
reference compound was tested with a reference compound with a known rate 
constant. In this case the rate constant of pNBA was determined (cf. Figure 5.5).  
 
Figure 5.5: Test of the concept for the determination of the rate constants in the peroxone process: 
Reaction of pNBA with hydroxyl radicals (generated by peroxone process) by the use of pCBA as 
reference compound; only the concentration of pCBA was determined and {([pCBAinitial]-[pCBAwithout 
addition of pNBA]) / ([pCBAinitial] – [pCBAwith addition of pNBA])}-1 was plotted instead of using ([pCBAreaction product; 
without pNBA addition] / [pCBA reaction product; with addition of pNBA])-1 on the y-axis against the relation of pNBA to 
reference substance (pCBA) on the x-axis 
kOH + pCBA = 5 x 10
9
 M
-1 
s
-1
 
slope = kOH + pNBA / kOH + pCBA = 0.2511 
r
2
 = 0.903 
would yield: kOH + pNBA = 1.44 ± 0.62 x 10
9
 M
-1
s
-1 
However: kOH + pNBA = 2.6 x 10
9
 M
-1 
s
-1
 [4] 
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As it is clearly shown, a determination of the rate constant applying this method leads 
to an underestimation of the rate constant. Usually, such competition plots are based 
on the determination of two reaction products [31]. In this case, the decrease of the 
reference compound was measured and used for the calculation of the rate constant. 
An underestimation of the rate constant is due to the assumption that more reference 
compound (in this case pCBA) has reacted with hydroxyl radicals than it truly has. If 
the reaction is via stable intermediates and hence a complete reaction (, which 
should be observable for such competition kinetics) is not detectable by decreasing 
concentration of the reference compound (in this case pCBA), the reaction of the 
reference compound (pCBA) with hydroxyl radicals is overestimated. Thus rate 
constants are underestimated. This known error is typically not higher than a factor of 
two or three which is acceptable for most applications [3]. 
Concerning the rate constants for the reaction with hydroxyl radicals, a correlation 
with complex stability, as it was found for the reaction with ozone, was not observed. 
Yet one has to consider that the reaction pathway of hydroxyl radicals is different to 
the one of ozone. Hydroxyl radicals react usually by either H-abstraction or electron 
transfer. It is proposed that the reaction of the chelates occurs via H-abstraction, 
analog to the reaction of EDTA with hydroxyl radicals [16]. This is supported by 
increasing rate constants of Gd-DTPA-BMA < Gd-DTPA < Gd-BT-DO3A. Usually one 
might have expected Gd-DTPA to react slower than Gd-DTPA-BMA, as the +I effect 
of the two keto-groups in Gd-DTPA-BMA should increase electron density at the 
neighboring carbon atoms, making it more prone to attacks. However, the +I effect 
effect is hindered due to the binding of gadolinium to the keto-groups. Hence, 
electron density at the reactive center is lower than in the basic structure of Gd-
DTPA. For Gd-DTPA, which is charged -2, kOH is higher (2.6 ± 0.2  10
9 M-1 s-1) due 
to the high electron density.  
Interestingly, the reactivity of the chelates can be linked to complex stability in 
another way. For DTPA, rate constants and stability constants are available for four 
different metal chelates. The plot of rate constants for the reaction with 
hydroxyl radicals vs. the complex stability is shown in Figure 5.6. 
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Figure 5.6: Correlation of hydroxyl radical rate constant at pH = 7 and stability constant for different 
metal DTPA complexes (DTPA speciation: DTPA-H2
3-
) 
This plot (cf. Figure 5.6) endorses the statements made above. Lower electron 
density at the reactive centers due to complexation with the metals will lead to a 
decreased rate constant. A correlation of k and complex stability was not notable by 
comparing the different gadolinium ligand systems, as the ligands vary strongly in 
donating groups. 
The highest of the three determined rate constants is the one of Gd-BT-DO3A which 
can be explained by the presence of the glycol group. This functional group has a 
rate constant of 1.4  109 M-1 s-1 [35] which is an explanation for the high rate 
constant of 4.3 ± 0.2  109 M-1 s-1 for the chelate. 
 
Due to the great difference in rate constants, it is assumed, that the fraction of the 
Gd chelates which react with •OH is higher than the fraction, which reacts with ozone. 
Yet, in a wastewater matrix with 10 mg L-1 DOC only 0.01% of the •OH generated by 
ozone reactions will react with Gd-BT-DO3A. Rate constants and concentrations for 
this calculation were adapted from Pocostales et al. [11] and Nöthe et. al [10]. 
However, even though only this small percentage of the generated •OH is available 
for reaction with the Gd chelates these will be degraded by •OH to a large extent. 
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Using ozone and •OH exposure data from a wastewater treatment plant, with a DOC 
of 8 mg L-1 and a specific ozone dosage of 0.9 mg L-1 (mg L-1 DOC)-1, the chelates 
Gd-BT-DO3A, Gd-DTPA and Gd-DTPA-BMA will be reduced within 3 min to 6, 15 
and 22%, respectively. This high reduction rates are to a major extent due to the 
reactions with •OH. In such a wastewater matrix with 0.7 µg L-1 Gdtotal (highest 
measured concentration in a monitoring campaign of European WWTPs 
(cf. chapter 3), potentially 0.66 µg L-1 of gadolinium (assumed that all of Gdtotal is 
present as Gd-BT-DO3A) may be released from the chelate after such a treatment. 
 
The results of the toxicity experiments are displayed in Figure 5.7 - Figure 5.8. The 
products of the reaction with ozone show no significant cyto- and genotoxic effect in 
the applied test systems for all three tested chelates. 
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Figure 5.7: a) Results of cytotoxicity test (for detailed test method cf. 5.2.3) for all tested chelates 
([Gd] = 0.1 mM) before and (black) after reaction with ozone (hatched) ([ozone] = 0.1 mM); b) Results 
of the cytotoxicity test for two experiments with each 0.1 mM Gd, 0.1 mM ozone and 0.05 mM H2O2 
(for detailed test method cf. 5.2.3) for reaction products of all three tested diagnostics with 
hydroxyl radicals 
a) 
b) 
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Figure 5.8: Results of the genotoxicity test for two experiments with each 0.1 mM Gd, 0.1 mM ozone 
and 0.05 mM H2O2 (detailed test method in 2.3) for reaction products of all three tested diagnostics 
with hydroxyl radicals 
For the reaction with hydroxyl radicals (cf. Figure 5.7 and Figure 5.8) also no toxic 
effects were observable. Neither cytotoxic nor genotoxic effects were detected for all 
tested chelates before and after treatment compared to negative controls. 
The mixtures of all reaction products, which are generated in the oxidation reactions 
with either hydroxyl radicals or ozone, have been tested and not a single, separated 
transformation product. Hence, it is concluded that none of the reaction products 
causes any cyto- and genotoxic effects in the tested concentration. The concentration 
used for the toxicity tests was set very high in comparison to any concentration 
expected in a real wastewater matrix (< 6  10-9 M Gd, as gadolinium chelates and / 
or Gd(III) (cf. chapter 3), to ensure that even minor effects of reaction products would 
be detectable in the toxicity tests. Since no effects have been detected in the applied 
tests, no further and / or more specific tests have been performed. 
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5.4 Conclusion 
It is concluded that degradation of gadolinium chelates via ozone is very slow and 
rather ineffective for their removal. However, degradation via hydroxyl radicals is very 
fast - almost diffusion controlled. This degradation pathway has only been 
investigated for other, smaller chelates before [12].  
Yet it has to be emphasized that degradation of these chelates is not desirable, in 
contrast to many organic trace substances. The chelates are very stable and 
degradation of these chelates might in principle lead to a release of the toxic non-
complexed Gd(III) ion, although such an effect of free gadolinium was not detectable 
in the applied toxicity tests.  
Furthermore, one has to consider that also the reaction products of the chelates may 
serve as ligands capable of binding the gadolinium ions. Yet it is unknown which new 
chelates are formed and how stable these are. Transformation products like IDA, 
which arises from ozonation of Fe-EDTA [16], forms less stable chelates with 
gadolinium (log K([Gd-EDTA]/[Gd][EDTA] = 17.4 [31] and  
log K([Gd-IDA]/[Gd][IDA] = 6.7 [31]). Hence, transmetalation may be facilitated. 
Transmetalation reactions may occur in flocculation processes for water treatment, 
but are rather unlikely in the environment. These reactions may lead to an 
incorporation of iron used in the flocculation process into the complex and a release 
of gadolinium due to a shift in the equilibrium (increased concentration of e.g. Fe(III)). 
For aluminum, which is also used as flocculant, the complex stability constants with 
the ligands in the diagnostics are smaller than the ones of gadolinium.  
It is proposed, that further research on newly formed metal-ligand-systems, 
especially on their stability, in hydroxyl radical based oxidation processes is needed. 
The bioavailability of metals might change due to newly formed complexes during 
oxidation steps in wastewater treatment. Furthermore, metal transport in the 
environment might be influenced. 
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5.5 Supplement 
5.5.1 Details for determination of rate constants 
 
Figure S 5.1: a) Transient absorption spectra observed after electron irradiation of N2O-saturated 
aqueous solutions of Gd-BT-DO3A, concentration is given in M; b) time dependence of the 
absorbance at 270 nm, for 5 different concentration levels of Gd-BT-DO3A. 
b) 
a) 
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Figure S 5.2: a) Plot of kobs against Gadovist concentration; the slope yields a bimolecular rate 
constant of 4.3 ± 0.2 × 10
9
M
-1
 s
-1
 for the reaction of hydroxyl radicals with Gd-BT-DO3A;                     
b) Competition kinetics, the plot of (A0/A)475nm – 1 vs. [Gd]/[SCN¯] and the known rate constant of 
kOH + SCN¯ = 1.1 × 10
10
 M
-1
 s
-1
 [29] yields a bimolecular rate constant of 4 ± 0.4 × 10
9
 M
-1
 s
-1
 for the 
reaction of hydroxyl radicals with Gd-BT-DO3A 
a) 
b) 
M-1s-1 
M-1s-1 
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Figure S 5.3: a) Transient absorption spectra observed after electron irradiation of N2O-saturated 
aqueous solutions of Gd-DTPA-BMA (Omniscan), concentration given in M; b) Time dependence of 
the absorbance at 270 nm, for 5 different concentration levels of Gd-DTPA-BMA 
b) 
a) 
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Figure S 5.4: a) Plot of kobs against Omniscan concentration; the slope yields a bimolecular rate 
constant of 1.9 ± 0.7 × 10
9
 M
-1
 s
-1
 for the reaction of hydroxyl radicals with Gd-DTPA-BMA.                 
b) Competition kinetics; plot of (A0/A)475nm – 1 vs. [Gd]/[SCN¯] and the known rate constant of 
kOH + SCN¯ = 1.1  10
10
 M
-1
 s
-1
 [29] yields a bimolecular rate constant of 3 ± 0.5 × 10
9
 M
-1
 s
-1
 for the 
reaction of hydroxyl radicals with Gd-DTPA-BMA. The small discrepancy of the competition value in 
comparison with the direct determination is still within margin of error 
 
 
b) 
a) 
M-1s-1 
M-1s-1 
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Figure S 5.5: Results of the experiment to verify if pCBA transformation products form complexes with 
gadolinium, to exclude that reaction products and / or pCBA form complexes with gadolinium, which 
might lead to an underestimation of pCBA, experiments have been performed, in which gadolinium 
chelate was added after the reaction of pCBA with 
•
OH (equal pCBA concentration with and without 
addition of gadolinium chelate). For this, Gd-DTPA was added after the addition of ozone, which 
initiates hydroxyl radical formation in the peroxone process. Hence, if pCBA was underestimated due 
to such complexation reactions, a decrease should be observable with increasing chelate addition 
  
146 
 
5.5.2 Estrogenity tests 
Eventhough an estrogen disrupting effect of oxidation reaction products is rather 
unlikely due to the structure of the parent compound, also estrogenic activity has 
been evaluate by applying a cell assay. The estrogenicity was investigated by using 
the ER Calux test (BioDetections Systems; Amsterdam, NL). For 
this, 1 × 104 T47D cells in 100 µL DMEM medium without phenol red were seeded 
into each inner well of a 96-well plate. The outer wells were filled with 200 µL PBS. 
After seeding, cells were incubated for 24 h at 37°C and 5% CO2. Then the medium 
was changed and cells were incubated for further 24 h. To expose cells to 
the 17β-estradiol standard series, medium and water were mixed at a ratio of 1:10. 
The final concentration of the standards in the wells was 
between 0 and 30 pM 17β-estradiol. The exposure medium for the gadolinium 
samples contained 1% DMSO and the exposure of the samples was then done at a 
ratio of 1:10 (90 µL medium containing 1% DMSO and 10 µL sample). After exposure 
the cells were incubated at 37°C and 5% CO2 for further 24 h. Each standard as well 
as the gadolinium sample were tested in triplicate. After 24 h of exposure of the T47D 
cells to the 17β-estradiol standards and the gadolinium samples the medium was 
removed, 50 µL lysis solution were added into each well and the plate was incubated 
at room temperature for 15 min. Then 30 µL supernatant were transferred into a 
white 96-well plate and after the addition of 30 µL GlowMix containing luciferin the 
luminescence was measured.  
Results of the ER Calux are presented in Figure S 5.6. The assumption, that no 
estrogen disrupting effect should be detectable could be verified by the outcome of 
the test. The test results of the oxidized samples do not differ from the ones of a 
negative control. 
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Figure S 5.6: Results of estrogenicity test (detailed test method in 2.3) for all tested chelates;            
a) positive controls; b) negative control and samples ([Gd] = 0.1 mM) before and (black) after reaction 
with ozone (hatched) ([O3] = 0.1 mM) 
 
  
a) 
b) 
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6 Concluding Remarks and Future Perspectives 
In the studies presented in this work it was demonstrated that gadolinium, in detail 
chelated gadolinium, has become a relevant substance in the water cycle. Monitoring 
campaigns in wastewater and drinking water have been performed. An average 
concentration of 118 ng L-1 gadolinium has been determined in a European 
monitoring campaign of wastewater treatment plant effluents, with a corresponding 
average anomaly of 69, which represents an anthropogenic gadolinium concentration 
of 116 ng L-1. By this European monitoring campaign it could be shown that 
anthropogenic gadolinium, which is assumed to be gadolinium in chelated from [1], is 
present in concentrations relevant for wastewater treatment. The results from a 
drinking water campaign in the Ruhr area, which is a densely populated region in 
western Germany with a high re-use rate of water, have shown that also in this water 
matrix the anomaly is detectable. The average gadolinium concentrations in this area 
were by a factor of 5 lower than the average concentrations in the investigated 
wastewater samples. Hence, gadolinium chelates are also found in drinking water 
and are as well affected by drinking water treatment processes. The determined 
concentrations are by orders of magnitude lower than acute toxic effect 
concentrations and ecotoxicological endpoints (e.g. EC50 for Gd-DTPA is 
0.18 mmol L-1 [2], which is 1.1 µg L-1 gadolinium). It is not known in which speciation 
gadolinium is present in the investigated samples, as only total element concentration 
has been determined. However, this speciation is of great importance when 
evaluating toxicological relevance. The Gd(III) ion is by orders of magnitude more 
toxic than the chelated form and the same applies for the ligands. Long term studies 
on toxicity of both Gd(III) and its chelated form are missing. In drinking water even 
lowest level concentrations of such micropollutants could be of concern, especially if 
it cannot be ruled out that applied treatment steps, such as flocculation, may change 
speciation of gadolinium into a more toxic form. 
 
To gain insight on water treatment processes which may change the speciation 
oxidation reactions of gadolinium chelates were investigated for both ozone and 
hydroxyl radicals. In drinking water ozonation, the reaction pathway via ozone is 
dominant because radical scavengers, such as bicarbonate, are present in high 
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concentration. Rate constants have been determined for three chemically different 
types of representative gadolinium chelates. For all three chelates, the rate constants 
were < 50 M-1s-1. Hence, the chelates are considered to be ozone refractory. This is 
mainly due to the electron withdrawing effect of gadolinium. Electrons of functional 
groups which are usually prone to electrophilic attack of ozone (e.g. amines) are 
incorporated in the binding of gadolinium and in consequence they are not available 
for such an attack. From determination of rate constants for ozone reactions it has 
been concluded that a reaction of these chelates via the ozone reaction pathway is 
rather unlikely and gadolinium chelates will stay intact during wastewater and 
drinking water treatment. For determination of reaction rate constants with 
hydroxyl radicals, several different methods were applied, and yielded comparable 
results. The rate constants for the representative gadolinium chelates have shown 
that the reactions are almost diffusion controlled (> 109 M-1 s-1). These high rate 
constants make a reaction feasible even in highly competitive matrices. It is 
concluded that in wastewater treatment a reaction of gadolinium chelates with 
hydroxyl radicals will occur. Taking a typical wastewater matrix into account, 
oxidation of 0.7 µg L-1 Gd, (, which was the highest measured gadolinium 
concentration in the European monitoring campaign) would yield 0.66 µg L-1 reacted 
chelate (assumed that all gadolinium is present as Gd-BT-DO3A, which had the 
highest measured rate constant). However, also low concentration levels might be of 
concern. Therefore, information on gadolinium speciation and long-term studies on 
toxicity are needed.  
 
The evaluation of adsorption processes for removal of gadolinium chelates from 
water has shown that adsorption strength of the investigated chelates is rather low. 
The chelates have KF values for adsorption on activated carbon similar to iopamidole, 
an X-ray contrast agent which is insufficiently removable by activated carbon [3]. 
Furthermore, synthetic activated polymers have been tested as adsorbent. Applying 
these, better adsorption could be achieved. However, one has to consider the high 
costs for such materials. Additional to the determination of bottle point isotherms, 
filtration experiments in drinking water matrix have been performed to evaluate the 
behavior of the chelates in filters. Again adsorption was rather poor and breakthrough 
of the chelates occurred early. The breakthrough behavior could be explained by 
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application of the Linear Driving Force model (LDF). A filter competition effect, 
different to the direct competition effect could be shown by using the LDF model.  
The direct competition effect is included in adsorption isotherm data, determined by 
bottle point isotherms in drinking water. The additional filter competition effect is due 
to competition of each fraction of the water matrix (from very well adsorbable to very 
poorly adsorbable) for each filter layer which is proceeding over the whole operation 
period with constant gadolinium and matrix feed. Furthermore, to support the results 
from lab scale experiments, samples were taken in a WWTP equipped with an 
activated carbon filter. The results of these first investigations indicated that the 
adsorption is as poor as expected. The breakthrough occurs even earlier than in a 
worst case scenario prediction for treatment of hospital wastewater. From data of lab 
scale experiments, as well as from the investigations at the WWTP, it is concluded 
that a removal of gadolinium chelates via adsorption on activated carbon in 
wastewater, as well as in drinking water, is negligible. Due to the poor adsorbability of 
gadolinium chelates, it is possible to use it as indicator compound for determination 
of filter breakthrough. This would allow even earlier breakthrough detection than by 
monitoring organic substances like atrazine. 
 
For future research it is necessary to have a reliable speciation method for 
quantification of lowest gadolinium concentrations. The speciation of gadolinium in 
the environment has not been performed up to date [4]. Only a pseudo-speciation by 
the gadolinium anomaly is performed. However, a sensitive speciation method is 
needed to fully understand environmental behavior of gadolinium. Research on 
oxidation of the chelates during water treatment pointed out the relevance of such 
speciation methods. It has been possible to determine kinetics of oxidation reactions, 
both via ozone and hydroxyl radicals. By the applied cytotoxicity and genotoxiciy and 
estrogenity tests, no toxic transformations products were determined. Yet it has to be 
considered, that the chosen tests are not a full toxicological assessment, but rather a 
screening. Reaction products other than formaldehyde during the reaction with 
hydroxyl radicals were not identified. It is expected that similar or even the same 
reaction products are formed as in the reaction of structural related chelates, like 
Fe-EDTA or Fe-DTPA, with hydroxyl radicals. These reaction products are, among 
others, formaldehyde and iminodiacetic acid [5]. However, speciation of the central 
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ion after such oxidation reactions has not been performed. It is most likely that the ion 
forms new chelates with ligands formed during oxidation. These newly formed 
chelates may have lower stability constants than the original chelates which benefits 
transmetalation. This effect might even be stronger in a wastewater matrix. It is 
pointed out that this may be of interest for all other chelates present in a wastewater 
matrix as well, consequently changing metal transport as well as bioavailability. 
Research, considering these effects is strongly recommended.  
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7 Appendix 
7.1 Abbreviations 
 
Symbol / 
Abbreviation 
Quantity name or names 
3D Three-dimensional 
A Absorbance 
AAS Atomic absorption spectroscopy 
AC Activated carbon 
ACN Acetonitrile 
BET Brunauer, Emmett, and Teller isotherm 
Bo Bochum 
Bot Bottrop 
BV Bed volumes 
C Competitor 
c0 Initial concentration 
CAT Computed axial tomography 
CE Capillary electrophoresis 
CHO Chinese hamster ovary 
CT Computer tomography 
D Düsseldorf 
DALE Disability-adjusted life expectancy 
DALY Disability-adjusted life year 
DAPI 2-(4-carbamimidoylphenyl)-1H-indol-6-carboximidamid 
di Inner diameter 
DL Diffusion coefficient 
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Symbol / 
Abbreviation 
Quantity name or names 
DMEM Dulbecco's modified eagle's medium 
DMSO Dimethylsulfoxide 
DNA Deoxyribonucleic acid 
Do Dortmund 
DOC Dissolved organic carbon 
DOTA 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid 
dP Particle diameter 
DTPA Diethylene triamine pentaacetic acid 
Du Duisburg 
E Essen 
ɛ Bed porosity 
ε Molar absorption coefficient 
EC50 Half maximal effective concentration 
E2 17β estradiol 
EE2 17α Ethinylestradiol 
EDTA Ethylenediaminetetraacetic acid 
ESI Electrosray ionization 
Eq Equation 
FCS Fetal calf serum 
GAC Granulated activated carbon 
GC Gaschromatography 
Gd-BOPTA 
Gadolinium(III) 2-[2-[2-[bis(carboxylatomethyl)amino]ethyl-
(carboxylatomethyl)amino] ethyl-(carboxylatomethyl)amino]-3-
phenylmethoxypropanoate;hydron 
Gd-BT-DO3A 
Gadolinium(III) 2,2',2''-(10-((2R,3S)-1,3,4-trihydroxybutan-2-yl)-1,4,7,10-
tetraazacyclododecane-1,4,7-triyl)triacetate 
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Symbol / 
Abbreviation 
Quantity name or names 
Gd-DTPA-BMA 
Gadolinium (III) 5,8-bis(carboxylatomethyl)-2-[2-(methylamino)-2-oxoethyl]-10-oxo-
2,5,8,11-tetraazadodecane-1-carboxylate hydrate 
Gd-DTPA-BMEA 
Gadolinium(III) 2-[bis[2-[carboxylatomethyl-[2-(2-methoxyethylamino)-2-
oxoethyl]amino] ethyl]amino]acetate  
Gd-EOB-DTPA 
Disodium;2-[[(2S)-2-[bis(carboxymethyl)amino]-3-(4-ethoxyphenyl)propyl]-[2-
[bis(carboxymethyl)amino]ethyl]amino]acetic acid gadolinium 
Gd-HP-DO3A 
Gadolinium(III) 2-[4,7-bis(carboxylatomethyl)-10-(2-hydroxypropyl)-1,4,7,10-
tetrazacyclododec-1-yl]acetate 
Gd-MS-325 
Trisodium 2-[[(2R)-2-[bis(2-oxido-2-oxoethyl)amino]-3-[(4,4-
diphenylcyclohexyl)oxy-oxidophosphoryl]oxypropyl]-[2-[bis(2-oxido-2-
oxoethyl)amino]ethyl]amino]acetate gadolinium(III) hydrate 
Ge Gelsenkirchen 
Her Herne 
HPLC High performance liquid chromatography 
HILIC Hydrophobic interaction liquid chromatography 
HPLC High-performance liquid chromatography 
HSDM Homogeneous surface diffusion model 
IAST Ideal adsorbed solution theory 
IC Ion chromatography  
ICP Inductive coupled plasma 
k Reaction rate constant 
KF Freundlich coefficient 
kf Liquid-phase mass transfer coefficient 
LD50 Median lethal dose 
LDF Linear driving force 
LOD Limit of detection 
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Symbol / 
Abbreviation 
Quantity name or names 
LOQ Limit of quantification 
LSF Large scale filter 
m Mass 
MBR Membrane bioreactor 
MEKC Micellar electrokinetic chromatography 
Mh Mülheim 
MRI Magnetic resonance imaging 
MS Mass spectrometry 
MTT 3-(4-dimethylthiazol-2-yl)-2,5-diphenyltetrazoliumbromid 
MUQ Mud from Queensland 
MW Molecular weight 
n Freundlich exponent 
η Stoichiometric number 
NASC North American shale composite 
NMR Nuclear magnetic resonance 
NOEC No observed effect concentration 
NTA Nitrilotriacetic acid 
Ob Oberhausen 
OECD Organisation for economic co-operation and development 
OES Optical emission spectrometry 
Ox Oxidant 
obs Observed 
P Probe compound 
P Particle density 
p.a. Pro analysis 
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Symbol / 
Abbreviation 
Quantity name or names 
PAC Powdered activated carbon 
PAAS Achaean Australian shell 
Pbutanol/water Partitioning coefficient between butanol and water 
PBS Phosphate buffered saline 
pCBA para-Chlorobenzoic acid 
PET Positron emission tomography 
pKa Acid dissociation constant 
pNBA para-Nitrobenzoic acid 
PFA Perfluoroalkoxy 
PP Polypropylene 
PSF Pilot scale filter 
PVC Polyvinyl chloride 
QSAR Quantitative structure activity relationship 
R Electrical resistence 
r Relaxivity 
REE Rare earth element 
REACH Registration, Evaluation, Authorization and Restriction of Chemicals 
RSD Residual standard deviation 
SDS Sodium dodecyl sulfate 
SEC Size-exclusion chromatography  
SMILES Simplified molecular input line entry system 
SPE Solid phase extraction 
T Temperature 
t Time 
T1 Spin-lattice relaxation time  
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Symbol / 
Abbreviation 
Quantity name or names 
T2 Spin spin relaxation time 
1/T1 Longitudinal relaxation rates 
1/T2 Transverse relaxation rates 
tBuOH tertiary-Butanol 
Tobs Observed solvent relaxation rate 
TXRF Total reflection X-ray fluorescence 
US EPA Environmental protection agency of the United States of America 
UV Ultra violet light 
V Volume 
 v Flow 
vf Filter velocity 
VIS Visible light 
WHO World Health Organization 
WWTP Wastewater treatment plant 
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